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Advisory Professor: Laurence Court, Ph.D. 
 
 The purpose of this work was to determine if prediction models using quantitative imaging 
measures in head and neck squamous cell carcinoma (HNSCC) patients could be improved when noise 
due to imaging was reduced. This was investigated separately for salivary gland function using dynamic 
contrast enhanced magnetic resonance imaging (DCE-MRI), overall survival using computed 
tomography (CT)-based radiomics, and overall survival using positron emission tomography (PET)-based 
radiomics. From DCE-MRI, where T1-weighted images are serially acquired after injection of contrast, 
quantitative measures of diffusion can be obtained from the series of images. Radiomics is the study of 
the relationship of voxels to one another providing measures of texture from the area of interest. 
Quantitative information obtained from imaging could help in radiation treatment planning by 
providing quantifiable spatial information with computational models for assigning dose to regions to 
improve patient outcome, both survival and quality of life. By reducing the noise within the quantitative 
data, the prediction accuracy could improve to move this type of work closer to clinical practice. 
 For each imaging modality sources of noise that could impact the patient analysis were 
identified, quantified, and if possible minimized during the patient analysis. In MRI, a large potential 
source of uncertainty was the image registration. To evaluate this, both physical and synthetic 
phantoms were used, which showed that registration of MR images was high, with all root mean square 
errors below 3 mm. Then, 15 HNSCC patients with pre-, mid-, and post-treatment DCE-MRI scans were 
evaluated. However, differences in algorithm output were found to be a large source of noise as 
different algorithms could not consistently rank patients as above or below the median for quantitative 
metrics from DCE-MRI. Therefore, further analysis using this modality was not pursued. 
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 In CT, a large potential source of noise that could impact patient analysis was the inter-scanner 
variability. To investigate this a controlled protocol was designed and used to image, along with the 
local head and chest protocols, a radiomics phantom on 100 CT scanners. This demonstrated that the 
inter-scanner variability could be reduced by over 50% using a controlled protocol compared to local 
protocols. Additionally, it was shown that the reconstruction parameters impact feature values while 
most acquisition parameters do not, therefore, most of this benefit can be achieved using a radiomics 
reconstruction with no additional dose to the patient. Then to evaluate this impact in patient studies, 
726 HNSCC patients with CT images were used to create and test a Cox proportional hazards model for 
overall survival. Those patients with the same imaging protocol were subset and a new Cox 
proportional hazards model was created and tested in order to determine if the reduction in noise due 
to controlling the imaging protocol translated into improved prediction. However, noise between 
patient populations from different institutions was shown to be larger than the reduction in noise due 
to a controlled imaging protocol. 
 In PET, a large potential source of noise that could impact patient analysis was the imaging 
protocol. A phantom scanned on three different scanners and vendors demonstrated that on a single 
vendor, imaging parameter choices did not affect radiomics feature values, but inter-scanner variances 
could be large. Then, 686 HNSCC patients with PET images were used to create and test a Cox 
proportional hazards model for overall survival. Those patients with the same imaging protocol were 
subset and a new Cox proportional hazards model was created and tested in order to determine if the 
reduction in noise due to controlling the imaging protocol on a vendor translated into improved 
prediction. However, no predictive radiomics signature could be determined for any subset of the 
patient cohort that resulted in significant stratification of patients into high and low risk. 
 This study demonstrated that the imaging variability could be quantified and controlled for in 
each modality. However, for each modality there were larger sources of noise identified that did not 
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allow for improvement in prediction modeling of salivary gland function or overall survival using 
quantitative imaging metrics for MRI, CT, or PET.  
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Chapter 1 : Introduction 
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide 
with more than 500,000 new cases annually [1]. The standard of care for HNSCC patients includes 
radiation therapy. Over a 40-year span with advances in radiation therapy and other cancer treatment 
modalities, the 5-year survival has improved from 53% in 1975 to 69% in 2010 [2]. However, radiation 
therapy also impacts normal tissues. Xerostomia, salivary gland dysfunction which adversely impacts 
swallowing and taste (and thus eating) as well as speech, is common due to the proximity of the normal 
tissue structures to the tumor: over 90% of patients suffer from xerostomia during treatment and 68% 
still suffer two years after treatment even with modern treatments like intensity modulated radiation 
therapy [3]. While there have been improvements in patient survival and localization of radiation to 
reduce xerostomia, there is evidence that quantitative imaging could further improve these. Dynamic-
contrast enhanced magnetic resonance imaging (DCE-MRI) and radiomics have shown potential in 
being able to do this. 
The current radiation treatment plan standard of care for HNSCC uses one assigned dose to the 
tumor and one dose to stay below for each normal tissue structure to avoid toxicity, ignoring the 
known heterogeneity in these tissues. Quantitative information obtained from imaging could help in 
radiation treatment planning by providing quantifiable spatial information with computational models 
for assigning dose to regions to improve patient outcome.  
In this dissertation we examined three different approaches to understanding and predicting 
patient outcomes from radiotherapy: DCE-MRI for salivary gland function, CT-based radiomics for 
overall survival, and PET-based radiomics for overall survival. In each case we first examined the 
expected major sources of uncertainty, before examining whether these approaches could provide 
additional information to inform clinical decision making by improving prediction models that included 
quantitative imaging metrics. 
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DCE-MRI 
DCE-MRI is a noninvasive tool for examination of the microvasculature of tumors and normal 
tissue which uses T1-weighted MRI scans acquired serially after injection of a contrast agent. The 
perfusion and permeability metrics estimated from pharmacokinetic modeling of DCE-MRI data may 
provide an indirect measure of tumor hypoxia, a condition associated with poor prognosis in HNSCC [4, 
5]. Therefore, it may be possible to build prognostic models to help tailor HNSCC treatments to 
individual patients based on that patient’s DCE-MRI signature. Investigators have used DCE-MRI to 
assess therapeutic response of HNSCC and have shown associations between DCE-MRI metrics and 
changes in salivary glands and mandible [6-11].  
Additionally, a sub-region within the parotid glands was identified which was directly 
associated with salivary gland function after one year [12]. This region is believed to be the stem cell 
region of the parotid gland, thus the spatial relationship of dose within the salivary glands is important. 
As patient quality of life is one of the primary concerns after radiation therapy, identifying an individual 
patient’s risk for developing normal tissue complications is vital to creating and adapting individualized 
radiation therapy plans and determining interventions to mitigate negative effects. Previous studies 
have only assessed DCE-MRI of parotid glands post-treatment using global metrics, e.g. mean. With the 
knowledge of this stem cell region within parotid glands and the ability of DCE-MRI to quantitatively 
describe the microvasculature, this could allow voxel-based tracking of these DCE-MRI parameters in 
the salivary glands to further define the parotid stem cell region for patients. This would allow 
improved guidelines for normal tissue doses in salivary glands which would result in improved patient 
quality of life. 
 
Radiomics 
Radiomics involves evaluating images on a voxel level to extract quantitative image features 
(i.e. texture). This process relies on the assumption that there is more information contained within the 
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images than the human eye can extract and these textures and patterns are related to the gene 
microenvironment within that tumor or tissue [13]. Interest in radiomics has grown as radiomics 
features have been shown to improve survival models when combined with conventional prognostic 
factors (e.g., age) [14-21]. 
Radiomics studies have primarily been conducted on images from non-small cell lung cancer 
(NSCLC) patients. Using computed tomography (CT) images, Fried et al. were able to identify radiomics 
features that significantly improved risk stratification compared to conventional prognostic factors 
alone for overall survival, locoregional control, and freedom from distant metastases [22]. Similarly, 
Fave et al. were able to identify radiomics and delta-radiomics features that significantly improved risk 
stratification [14]. Thawani et al. summarized 11 CT radiomics studies using NSCLC patients where each 
study chose a different assortment of radiomics features to study, all found at least one radiomics 
feature that created a significant model related to survival [23]. Radiomics studies in NSCLC have found 
similar results using positron emission tomography (PET) images: Fried et al. were able to identify 
radiomics feature correlated with survival and additionally use it to identify subgroups of patients who 
did or did not receive a benefit from dose escalation [15, 24]; and Cook et al. summarized four other 
studies that also found radiomics features associated with patient outcomes [25].  
This analysis has more recently transferred into head and neck patients. Studies using CT 
images of head and neck patients have found radiomics features significantly associated with local 
control, tumor failure, overall survival, and human papillomavirus (HPV) status [17, 18, 20, 26-29]. 
Similar findings using PET images of head and neck patients have been found where radiomics features 
were significantly associated with local control, tumor failure, overall survival, and freedom from 
distant metastases [18, 29-31]. 
However, there are known imaging protocol variabilities that can add noise to patient cohorts 
in studies. For CT images, the impacts of differences in kernel, pixel size, image thickness, and tube 
current have been studied [32-38]. For parameters such as pixel size, it has been shown that resampling 
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can reduce imaging differences [32, 37], while for parameters such as the reconstruction kernel, it has 
been shown that combining patient data that includes both sharp and smooth kernels can lead to large 
discrepancies [34]. For PET images, acquisition and reconstruction parameters have been shown to 
impact radiomics features; particularly, the number of iterations, matrix size, and smoothing filter have 
demonstrated variability, mostly in lung patient cohorts [39-49]. Reuzé et al. even demonstrated that 
models using radiomics features developed on one scanner may not be applicable to images from a 
different scanner [50]. 
 Radiomics studies require large patient cohorts to power the modeling process. Due to this, 
images acquired under different imaging protocols from the same institution or different institutions 
are included in a patient cohort. If a protocol could be designed to minimize the known imaging 
protocol variabilities, this would reduce the noise within a patient cohort. This would likely result in 
improved patient outcome modeling performance. 
 
Study Goal 
 The goals of this study were to determine if DCE-MRI parameters could be correlated with 
salivary gland dose response on a voxel basis, and to determine if minimizing CT and PET imaging 
protocol variabilities improves patient outcome modeling when using radiomics features. The DCE-MRI 
parameters would allow to better define salivary gland dose limits when creating patient treatment 
plans. If radiomics models could be improved by reducing the noise in the patient cohorts through 
imaging protocols, this would encourage others to focus on only including patients whose imaging 
protocols matched, thus producing better studies and allowing radiomics to approach use within clinics. 
These two quantitative measures, DCE-MRI and radiomics, were used to investigate improving both 
salivary gland function models and overall survival models. 
  
 
5 
 
Chapter 2 : Purpose and Central Hypothesis 
Central Hypothesis: 
DCE-MRI parameter changes during treatment are associated with salivary gland toxicity and pre-
treatment CT and PET-based radiomics features are predictive of patient outcome in HNSCC. 
Specific Aim 1: Determine DCE-MRI parameters associated with salivary gland dose response. 
Specific Aim 1 Hypothesis: DCE-MRI parameters at pre- and mid-treatment time points are associated 
with normal tissue outcomes. 
 Project 1.1: Determine the uncertainty in MRI-to-MRI deformable image registration. 
Project 1.2: Identify DCE-MRI parameters associated with dose response in salivary glands. 
Specific Aim 2: Identify imaging protocols that minimize variability in CT-based radiomics features to 
improve patient outcome models. 
Specific Aim 2 Hypothesis: Reducing the variability in CT-based radiomics features due to imaging 
protocols improves prediction accuracy when these features are used in HNSCC patient outcome 
models (overall survival, local-regional control, and freedom from distant metastases). 
Project 2.1: Evaluate the variability in CT-based radiomics features due to tube voltage, 
artifacts in the head and neck region, and inter-scanner variability. 
Project 2.2: Determine CT-based radiomics features predictive of patient outcome. 
Specific Aim 3: Determine imaging protocols that minimize variability in PET-based radiomics features 
to improve patient outcome models. 
Specific Aim 3 Hypothesis: Reducing the variability in PET-based radiomics features due to imaging 
protocols improves prediction accuracy when these features are used in HNSCC patient outcome 
models. 
 Project 3.1: Evaluate inter-scanner variability of PET-based radiomics features. 
Project 3.2: Identify PET-based radiomics features predictive of patient outcome.  
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Chapter 3 : Magnetic Resonance Imaging Registration Uncertainty 
This chapter is based upon: 
Ger RB, Yang Y, Ding Y, Jacobsen MC, Fuller CD, Howell RM, Li H, Stafford RJ, Zhou S, Court LE. Accuracy 
of Deformable Image Registration on Magnetic Resonance Images in Digital and Physical Phantoms. 
Medical Physics doi: 10.1002/mp.12406. Volume 44, Issue 10, Pages 5153-5161. ©Wiley. 
The permissions for reuse of these materials were obtained from Wiley. 
 
3.1 Introduction 
The use of MRI has increased because it allows for non-invasive evaluation of patients without 
ionizing radiation and provides superior soft tissue contrast in comparison with CT. With these 
attributes, MRI has great potential for use in longitudinal studies [9, 10, 51-53]. A longitudinal study is 
when data is acquired for the same subjects over a period of time and may have different designs 
based on the type of study, such as prospective or retrospective [54]. An example of a prospective 
longitudinal study is the recent DCE-MRI study evaluating mandible changes in patients that were 
scanned before chemoradiotherapy treatment started, 3-4 weeks after initiation of treatment, and 6-8 
weeks after treatment concluded [55]. An example of a retrospective longitudinal study is the recent 
delta radiomics study on non-small cell lung cancer patient outcome predictions [14]. However, for MRI 
to be useful in the setting of longitudinal studies, accurate deformable image registration is needed. 
Many commercial and in-house image registration systems have been benchmarked using CT 
[56-61]. For MRI, various in-house algorithms have been validated for different anatomic sites, 
including the liver [62, 63], prostate [64-66], and breast [67, 68]. However, image registration error on 
commercial software using MRI has not been widely reported. A b-spline-based commercial software, 
Velocity (Velocity AI version 3.0.1, Varian Medical Systems, Palo Alto, CA), has been evaluated for CT-
based image registration and shown to have an average registration error below 5 mm [57, 69-73]. In 
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addition, our in-house demons-based algorithm has been validated for CT with registration error below 
2 mm [58, 59, 74]. Both systems are used for MRI applications, but have not been validated for this use. 
The current study aimed to evaluate two registration systems, Velocity commercial deformable 
image registration software and an in-house demons-based algorithm, for MRI. This was accomplished 
using synthetic images derived from patient longitudinal deformations and a phantom with implanted 
markers. 
 
3.2 Methods and Materials 
The deformable image registration uncertainty of the two registration systems was evaluated 
using two methods: synthetic images and a porcine phantom. 
 
3.2.1 Porcine Phantom 
 Porcine meat was implanted with ten 0.35mm gold markers. These markers are currently the 
smallest commercially available gold markers and therefore do not appear in the MR images for the 
imaging protocol used. This allowed for accurate assessment of the imaging registration error. If the 
markers appeared on the image they could bias the registration at those points leading to inaccurate 
registration error estimates. 
The porcine tissue was placed in a plastic container with movable dividers (United States Plastic 
Company, Lima, OH) to secure it in place. The porcine tissue was imaged using T1-weighted and T2-
weighted MRI sequences where the markers were not visible and then imaged using CT where the 
markers were identifiable. The porcine tissue was then deformed by changing the placement of the 
dividers (as shown in Figure 3-1) and re-imaged. This process was repeated three times for a total of 
four sets of T1-weighted, T2-weighted, and CT images. The container is 27.6 cm x 21.0 cm x 12.7 cm 
with 5 notches in the short direction and 7 notches in the long direction. The notches are spaced 3.25 
cm apart, and the first and last notches are 1.6 cm from the edge in the short direction and 1.8 cm in 
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the long direction. Long dividers are placed using the notches in the short direction and short dividers 
are placed using the notches in the long direction. The four different positions were as follows: (1) no 
dividers in the short direction, 1 divider in the first notch in the long direction; (2) 1 divider in the first 
notch in the short direction, 1 divider in the first notch in the long direction, (3) 1 divider in the first 
notch and 1 divider in the last notch in the short direction, 1 divider in the first notch in the long 
direction; and (4) 1 divider in the first notch and 1 divider in the last notch in the short direction, 1 
divider in the first notch and 1 divider in the last notch in the long direction. 
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Figure 3-1: Porcine Phantom Representative Deformation. 
A deformation was applied to the porcine phantom by moving the dividers. The red box represents the 
container with the grooves for the movable dividers and the position of the dividers is shown in blue. 
The original position is shown on the left and a deformed position using more movable dividers to 
secure the phantom in place is shown on the right. 
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The images were imported into the registration system where the MR images were rigidly 
registered to the CT image for each divider position and then deformably registered to the MR images 
at different divider positions. The gold markers were contoured for each divider position on the CT 
images and their center location was extracted. The markers were propagated through the registrations 
to determine the virtual location, and the error was measured by the distance between the virtual 
location and the known location. For example, the gold markers were transferred from CT-1 to MR-1 
through rigid registration, then from MR-1 to MR-2 through deformable registration, then from MR-2 
to CT-2 through rigid registration, and the error was measured as the distance between the propagated 
marker location on CT-2 and the actual marker location in CT-2. This method was applied to both 
registration systems. 
 
3.2.2 Synthetic Images 
The image registration methodology from Yu, et al. [75] was followed for 28 patients’ with 
human papillomavirus-positive oropharyngeal squamous cell carcinoma who were treated with 
definitive chemoradiotherapy. The patients were selected from a prospective trial under a protocol 
approved by the institutional review board at MD Anderson Cancer Center with study-specific informed 
consent. The first 28 patients to complete the three MRI scans were included. Patients underwent MRI 
scans from December 2013 to October 2015. Patient median age was 57 (range 46-70), with 26 men 
and 2 women. The median left parotid volume was 30.9 cm3 (range 22.4-47.1 cm3), median right 
parotid volume was 33.5 cm3 (range 18.0-46.7 cm3), median left submandibular volume was 9.6 cm3 
(range 5.7-19.7 cm3), median right submandibular volume was 9.4 cm3 (range 4.3-17.5 cm3), and 
median sublingual volume was 4.8 cm3 (range 1.6-9.4 cm3).  
Patients underwent T1-weighted and T2-weighted MRI scans before treatment (within 1 week 
prior to treatment), during treatment (3-4 weeks after the start of treatment), and after treatment (6-8 
weeks after completion of treatment). This methodology has been described previously [75]; briefly, 
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models were trained on the patient images using an in-house demons-based algorithm. An intra-
patient variation model was created by deforming each patient’s mid-treatment and post-treatment 
images to the pre-treatment image. One patient was selected to be the template for the synthetic 
images based on being the median age and having salivary glands with volumes near the median 
volume for all glands. An inter-patient variation model was created by deforming each patient’s pre-
treatment image to the selected patient’s pre-treatment image. 95% of the variation was included in 
the intra- and inter-patient variation models. This was done separately for T1-weighted and T2-
weighted images. 
Synthetic pre-treatment images were created by deforming the selected patient’s pre-treatment 
image using the inter-patient variation model. Synthetic post-treatment images were created by 
deforming the synthetic pre-treatment image using the intra-patient variation model. For each 
synthetic pre-treatment image, four synthetic post-treatment images were created. Four synthetic pre-
treatment images were created, resulting in 16 image registrations for both T1- and T2-weighted 
images. This process is demonstrated in Figure 3-2. An example of the applied deformation is shown in 
Figure 3-3. 
  
 
12 
 
 
Figure 3-2: Workflow of Synthetic Image Generation. 
The generation of synthetic images is represented visually. The selected patient’s pre-treatment image 
is deformed by the inter-patient variation model to generate the synthetic pre-treatment images 
(highlighted in pink). For each of the synthetic pre-treatment images, four synthetic post-treatment 
images (highlighted in blue) are generated by deforming the synthetic pre-treatment image using the 
intra-patient variation model.  
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Figure 3-3: Parotid Deformation in Synthetic Image Generation. 
An example of one of the deformations applied to the T1-weighted synthetic pre-treatment image left 
parotid to generate a synthetic post-treatment image. The arrows show the direction of the left-right 
and anteroposterior deformation and the size shows the magnitude of the deformation for that voxel.  
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 The synthetic post-treatment images were registered to the synthetic pre-treatment images in 
the image registration system and the deformation vector field for each registration was exported. The 
difference between the registration system’s deformation vector field and the applied deformation 
from the intra-patient variation model was evaluated within the salivary glands (left/right parotid, 
left/right submandibular, and sublingual). This method was not applied to the in-house demons-based 
algorithm because the algorithm was used to generate the inter- and intra-patient variation models 
used to generate the synthetic images for this method, and this would cause bias.  
 
3.2.3 Imaging 
3.2.3.1 Porcine MRI protocol 
 The T1-weighted MRI sequence was a three-dimensional spoiled gradient recalled echo 
sequence with flip angle 12˚, repetition time 4.96 ms, echo time 2.1 ms, effective number of excitations 
2, pixel bandwidth 325 Hz, field of view 25.6 cm, slice thickness 1 mm, and pixel size 1 mm × 1 mm. The 
T2-weighted MRI sequence was a two-dimensional fast spin echo sequence with flip angle 90˚, 
repetition time 5884 ms, echo time 98 ms, effective number of excitations 2, pixel bandwidth 325 Hz, 
field of view 25.6 cm, slice thickness 2.5 mm, gap 1.5 mm, and acquisition pixel size 1 mm × 1 mm, and 
zero filling interpolation × 2. The MRI sequences were executed on the same 3.0T GE machine as the 
patient scans using an 8US TORSOPA coil (GE Healthcare, Waukesha, WI). The CT images were 
acquired on a GE Discovery CT 750HD (GE Healthcare) in helical mode at 120 kVp, 150 mA, 0.516 pitch, 
0.8-s rotation time, 0.625-mm slice thickness, 0.625-mm spacing between slices, pixel size 0.39 mm × 
0.39 mm, and CTDIvol 41.07 mGy. 
 
3.2.3.2 Patient MRI Protocol 
 MRI scans were performed using a 3.0T Discovery 750 MRI scanner (GE Healthcare) with 6-
element flex coils and a flat insert table (GE Healthcare). Thirty slices with an axial field of view of 
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25.6 cm and slice direction in the superior-inferior direction (slice thickness of 4 mm) were selected 
to cover the spatial region encompassing the palatine process region cranially to the cricoid 
cartilage caudally for all scans. The T1-weighted MRI sequence was a three-dimensional spoiled 
gradient recalled echo sequence with flip angle 15˚, repetition time 3.6 ms, echo time 1 ms, effective 
number of excitations 0.7, pixel bandwidth 325 Hz, acquisition pixel size 2 mm × 2mm (matrix size 128 x 
128), and zero filling interpolation × 2. This resulted in reconstructed voxel sizes of 1 mm x 1 mm x 4 
mm. The T2-weighted MRI sequence was a two-dimensional fast spin echo multi-slice sequence with 
flip angle 90˚, repetition time ~3600 ms, echo time ~100 ms, effective number of excitations 1, pixel 
bandwidth 195 Hz, slice thickness 2.5 mm, gap 1.5 mm, acquisition pixel size 1 mm × 1 mm, and zero 
filling interpolation × 2. 
 
3.2.4 Registration Techniques 
3.2.4.1 Velocity 
 The images were first registered using manual alignment by shifting and rotating the secondary 
image. Then a region of interest that encompassed the whole porcine phantom or patient anatomy was 
drawn. Within this region of interest, the images were aligned first using Rigid 3 Passes. The Velocity 
rigid registration uses mutual information to align anatomy. Then MR Corrected Deformable was used 
to deformably align the images. Velocity’s deformable image registration uses a cubic B-spline 
algorithm with a uniform knot vector and a steepest gradient descent optimizer. Mattes Mutual 
Information is used as the “good of match” driver for the registration. The MR correction applies a fade 
correction to the image to correct for shading artifacts typically caused by inhomogeneities in the 
magnetic field and then proceeds with the deformable image registration. 
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3.2.4.1 In-house Demons-Based Algorithm 
 The in-house deformable image registration is a dual-force Demons algorithm [59]. Before 
performing the deformable registration, we performed histogram equalization to match the contrast of 
the 2 images. The histogram equalization was performed locally by separating the images into small 
blocks. A multiresolution scheme was used to accelerate the registration and improve the robustness of 
the registration. The parameter settings for the deformable registration are specified in Table 3-1. 
These parameters were chosen based on our experience in optimizing the algorithm for the MR-MR 
registration. Refer to Wang et al. [59] for details about this deformable registration algorithm. 
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Table 3-1. Parameter Settings for the Dual-force Demons Deformable Image Registration 
Parameter Value 
Number of bins for histogram equalization 256 
Block size for histogram equalization 20 
Multi-resolution levels 6 
Number of iterations 200 
Upper bound of step size 1.25 
Gaussian variance for regularization 1.5 
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3.2.5 Statistical Methods 
 The applied deformation for the synthetic images was obtained from the deformation vector 
field used to generate the synthetic post-treatment image from the synthetic pre-treatment image. The 
applied deformation for the porcine phantom was calculated from the difference in marker location on 
the CT images. The applied deformation was summarized using the root mean square (RMSD) and 
maximum. The registration error was calculated as described above and was also summarized using the 
root mean square (RMSE) and maximum. 
 
3.3 Results 
3.3.1 Porcine Phantom 
 The four image sets were registered producing six different pairs of images. In our analysis 
using Velocity one of the gold markers was not mapped to a voxel. For the T1-weighted MR image 
registrations using the in-house demons-based algorithm, one of the gold markers was mapped to the 
registered image for only one of the registrations. For the T2-weighted MR image registrations using 
the in-house demons-based algorithm, one of the gold markers was not mapped to the registered 
image in two of the registrations. The markers in our study are represented by regions of interest 
(ROIs). Some markers have very small volume. The deformable mapping of these small ROIs could not 
produce a reasonable volume so that the software treated the deformed ROIs as noise and removed 
them. To avoid the confusion, we take out these small ROIs from our results. 
For both the T1- and T2-weighted MR images, the RMSD was 5.0 mm in the left-right (LR) direction, 
9.0 mm in the anteroposterior (AP) direction, and 6.1 mm in the superior-inferior (SI) direction. The T1-
weighted MR images registered using Velocity had RMSEs of 1.8 mm in the LR direction, 1.5 mm in the 
AP direction, and 2.7 mm in the SI direction. The T1-weighted MR images registered using the in-house 
demons-based algorithm had RMSEs of 1.2 mm in the LR direction, 1.5 mm in the AP direction, and 2.1 
mm in the SI direction. The T2-weighted MR images registered using Velocity had RMSEs of 1.3 mm in 
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the LR direction, 1.2 mm in the AP direction, and 1.6 mm in the SI direction. The T2-weighted MR 
images registered using the in-house demons-based algorithm had RMSEs of 0.81 mm in the LR 
direction, 1.1 mm in the AP direction, and 1.1 mm in the SI direction. Boxplots of the RMSE and RMSD 
in the LR, AP, and SI directions from Velocity are shown in Figure 3-4. The maximum registration errors 
from both registration systems are summarized in Table 3-2. 
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Figure 3-4: Porcine Phantom Registration Error. 
The registration error using the T1-weighted MR images is shown in red, the registration error using the 
T2-weighted MR images is shown in green, and the applied deformation is shown in blue. Values are 
shown for the left-right (LR) direction, anteroposterior (AP) direction, superior-inferior (SI) direction, 
and magnitude. 
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3.3.2 Synthetic Images 
 For the T1-weighted MR images, the RMSD was 1.5 mm in the left-right (LR) direction, 2.1 mm 
in the anteroposterior (AP) direction, and 0.79 mm in the superior-inferior (SI) direction. The RMSE was 
0.76 mm in the LR direction, 0.76 mm in the AP direction, and 0.69 mm in the SI direction. RMSD and 
RMSE for each gland can be found in Figure 3-5. The maximum registration error was 1.1-5.7 mm in the 
LR direction, 1.3-3.8 mm in the AP direction, and 1.7-10 mm in the SI direction for the five salivary 
glands. The applied deformation is larger for the left parotid than the right parotid for these synthetic 
images. This was a result of the patients included in this study. A larger sample size would likely not 
have seen this effect. 
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Figure 3-5: Root Mean Square (RMS) Applied Deformation and Registration Error in T1-Weighted 
Synthetic Images. 
RMS registration error is shown in red and RMS applied deformation is shown in blue for the left-right 
(LR) direction, anteroposterior (AP) direction, superior-inferior (SI) direction, and magnitude (bottom 
right). Each boxplot shows RMS registration error and applied deformation for the left parotid (Lt Par), 
right parotid (Rt Par), left submandibular (Lt Sub), right submandibular (Rt Sub), and sublingual (Subl) 
glands. In each plot, the RMS registration error is shown to the right of the RMS applied deformation 
for each gland. 
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 For the T2-weighted MR images, the RMSD was 1.1 mm in the LR direction, 3.4 mm in the AP 
direction, and 1.4 mm in the SI direction. The RMSE was 1.1 mm, 0.75 mm, and 0.81 mm in the LR, AP, 
and SI directions, respectively. RMSD and RMSE for each gland can be found in Figure 3-6. The 
maximum registration error was 1.9-6.0 mm in the LR direction, 1.5-4.3 mm in the AP direction, and 
2.0-3.4 mm in the SI direction for the five salivary glands. The maximum registration error for each 
salivary gland is shown in Table 3-2. 
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Figure 3-6: Root Mean Square (RMS) Applied Deformation and Registration Error in T2-Weighted 
Synthetic Images. 
RMS registration error is shown in red and RMS applied deformation is shown in blue for the left-right 
(LR) direction, anteroposterior (AP) direction, superior-inferior (SI) direction, and magnitude. Each 
boxplot shows RMS registration error and RMS applied deformation for the left parotid (Lt Par), right 
parotid (Rt Par), left submandibular (Lt Sub), right submandibular (Rt Sub), and sublingual (Subl) glands. 
In each plot, the RMS registration error is shown to the right of the RMS applied deformation for each 
gland. 
  
 
25 
 
Table 3-2. Maximum Registration Error from Synthetic Images and the Porcine Phantom 
Source 
T1-weighted images (mm) T2-weighted images (mm) 
LR AP SI LR AP SI 
Left parotid gland 3.37 2.65 4.62 4.51 3.25 2.60 
Right parotid gland 2.77 1.99 4.38 5.97 4.27 3.40 
Left submandibular gland 4.90 3.80 10.2 3.66 1.95 2.04 
Right submandibular gland 5.72 1.94 2.44 2.31 1.78 2.37 
Sublingual gland 1.09 1.34 1.71 1.87 1.52 2.84 
Porcine phantom, Velocity 6.5 5.9 12.9 3.7 2.9 4.3 
Porcine phantom, 
in-house algorithm 
2.9 5.1 10.8 2.4 3.8 2.4 
LR, left-right; AP, anteroposterior; SI, superior-inferior. 
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3.4 Discussion 
MRI use in the United States has increased more than three-fold over the past 20 years 
according to the Organisation for Economic Co-Operation and Development database [76]. This 
increased use includes longitudinal studies that require deformable image registration. The current 
study evaluated the performance of two image registration systems for MRI deformable image 
registration. The porcine phantom validated both image registration systems, Velocity and the in-house 
demons-based algorithm. Then in order to validate Velocity further, the in-house demons-based 
algorithm was used to generate synthetic images. The use of synthetic images relies on the accuracy of 
the in-house demons-based algorithm to create the inter- and intra-patient variation models. This 
system has been previously validated using CT [58, 59, 74]. The porcine phantom results demonstrated 
that this validation is also applicable to MRI. These evaluation measures, the porcine phantom and 
synthetic images, showed that both Velocity and the in-house demons-based image registration system 
performed well, with all RMSEs below 3 mm. 
The RMSE was relatively stable, as shown by the increase in the applied deformation in the AP 
direction compared with the LR and SI direction for the synthetic images, even though the registration 
error stayed around the same values for the LR, AP, and SI directions. Furthermore, when applied 
deformations were pushed past physiological bounds in the porcine phantom, the registration errors 
were similar to the registration errors from the synthetic images. 
The generally low RMSEs for both image registration systems are consistent with average 
registration errors reported in the literature when evaluated using CT [57-59, 69-74]. However, we did 
find occurrences of registration errors greater than 10 mm in both image registration systems. The 
maximum registration errors of 10.2 mm for the SI direction of the left submandibular gland on the T1-
weighted synthetic images and 12.9 mm for the SI direction of the porcine phantom T1-weighted MR 
images in Velocity were higher than the maximum registration errors measured in CT-based 
registration with Velocity [57, 69-73]. These large registration errors may be due to the type of 
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surrounding tissue. Both of these points were in the vicinity of bone but at least 3 cm away. Singhrao et 
al used a head and neck phantom that included representative bony anatomy, and they found 
maximum errors between 6.5 and 8.3 mm for Velocity’s deformable image registration with CT images 
[70]. This maximum error is closer to the error we found in the current study than are the maximum 
errors found in studies of anatomical regions outside the head and neck images [71, 72]. 
The porcine phantom results showed that the maximum registration errors for both the T1-
weighted and T2-weighted MR images were lower than those observed for CT using the in-house 
demons-based algorithm [58]. This system has been previously validated and subsequently used for a 
variety of CT studies [77-79]. Results from the current study presented here imply that the in-house 
demons-based algorithm can be used reliably for MRI as well as CT. 
However, there is a limitation with the use of a porcine phantom in this setup because we were 
only able to deform and not shrink the phantom. The synthetic images included shrinkage as part of the 
intra-patient variation model. The lack of shrinking in the porcine model limits its applicability in regions 
of interest that shrink or grow over time. Nevertheless, the current study expands on other studies that 
have evaluated deformable image registration using only a few markers [64, 65]. Our study design is 
similar to that used by Lian et al. [66] who used 10-15 markers, but the phantom in the current study 
was meat rather than tissue-equivalent bolus material, so that it included muscle, bone, and fat. 
Another limitation of this porcine phantom is the size of deformations that were applied. The 
deformations applied are directly linked to the spacing of the notches for the movable dividers in the 
container which was larger than the typical deformation seen in the synthetic images. Therefore, these 
deformations provide an extreme scenario. The low RMSE by both registration systems in this extreme 
case shows the good performance of these two systems for MRI deformable image registration. 
Both studies utilized consistent imaging parameters and did not investigate the influence of 
acquisition parameters, such as coil placement, on the MRI deformable image registration. Therefore, 
these results demonstrate a controlled study which may not fully represent what is seen within clinics. 
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Additionally, image noise and artifacts can impact deformable image registration accuracy- high image 
noise would degrade accuracy as would the presence of artifacts- and their impacts were not evaluated 
in this study. However, it is not unreasonable to assume that these error estimates are applicable when 
imaging parameters are controlled, such as using a repeatable setup in a thermoplastic mask. Setup in a 
head and shoulder thermoplastic mask with dental stent and coils centered on the base of tongue 
region showed significantly improved image quality and reproducibility [80] and has consequently been 
used in a DCE-MRI longitudinal study for radiotherapy-induced mandibular changes [55].  
The synthetic images experiment produced SI RMSDs that were typically less than the slice 
thickness, 4 mm. This is due to the patient population that was used to create the inter- and intra-
patient variation models. Therefore, extending the results to different patient populations that have 
larger SI displacement must be done with caution. The porcine phantom results have larger SI 
displacement and demonstrated similar registration error. However, these larger SI displacements 
should be verified with patient data, such as synthetic images derived from patients with larger 
displacements, for full confidence in the registration error in different patient populations. 
Additionally, the synthetic images experiment was limited to the salivary glands as these are often 
analyzed in normal tissue studies. However, the porcine phantom experiment is not site limited. While 
it was used in this study to support the synthetic image data, the results from this experiment are 
applicable to other body sites. Therefore, with similar synthetic image experiments, the results can be 
applied to other locations within the body. 
 
3.5 Conclusions 
Both Velocity and the in-house demons-based algorithm demonstrated low registration errors, 
with all RMSEs below 3 mm for RMSDs between 0.79 and 9.0 mm, indicating that these deformable 
image registration systems can be used for MRI longitudinal studies. 
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Chapter 4 : Dynamic Contrast-Enhanced Magnetic Resonance Imaging Feature 
Stability 
This chapter is based upon: 
Joint Head and Neck Radiotherapy-MRI Development Cooperative. A Multi-Institutional Comparison of 
Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations. Scientific Reports 
doi: 10.1038/s41598-017-11554-w. Volume 7, Article 11185. 2017. ©Nature Publishing Group. 
This article is under a Creative Commons license (http://creativecommons.org/licenses/by/4.0/) which 
permits reproduction in any format. 
 
4.1 Introduction 
DCE-MRI is a noninvasive tool for examination of the microvasculature of tumors and normal 
tissue. Investigators have used DCE-MRI to assess therapeutic response of HNSCC and have shown 
associations between DCE-MRI metrics and changes in salivary glands and mandible [6-11, 55]. To the 
best of our knowledge, its use as a prognostic tool to inform treatment decisions for HNSCC has yet to 
be investigated in a large multisite prospective trial. Before such trials can begin, DCE-MRI inter-
algorithm comparisons must be conducted to ensure consistency of output parameter maps for 
collating data during the multi-institution trial. Two quantitative metrics for DCE-MRI are the transfer 
constant for contrast agent transport from the blood plasma into the extravascular extracellular space 
(Ktrans) and the volume fraction of the extravascular extracellular space (ve). The calculation of these 
quantitative metrics can be impacted by the acquisition parameters. The accuracy and precision of 
these quantitative metrics can be influenced by arterial input function (AIF) quantification, temporal 
resolution in data acquisition, signal-to-noise ratio (SNR), and pharmacokinetic model selection [81-91]. 
For example, uncertainties in T1 map values and applied flip angle have been reported to cause errors 
of 88% in Ktrans and 73% in ve, while reduced temporal resolution by 7-fold have reported decreases in 
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Ktrans up to 48% [88]. Therefore, acquisition parameters must be thoroughly tested and uniform across 
patients as they can dramatically impact measured DCE-MRI parameters.  
The Tofts-Kermode pharmacokinetic model [92] is the most commonly used model for DCE-
MRI analysis, but implementation of each algorithm differs in facets such as data preprocessing, 
approaches to numerical optimizations in kinetic analysis, and data postprocessing, which may impact 
the values of the output quantitative metrics. Several recent studies demonstrated significant inter-
algorithm variability when evaluating DCE-MRI of the female pelvis, breast, and rectum [93-95]. Of 
these studies, the one by Huang et al. [94] demonstrated systematic differences in output parameter 
values between algorithms, which meant that results from different algorithms could be used together 
if correction factors were applied; the other studies, however, did not demonstrate any systematic 
errors. In addition, Cron et al. [96] found that the percentage of nonphysical values (e.g. ve values 
greater than 1) in the quantitative metrics increased as noise increased when they tested three 
software packages. This noise dependence and inter-algorithm variance in quantitative DCE-MRI 
metrics are large obstacles to the clinical implementation of DCE-MRI and must be thoroughly 
investigated before proceeding with large multisite clinical trials using DCE-MRI in HNSCC patients. 
In this study, we investigated the variability in Ktrans and ve across algorithms that are based on 
the Tofts-Kermode and extended Tofts pharmacokinetic models [97, 98]. For this purpose, we used 
digital reference objects (DROs) from the Radiological Society of North America Quantitative Imaging 
Biomarkers Alliance and DCE-MRI data from oropharyngeal squamous cell carcinoma patients who 
underwent multiple DCE-MRI scans during treatment with definitive chemoradiotherapy. 
 
4.2 Methods and Materials 
4.2.1 Algorithms 
 Eleven algorithms from six institutions and one commercial software package were analyzed. 
They consisted of seven Tofts-Kermode models (identified herein as algorithms 2, 3, 5, 6, 8, 10, 11) and 
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four extended Tofts models (algorithms 1, 4, 7, 9). Spatial averaging on the DCE-MRI images was used in 
algorithms 5, 6, 7, 8, and 9. All algorithms are currently used for research applications at the respective 
institutions. The algorithms are described in Table 4-1. 
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Table 4-1. Description of Algorithms 
Institution Model(s) Used 
Massachusetts General Hospital Tofts-Kermode  
(description in Appendix A) 
MD Anderson Cancer Center Tofts-Kermode and Extended Tofts (description 
in Appendix A) 
Netherlands Cancer Institute Tofts-Kermode and Extended Tofts [99] 
nordicICE Extended Tofts [100] 
Oregon Health & Science University Tofts-Kermode and Tofts-Kermode [83, 101, 102] 
Princess Margaret Cancer Center Tofts-Kermode and Extended Tofts [103, 104] 
University of Texas at Austin Tofts-Kermode [105, 106] 
Algorithms are listed in alphabetical order not order displayed in figures. 
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4.2.2 DROs 
DROs provided by the Radiological Society of North America Quantitative Imaging Biomarkers 
Alliance were used to assess algorithm performance. The DROs had six Ktrans values ranging from 0.01 
min-1 to 0.35 min-1 that were constant across the rows and five ve values ranging from 0.01 to 0.5 that 
were constant down the columns, resulting in 30 different Ktrans-ve pairs, each encompassing 10 x 10 
pixels. The Ktrans and ve values were used to generate synthetic image data using the Tofts-Kermode 
two-parameter model run in JSim, an open-source modeling system [92, 107]. One DRO without noise 
[108] and 28 DROs with noise (SNR 0.18-1.8) [109] simulated by varying the sampling interval, timing 
offset, S0, and sigma value were used to evaluate algorithm performance. For each Ktrans-ve pair, the 
output pixels from the algorithms were subjected to a threshold to non-physiologic pixels (0 < Ktrans 
output < 5 and 0 < ve output < 1) and then averaged. 
 
4.2.3 Patients 
Fifteen patients diagnosed with human papillomavirus-positive oropharyngeal squamous cell 
carcinoma were included in this study under a protocol approved by the institutional review board at 
MD Anderson Cancer Center. All patients gave their study-specific informed consent. All methods were 
performed in accordance with the relevant guidelines and regulations. Patients underwent DCE-MRI 
scans from December 2013 to October 2014. The criteria for study inclusion were an age older than 18 
years, histologically documented stage III or IV human papillomavirus-positive oropharyngeal squamous 
cell carcinoma according to the American Joint Committee on Cancer 7th edition staging criteria, 
eligibility for definitive chemoradiotherapy, and an Eastern Cooperative Oncology Group performance 
status of 0 to 2. Patients were excluded for any of the following reasons: definitive resection of a 
primary tumor, administration of induction chemotherapy before radiotherapy, a prior cancer diagnosis 
except that of appropriately treated localized epithelial skin cancer or cervical cancer, prior 
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radiotherapy to the head and neck, contraindications for gadolinium-based contrast agents, and 
claustrophobia. 
Patient median age was 56 years (range, 47-68), with 14 men and 1 woman. All patients 
received radiotherapy at 70 Gy in 33 fractions. The majority of the patients (87%) received cisplatin-
based chemotherapy concurrently with radiotherapy. Patient, disease, and treatment characteristics 
are listed in Table 4-2. Patient 12 did not have a primary tumor because he underwent bilateral 
tonsillectomy before scanning.  
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Table 4-2. Study Patient Demographics 
Patient 
Number 
Sex Age 
(years) 
Race/ 
Ethnicity 
Smoking 
Status 
Primary 
Tumor Site 
TNM 
Category  
Chemotherapy 
(weekly) 
1 M 52 White N Base of 
tongue 
T3N1M0 Cisplatin 
2 M 53 White Y Base of 
tongue 
T2N2aM0 Cetuximab 
3 M 60 White Y Tonsil T4N2bM0 Cisplatin 
4 M 55 White Y Tonsil T3N2bM0 Cisplatin 
5 M 65 White N Base of 
tongue 
T2N1M0 Cetuximab 
6 M 57 Hispanic Y Tonsil T2N2cM0 Cisplatin 
7 M 60 White Y Base of 
tongue 
T2N2bM0 Cisplatin 
8 M 58 Black Y Base of 
tongue 
T2N2cM0 Cisplatin 
9 M 62 Asian Y Tonsil T4N2cM0 Cisplatin 
10 F 48 White Y Tonsil T4N2bM0 Cisplatin 
11 M 56 White N Tonsil T2N2cM0 Cisplatin 
12 M 68 White Y Tonsil TxN2cM0 Cisplatin 
13 M 47 White N Tonsil T3N2bM0 Cisplatin 
14 M 47 White Y Tonsil T3N2bM0 Cisplatin 
15 M 55 White N Base of 
tongue 
T4N2bM0 Cisplatin 
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All patients underwent DCE-MRI scans within 1 week prior to treatment, 3-4 weeks after the 
start of treatment, and 6-8 weeks after the completion of treatment. The DCE-MRI scans were done 
using a 3.0T Discovery 750 MRI scanner (GE Healthcare) with six-element flex coils and a flat insert 
table (GE Healthcare). The same immobilization devices (individualized head and shoulder mask, 
customized head support, and intraoral tongue-immobilizing/swallow-suppressing dental stent) were 
employed in longitudinal scans to improve image co-registration and to reduce interval physiologic 
motion (e.g., swallowing). 
Thirty axial slices with a field of view of 25.6 cm and thickness of 4 mm were selected to cover 
the spatial region encompassing the palatine process region cranially to the cricoid cartilage caudally 
for all scans. Prior to DCE-MRI, T1 mapping was performed using a total of six variable-flip-angle three-
dimensional spoiled gradient recalled echo sequences (flip angles: 2°, 5°, 10°, 15°, 20°, and 25°; 
repetition time/echo time, 5.5/2.1 ms; number of effective excitations, 0.7; spatial 
resolution, 2 mm × 2 mm × 4 mm; scan time, 3 minutes). The DCE-MRI acquisition consisted of a three-
dimensional fast spoiled gradient recalled echo sequence to gain sufficient SNR, contrast, and temporal 
resolution. The following scan parameters were used: flip angle, 15°; repetition time/echo 
time, 3.6/1.0 ms; number of effective excitations, 0.7; spatial resolution, 2 mm × 2 mm × 4 mm; 
temporal resolution, 5.5 s; number of temporal frames, 56; pixel bandwidth, 326 Hz; acceleration 
factor, 2; and scan time, 6 minutes. Gadopentetate dimeglumine (Magnevist; Bayer HealthCare 
Pharmaceuticals, Berlin, Germany) was administered intravenously to the patients at the end of the 
sixth frame (dose, 0.1 mmol/kg at a rate of 3 mL/second) followed by a 20-mL saline flush via a power 
injector (Spectris MR Injector; Medrad, Warrendale, PA) at a rate of 3 mL/second. 
Variable-flip-angle images, DCE-MRI images, and a bootstrapped population AIF measured in a 
region of interest in the carotid artery [55] were distributed to each institution to use in their 
algorithm(s) to generate Ktrans and ve parameter maps for each patient. 
 
37 
 
Each patient had 6 ROIs—contralateral and ipsilateral parotid glands, contralateral and 
ipsilateral submandibular glands, sublingual glands, and a primary gross tumor volume (GTV-P)—
contoured on his or her pretreatment images by a radiation oncologist with 7 years of experience 
(A.S.R. Mohamed). Midtreatment and posttreatment images were deformably registered to the 
pretreatment images using a commercially available software program (Velocity AI, version 3.0.1; 
Varian Medical Systems, Palo Alto, CA). The deformation vector fields were exported from the 
deformation software and used with an in-house MATLAB code (MATLAB 2014b; MathWorks, Natick, 
MA) to deform the ROIs and extract Ktrans and ve values from the six ROIs on each parameter map at the 
three time points. For each ROI, Ktrans and ve values were subjected to the same threshold constraints as 
in the DROs and then averaged. 
 
4.2.4 Statistical Methods 
A stratified permutation test was designed to determine whether the Ktrans and ve values from 
an algorithm for a specific DRO were generally ordered correctly in the DRO. Permutation tests work by 
rearranging data in many possible ways in order to estimate the sampling distribution for the test 
statistic. Algorithms were compared on a pairwise basis using a paired Wilcoxon rank-sum test to 
determine if the outputs of two algorithms were statistically different (R software package, version 
3.3.1). Algorithms were split into two groups based on if spatial averaging was used on the DCE-MRI 
scans. The two groups were compared using a one-sided student’s t-test to determine if lower error on 
the DROs was calculated when spatial averaging was used. All p-values were adjusted using the 
Benjamini-Hochberg correction for multiple comparisons. 
For patient DCE-MRI data, consistency of trends across algorithms was assessed using linear 
mixed effects models (R lme4 package, version 1.1.12) constructed for the differences between the 
pretreatment and midtreatment, pretreatment and posttreatment, and midtreatment and 
posttreatment quantitative metrics, and percent change in these three time differences. Two mixed 
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effects models were created: one in which the algorithm was a fixed effect and the ROI was a random 
effect (∆ ~ algorithm + (1|ROI)) and one in which only the random effect of the ROI was included (∆ ~ 1 
+ (1|ROI)). A likelihood ratio test was performed for these two models to determine if the algorithm 
was a significant factor in the measured changes. All p-values were adjusted using the Benjamini-
Hochberg correction for multiple comparisons (R, version 3.3.1). We used linear mixed effects models 
with likelihood ratio tests instead of ANOVA tests because in most comparisons we observed 
statistically different variances as determined using the Levene test, which violates one of the 
assumptions of ANOVA tests. Intraclass correlation coefficient is more appropriate for complete data 
sets 46, so it was not applicable for this data set. 
For all ROIs, patients were categorized as above or below the median values from a given 
algorithm using three different metrics: (1) each time point, (2) difference between time points, and (3) 
percent difference between time points. Krippendorff’s alpha was used to assess inter-algorithm 
reliability (R, irr package, version 0.84). We used Krippendorff’s alpha to compare algorithms because of 
its ability to handle missing data, which occurred because for some algorithms, all Ktrans and ve values 
were outside the threshold for a given patient’s ROI. 
Trends within each algorithm were assessed using Spearman’s rank correlation coefficient (R, 
version 3.3.1). Spearman correlations were conducted using three different sets of time points: (1) all 
three time points, (2) only the pretreatment and midtreatment time points, and (3) only the 
pretreatment and posttreatment time points were evaluated. All p-values were adjusted using the 
Benjamini-Hochberg correction for multiple comparisons. For all statistical tests, p-values below 0.05 
after adjustment were considered significant. 
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4.3 Results 
4.3.1 DROs 
One of the Tofts-Kermode algorithms (algorithm 11) could not process the DROs because of the 
algorithm’s structure. Therefore, the remaining 10 algorithms were used for DRO analysis. For the 
noiseless DRO, the stratified permutation test demonstrated that both Ktrans and ve were statistically 
significantly ordered correctly (p < 0.05) for all of the algorithms. Eighty-two percent of pairwise 
algorithm comparisons were statistically significantly different (p < 0.05) regarding Ktrans, and 69% of the 
comparisons were statistically significantly different (p < 0.05) regarding ve based on the Wilcoxon rank-
sum test. Figure 4-1 shows the algorithm performance for the noiseless DRO. Most of the Ktrans and ve 
measured values in the noiseless DRO were close to the true simulated values: 96% of Ktrans and 96% of 
ve measured values were within 10% of the simulated values. More spread in the measured values was 
observed at higher simulated values of Ktrans or ve. Heat maps of the percentage error of Ktrans and ve 
measured values in comparison to the simulated values are shown in the appendix (Appendix A Figure 
A-1). 
  
 
40 
 
 
Figure 4-1: No Noise DRO Performance. 
Plots of algorithm performance in a DRO with no noise for (a) Ktrans and (b) ve. The simulated values are 
on the x-axis, and the measured values from each algorithm are on the y-axis. The 45° line represents 
100% accuracy of the measured values. Each color represents a different algorithm, and each shape 
represents a different ve column in (a) and a different Ktrans row in (b). 
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The stratified permutation test for the 28 DROs with noise demonstrated that in 86% and 84% 
of the cases (algorithm-DRO combinations), Ktrans and ve were statistically ordered correctly (p < 0.05) 
when one of the algorithms was excluded because of missing Ktrans values and failure of the ve test for 
all 28 of these DROs. Most of the test failures occurred at the lowest SNR (0.18). Eighty-four percent of 
the Ktrans pairwise comparisons and 81% of the ve pairwise comparisons were statistically significantly 
different (p < 0.05) based on the Wilcoxon rank-sum test results. 
Heat maps of the percent error in Ktrans and ve relative to the simulated values in the 28 DROs 
with noise are shown in Figure 4-2. The maximum percent error in this figure was set to 100% and the 
minimum percent error was set to -100%. Therefore, any Ktrans and ve values greater than the maximum 
percent error are mapped to red. The only trend found was less error at higher Ktrans and ve simulated 
values although there is more spread in the measured values at these higher Ktrans and ve simulated 
values. Algorithms that used spatial averaging were found to have statistically significantly less (p < 
0.05) Ktrans and ve calculated error than algorithms that did not have spatial averaging according to the 
student’s t-tests. 
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Figure 4-2: Heat Maps of DRO Error. 
Heat maps of the percentage error for Ktrans (top left) and ve (bottom left) by algorithm in the 28 DROs 
with noise. The percentage error is defined using the formula ([measured - simulated]/simulated *100). 
The left side of the heat map is grouped by the timing interval used for the DRO (6 or 10 s), the timing 
offset used for the DRO (0 or 3 s for the 6 s timing interval, 0 or 5 s for the 10 s timing interval), and the 
SNR (0.18-1.8). The inset (top right) shows the Ktrans and SNR values for each block in the heat maps. The 
maximum percentage error is defined as 100%, and the minimum percentage error is set to -100%. Any 
errors greater than the maximum percentage are also mapped as 100% error in color. Each DRO is 
 
43 
 
differentiated by its sampling interval, timing offset, and SNR as determined by the S0 and sigma value 
used to create the DRO. 
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We observed large variation in the percentage of values removed due to the threshold for Ktrans 
and ve for each algorithm. Some algorithms had almost no values removed, and some had a median of 
70% of values removed. 
These DRO results are for one method of excluding Ktrans and ve values. We also analyzed the 
data using the central 95% of the data for each Ktrans-ve pair with no threshold restrictions, which 
produced consistent test results. 
 
4.3.2 Patients 
The percentages of Ktrans and ve values removed from patient ROIs because they were outside 
the bounds of the threshold are shown in Figure 4-3 for the pretreatment, midtreatment, and 
posttreatment Ktrans and ve. As in the DROs, the percentages varied: some algorithms had low 
percentages removed, implying that they mostly produced realistic values, whereas some algorithms 
produced almost nothing but unrealistic values for certain patients. The average percentage removed 
for Ktrans was 27%, 26%, and 22% for pretreatment, midtreatment, and posttreatment respectively. The 
average percentage removed for ve was 46%, 49%, and 48% for pretreatment, midtreatment, and 
posttreatment respectively. 
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Figure 4-3: Percent of Values Removed. 
Percentages of (a) Ktrans and (b) ve values removed from patient images. The box plots for each 
algorithm include the percentages removed for all patients and contours. 
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According to results of the likelihood ratio test, all differences were statistically significantly (p < 
0.05) dependent upon the algorithm except for the pretreatment-to-posttreatment change in Ktrans 
when all algorithms were included in the model. Algorithms were subset into Tofts-Kermode and 
extended Tofts groups. In the Tofts-Kermode group, three changes were not statistically significantly 
dependent on algorithm (p < 0.05): pretreatment-to-midtreatment change in Ktrans, midtreatment-to-
posttreatment change in Ktrans, and midtreatment-to-posttreatment change in ve. In the extended Tofts 
group, algorithm was not a significant factor (p < 0.05) in pretreatment-to-posttreatment change. In all 
other changes, the algorithm was a significant factor. In all linear mixed effects models, the variance 
explained by the ROI was much smaller than the residual variance, suggesting that the ROI does not 
explain much of the variation seen in the linear mixed effects model. All organ variance was less than 
30% of the residual variance; on average, it was 8% of the residual variance.  
Figure 4-4 demonstrates an example of the difference in parameter values exported from 
different algorithms. The Ktrans maps from the same axial slice of a patient are shown for all algorithms. 
It can be seen that some algorithms output mostly lower Ktrans values while others output mostly higher 
Ktrans values. In addition, some algorithms fit the noise data in voxels outside of the anatomy while other 
algorithms generated Ktrans maps only within the anatomy. 
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Figure 4-4: Differences in Ktrans from Algorithms. 
Illustration of differences in Ktrans (min-1) maps exported by different algorithms for one axial DCE-MRI 
slice. 
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Carletta’s thresholds for good agreement between algorithms (α ≥ 0.8) and sufficient 
agreement for tentative conclusions (0.800 > α > 0.667) were used [110] to assess the results of 
Krippendorff’s alpha tests. The tests were run using all of the algorithms and also subsets of the 
algorithms, which were placed into Tofts-Kermode and extended Tofts groups. Of all of these tests, only 
those in the extended Tofts group had alphas that fell in range for tentative conclusions: 7 of the 108 
tested correlations in this group had alphas in this tentative conclusions range. No alphas were in the 
good agreement range. An illustration of this inconsistent sorting of patients is shown in the appendix 
(Appendix A Figure A-3). Carletta’s thresholds for good agreement and tentative conclusions are 
weaker than those suggested by others. Krippendorff [111] and Neuendorf [112] suggested using 
higher standards, which would remove all the metrics found to be partially reliable across algorithms. 
Few statistically significant Spearman correlations (p < 0.05) were observed: 8% of all tested 
Ktrans correlations and 29% of all tested ve correlations across all algorithms. The only trend in these 
correlations across algorithms was a statistically significant Spearman correlation of ve in the GTV-P.  
 
4.4 Discussion 
Use of DCE-MRI is increasing in oncology research and investigators have performed many 
promising studies indicating correlations between predicted therapeutic outcome and DCE-MRI metrics 
[9, 10]. However, many different DCE-MRI platforms were employed in these studies, and no studies 
have demonstrated whether data and conclusions regarding HNSCC can be aggregated. We addressed 
this issue by analyzing the same sets of DRO and HNSCC patient data with a subset of the currently used 
algorithms that are based on the Tofts-Kermode or extended Tofts model, as these pharmacokinetic 
models are the ones most commonly employed in DCE-MRI. 
The key results from this study are that algorithms were able to determine high values from 
low values on DROs, but workflow differences may obscure the ability to discern values across 
algorithms in patients.  This may be specifically related to T1 mapping which was not controlled in the 
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patient portion of this study. Specifically, trends among algorithms from the same institution 
(institution supplied both Tofts-Kermode and extended Tofts algorithms) were consistent, but not 
across institutions. This highlights the effect of preprocessing, also shown by the impact of spatial 
averaging on the calculated error. Therefore, translatability of DCE-MRI across algorithms is not 
currently feasible. 
A digital phantom was used to assess algorithms with a known “ground truth”. The DROs we 
used had SNRs of 0.18 to 1.80 in the noisy DROs. Although these SNR values and Ktrans and ve values 
within the DRO are below that typically found in head and neck cancer cases [113-116], the DROs were 
used due to their availability and Quantitative Imaging Biomarkers Alliance-backed quality. The DROs, 
however, do not come with instructions for interpretation of results, which makes conclusions difficult 
especially for the DROs that contain very high noise.  
The good algorithm performance for the noiseless DRO is consistent with the results reported 
by Huang et al. [94] and suggest that the algorithms tested here are constructed properly. However, 
the error increased dramatically when high levels of noise were added to the images. Our assessment 
using percentage error may explain why the error appeared extremely high in the low Ktrans and ve 
regions as a small absolute error in this region will appear with a high percentage error. Heat maps of 
the error with the noisy DROs are shown in the appendix (Appendix A Figure A-2) to remove this 
discrepancy in percentage error between low and high values. 
The difference between algorithms was significant for DROs according to the Wilcoxon rank-
sum test results, which is consistent with the results reported by Beuzit et al. [95], who used SNRs of 10 
and 100 and still found significant differences between different software packages. A limitation of this 
test is that if the differences between two algorithms are small but all of one sign (such that all values 
from one algorithm are higher than all values from another algorithm), the differences will be 
statistically significant. This does not appear to be the cause of the statistically significant differences 
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observed here because each algorithm has its own error signature, and we could not identify a 
systematic error in any of the algorithms. 
The DRO results demonstrated the potential of DCE-MRI quantitative metrics for clinical 
application, an illustration of which was the patient data set we used. The significance of including 
algorithm in the linear mixed effects models was consistent with the Wilcoxon rank-sum test results for 
the DROs. The small variance explained by the ROI compared with the residual variance in the linear 
mixed effects models was surprising. If associations can be found using DCE-MRI, different trends 
between normal tissue and tumor would particularly be expected, yet the ROI provided little 
explanation of the variance in the data in the linear mixed effects models.  
A majority of the algorithms tested produced statistically significant Spearman correlations of 
ve in the GTV-P. The agreement of Spearman correlations across algorithms within the GTV-P but not 
within normal tissue may be due to a difference in contrast-induced signal change, as the GTV-P has a 
much higher signal change than does normal tissue in DCE-MRI. This means that the GTV-P has higher 
Ktrans and lower error in the presence of noise based on the DRO data. However, this agreement of 
Spearman correlations of ve in the GTV-P is contradicted by the Krippendorff’s alpha results for the 
GTV-P. Only the midtreatment Ktrans value in the extended Tofts group had an alpha in the range where 
tentative conclusions can be drawn. This discrepancy may be explained by small interpatient variability 
in the Ktrans and ve values, which limited the algorithms’ ability to separate patients into above or below 
the median. However, the Spearman rank correlation coefficient identifies trends and is not as affected 
by interpatient differences in values as Krippendorff’s alpha if the trend is consistent. 
The Krippendorff’s alpha results demonstrated that different algorithms do not consistently 
classify patients’ Ktrans and ve values, change in values, or percent change in values. These results 
indicate that there is currently no clinical level at which these quantitative metrics can be used across 
algorithms to quantify patients. Based on the algorithms’ performance for the DROs in the stratified 
permutation test in our study, this result from Krippendorff’s alpha tests is surprising. However, small 
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interpatient variation in the Ktrans and ve values may have caused the low inter-algorithm reliability. This 
low inter-algorithm reliability, even within the Tofts-Kermode and extended Tofts groups, contrasts 
with the results described by Huang et al. [94]. They found good parameter agreement for percentage 
change when they grouped algorithms by pharmacokinetic model and that all of the algorithms 
provided good prediction of response to therapy as assessed using univariate logistic regression. This 
difference may have resulted from the imaging technique used, tissue of interest, and/or patient 
distribution of Ktrans and ve values. 
Uncertainties in DCE-MRI exist due to AIF selection and imaging parameters [81, 82, 85-87, 91], 
but we did not explore them in this study because they were controlled: we examined each algorithm 
with the same patient DCE-MRI images, variable-flip-angle images, and AIF. In previous studies, T1 
mapping and AIF selection impacted Ktrans and ve values [81-86, 91, 117-119]. The agreement between 
algorithms that we observed may have been lower if we had included all of the differences typically 
seen in a multisite clinical trial, including different scanners, scanning protocols, AIFs, and DCE-MRI 
algorithms at each institution. In our relatively controlled study, we observed statistically significant 
differences in both DRO and patient data among the algorithms. It must be acknowledged that there is 
no “ground truth” against which these algorithms can be compared, and it is unclear whether there was 
a true therapeutic effect that should have been identified by DCE-MRI in the patient data. Even if there 
was no net effect across this population of patients, however, it is clear that different approaches to 
DCE-MRI analysis has significant impact on within-patient trends. 
We chose the upper bound for Ktrans since one of the algorithms in this study used 5 min-1, 
providing a feasible physical upper limit. We chose the lower bound for Ktrans because when a given 
pixel or voxel has a poor fit within an algorithm, it is often given a value of 0 or a negative value. 
Accordingly, we excluded these values from analysis. We chose the bounds for ve based on the physical 
limits given by its definition as a fractional space. Furthermore, poor fits in an algorithm are often 
mapped to 0 or 1. Therefore, we excluded these values. While 0 is a physically realistic value for Ktrans 
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and 0 and 1 are physically realistic values for ve, these values must be excluded owing to a high 
proportion of bad pharmacokinetic model fits mapped to these values. The high percentage of values 
that must be removed represents an area of improvement for future algorithms. Cron et al. [96] 
demonstrated that as noise in DCE-MRI scans increases, the percentage of nonphysical Ktrans and ve 
values increases. Thus, voxel-based analysis of DCE-MRI quantitative metrics may not be reliable, so 
global metrics, such as average, of regions must be used for studies. For regions in which a high 
percentage of values are excluded, the average value extracted is not a reliable metric, as it comes from 
only a small subregion which is not representative of the whole region. This issue can be mitigated on 
the imaging end by increasing the SNR at the cost of the increased scan time, poorer temporal 
resolution, spatial resolution, or coverage, and potentially on the software end by improving how 
algorithms handle noise through the use of DROs. 
In summary, we showed that rigorous standardization and careful quality assurance of software 
programs, including comparison of parameter calculations with standard data sets, are needed for 
collating pharmacokinetic analysis of DCE-MRI data among different algorithms. This must include 
assessment of the impact of image noise on quantitative metric error. Authors recently reported the 
need for careful quality assurance for functional MRI [120]. Efforts like those by the Quantitative 
Imaging Biomarkers Alliance to standardize DCE-MRI acquisition parameters represent a natural step 
forward for quality assurance and serve as the foundation for the current quality assurance work used 
in the present study. 
To support these efforts, we provided our data set in a repository to allow for their use as 
perpetual head and neck cancer patient-derived standards for future DCE-MRI software and/or 
algorithm development [121] in addition to the extant DRO library maintained by one of the authors (D. 
Barboriak). To that end, we recommend the following: 
1. Consistent use of the same software for DCE-MRI analysis within a given study and for cross-
comparisons between studies. 
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2. Specification and setting of acquisition parameters before proceeding with clinical trials as with the 
present data set. 
3. Before performing multi-institution clinical trials, confirmation that DCE-MRI parameter values are 
consistent across institutions. 
4. Inclusion of reference to a DRO with clinically relevant SNRs to benchmark performance of DCE-MRI 
software using clear evaluation criteria. 
Clinically, our DRO data point to the fact that algorithms differed substantially despite reliance 
on the same basic underlying pharmacokinetic model(s), performing relatively stable in low-noise 
conditions. This, coupled with the inter-algorithm variability observed with the in vivo head and neck 
cases (which were performed in immobilization on a single MRI platform with standard AIF selection) 
suggests that, at present, any clinical trial desiring to implement DCE-MRI, should at a minimum, use a 
single pre-specified DCE-MRI software workflow, and eschew use of multiple algorithms. This also 
means that DCE-MRI findings from one software are broadly uninterpretable in a differing platform at 
present.  
Until quantitative metrics can be reliably calculated across algorithms, patient-derived DCE-MRI 
analyses with different algorithms cannot be aggregated. Semiquantitative metrics, such as the area 
under the curve, have been shown to be more reproducible than quantitative metrics and may be the 
best interim option for use in prognostic studies using different algorithms [122]. Further refinement is 
required before DCE-MRI software-derived parameters can be used as a routine cross-institutional 
metric for multi-site clinical trials. 
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Chapter 5 : Computed Tomography Radiomics Feature Dependence on Tube 
Voltage 
5.1 Introduction 
CT imaging protocols can impact radiomics feature values. Many of the reconstruction 
parameters have been investigated. Several recent studies have also investigated the effect of some 
acquisition parameters. Fave et al. conducted a preliminary investigation of the effect of tube voltage 
on radiomics features [123]. Images at different tube voltages were simulated by applying an offset to 
patient images that were acquired at 120 kVp. They found that tube voltage did not affect feature 
values as the inter-patient variation was significantly higher than the intra-patient variation. Mackin et 
al. evaluated the effect of tube current changes using a phantom with inserts of different textures. They 
concluded that tube current did not have a significant effect on radiomics features in textured objects 
[38]. Berenguer et al. used a similar radiomics phantom as that used by Mackin et al. and found that the 
tube current had no effect on over 70% of radiomics features using cut-offs for the metrics of 
coefficient of variation, quartile coefficient of dispersion, and intraclass correlation coefficient [124]. 
They found that tube voltage affected more features than tube current, as only 42%-68% of radiomics 
features passed the cut-offs for the same metrics. In that study, the robustness of features was 
computed based solely on changes due to different parameter settings; in this study, we related the 
robustness of features due to changes in tube voltage to patients. 
Until the recent study by Berenguer et al.[124], the effect of tube voltage on radiomics feature 
values had not been thoroughly investigated using multiple acquired CT scans. Tube voltage 
experiments require additional CT scans; this increases the dose to the patient, unlike the voxel size, 
image thickness, and convolution kernel, which can be analyzed by creating additional reconstructions 
after one CT scan has been acquired. While most clinics use 120 kV for their CT examinations, there 
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have been several studies that have recommended adjusting the tube voltage based on the patient size 
or the purpose of the examination [125-131].  
In the current study, we investigated the effect of tube voltage on radiomics feature variability 
using a phantom with different cartridges by comparing the induced change to the variability between 
patients in two different cohorts. This was done using a phantom developed by Mackin et al. [132]. We 
evaluated features using four different pre-processing techniques and compared them in two patient 
cohorts using the same pre-processing techniques to determine the relative effect of tube voltage-
induced radiomics feature changes. On the basis of the results of studies by Fave et al. and Mackin et al. 
[38, 123], we hypothesized that tube voltage would not have a significant effect on radiomics features 
measured in textured materials. 
 
5.2 Methods 
The credence cartridge radiomics (CCR) phantom developed by Mackin et al. [132] was used to 
evaluate the effect of tube voltage on radiomics features. For this study, acrylic, wood, cork, dense 
cork, and rubber cartridges were analyzed. These cartridges were organized by the amount of texture, 
as determined by the standard deviation of the CT numbers within the material. The order of the 
materials, from the least texture to the most texture, was determined using the standard deviation 
(sd): acrylic (sd: 4), cork (sd: 34), wood (sd: 36), dense cork (sd: 47), and rubber (sd: 100). The difference 
between a material with low texture and high texture is demonstrated in Figure 5-1: acrylic has no 
texture pattern, while cork has a rough texture pattern. Images of the other cartridges can be seen in 
the report by Mackin et al. [132]. 
 
5.2.1 Effective Atomic Number of Phantom Materials 
Materials of similar effective atomic number will have similar relative contributions of 
photoelectric and Compton interactions, so the impact of x-ray energy on the attenuation coefficient 
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(and therefore Hounsfield Units) will be similar. Therefore it was necessary to estimate the effective 
atomic number for each material in the phantom.   
The effective atomic number was calculated for each material [133]. The weight fractions for 
each element in the material were taken from the literature for cork, dense cork, and wood [134, 135]. 
The weight fractions for the other materials could not be found in the literature and instead were 
calculated based on their molecular formulas: acrylic = C5H8O2 and rubber = C5H8. 
 
5.2.2 Phantom Scans 
The CCR phantom was imaged on two CT scanners: a GE Lightspeed RT (GE Healthcare) and a 
Philips Brilliance Big Bore (Philips Healthcare, Eindhoven, The Netherlands). On each scanner, the 
impact of tube voltage was assessed by keeping the CT dose index (CTDIvol) constant. A recent study 
showed that the tube current does not affect feature values [38]; thus, the tube current changes that 
were necessary to keep the CTDIvol constant as the tube voltage changed was not a confounding factor. 
The imaging protocols used were designed to align as much as possible with the controlled protocol 
used by Ger et al. on 100 CT scanners [136]. 
For the GE CT scans, the CTDIvol was set as close to 13.3 mGy as possible (mean, 13.27 mGy; 
standard deviation, 0.12 mGy). The acquisition parameters were as follows: 0.75 pitch, 1.0 s rotation 
time, 2.5 mm image thickness, 0.976 mm x 0.976 mm pixel size, body bowtie filter, and 4 x 1.25 
collimation. The tube voltage varied from 80 to 140 kVp in increments of 20, with tube current values of 
315, 175, 105, and 75 mA for the four tube voltage settings, respectively. 
For the Philips CT scans, the CTDIvol was set as close to 13.3 mGy as possible (mean, 11.6 mGy; 
standard deviation, 3.4 mGy). The acquisition parameters were as follows: 0.938 pitch, 1.0 s rotation 
time, 3 mm image thickness, 0.976 mm x 0.976 mm pixel size, body bowtie filter, and 16 x 1.5 
collimation. The tube voltage varied among three settings of 90, 120, and 140 kVp, with tube current 
values of 265, 250, and 150 mA for the three tube voltage settings, respectively.  
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The half-value layer for the GE CT with the body bowtie filter at 80, 100, 120, and 140 kVp was 
measured to be 5.5 mm Al, 6.7 mm Al, 7.8 mm Al, and 8.8 mm Al, respectively. The half-value layer for 
the Philips CT with the body bowtie filter at 90, 120, and 140 kVp was measured to be 7.1 mm Al, 8.7 
mm Al, and 9.8 mm Al, respectively.  
 
5.2.3 Patient Scans  
For this study, we retrospectively reviewed the images and medical records of NSCLC and 
HNSCC patients with a waiver of informed consent from the Institutional Review Board at the University 
of Texas MD Anderson Cancer Center. Both of these cancer types have been investigated in previous 
studies, and for both, radiomics features added to models with conventional prognostic factors (e.g., 
age) have demonstrated promising prognostic ability [15, 17, 20, 22, 29]. 
Twenty patients with NSCLC were selected. Their mean age was 67 years (range, 52-78 years), 
mean height 170 cm (range, 154-182 cm), mean weight 72.9 kg (range, 41.0-97.6 kg), and mean tumor 
volume 77 cm3 (range, 11-389 cm3). The non-contrast CT scans were acquired on a GE Discovery CT 
scanner with the following parameters: 120 kVp, 300 mA, 1.35 pitch, 0.5 s rotation time, 2.5 mm image 
thickness, and 0.976 mm x 0.976 mm pixel size. Patients’ tumors were contoured by the treating 
radiation oncologist. 
Thirty patients with HNSCC were selected. Their mean age was 64 years (range, 50-87 years), 
mean height 175 cm (range, 149-193 cm), mean weight 80.5 kg (range, 43.9-114.9 kg), and mean tumor 
volume 13 cm3 (range, 1.2-91 cm3). The contrast-enhanced CT scans were acquired using a GE 
LightSpeed CT scanner with the given parameters: 120 kVp, 220 mA, 1.375 pitch, 1.0 s rotation time, 
1.25 mm image thickness, and 0.488 mm x 0.488 mm pixel size. Patients’ tumors were contoured by a 
radiation oncologist. 
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5.2.4 Radiomics Feature Analysis 
Images were analyzed using IBEX, an open-source radiomics tool [137, 138]. The CCR phantom 
scans were contoured using the location of a small radiopaque marker on the edge of the phantom; the 
x, y, and z location of the marker was entered into an in-house Python (version 2.7) script, creating an 8 
x 8 x 2 cm3 region of interest (ROI) for each cartridge. Forty-nine features were calculated in IBEX: 11 
intensity histogram, 22 gray level co-occurrence matrix [139], 11 gray level run length matrix [140, 141], 
and five neighborhood gray tone difference matrix features [142] (Table 5-1). Each feature was 
calculated four times: (1) with no image pre-processing other than thresholding, (2) with thresholding 
and a Butterworth smoothing filter with an order of 2 and a cut-off of 125, (3) with thresholding and 8-
bit depth resampling, and (4) with thresholding, Butterworth smoothing, and 8-bit depth resampling. 
Pre-processing has been demonstrated to affect the prognostic value of features [143]. The settings 
used for the features and the pre-processing were based on the work of Fave et al., who found that 
these were the most prognostic and appropriate for noise levels in CT [143]. No voxel resampling was 
used for this analysis as all images on each scanner had the same voxel size. 
The lower threshold for the NSCLC patients was -100 HU, and the upper threshold was 200 HU. 
For the HNSCC patients, only a lower threshold of -100 HU was applied. These thresholds were chosen 
to remove air and bone from the ROIs. An upper threshold was not applied to the HNSCC patients as 
this sometimes removed contrast from the ROIs. For the phantom images, no thresholding was applied. 
The settings used for each feature are described in detail in Fave et al.’s supplemental material [14]. For 
gray level co-occurrence and gray level run length matrix features, the feature value used in the 
analysis was averaged over the angles. 
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Table 5-1. Radiomics Features Analyzed 
Gray Level Co-occurrence Gray Level Run Length Neighborhood Gray Tone 
Difference 
Intensity Histogram 
Auto Correlation Gray Level Nonuniformity Busyness Energy 
Cluster Prominence High Gray Level Run Emphasis Coarseness Entropy 
Cluster Shade Long Run Emphasis Complexity Maximum 
Cluster Tendency Long Run High Gray Level Emphasis Contrast Mean 
Contrast Long Run Low Gray Level Emphasis Texture Strength Median 
Correlation Low Gray Level Run Emphasis  Minimum 
Difference Entropy Run Length Nonuniformity  Standard Deviation 
Dissimilarity Run Percentage  Uniformity 
Energy Short Run Emphasis  Kurtosis 
Entropy Short Run High Gray Level Emphasis  Skewness 
Homogeneity Short Run Low Gray Level Emphasis  Variance 
Homogeneity 2    
Information Measure Correlation 1    
Information Measure Correlation 2    
Inverse Difference Moment Norm    
Inverse Difference Norm    
Inverse Variance    
Max Probability    
Sum Average    
Sum Entropy    
Sum Variance    
Variance    
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5.2.5 Statistical Methods  
The Spearman correlation of feature values with tube voltage was calculated with the null 
hypothesis that there is no correlation. The Spearman correlation was computed for each feature in a 
material with a given pre-processing technique using R (R software package, version 3.4.3). As the 
Spearman correlation cannot handle ties, the p-value was computed using permutations through the R 
software package coin (version 1.2-2). To determine how common statistically significant correlations 
were, we tallied the total number of instances in which a given feature had a statistically significant 
correlation (p < 0.1). This p-value was chosen due to the small number of tube voltage data points that 
could be acquired which limits small p-values from being achieved. Multiple hypothesis testing was not 
used for the Spearman correlation tests in order to give a “worst case” estimate as multiple hypothesis 
testing would shift more instances to non-significant p-values.  
The variability in radiomics features induced by changing the tube voltage was evaluated by 
comparing it to the variability in radiomics features in patients:  
𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 − 𝑃𝑃𝑛𝑛𝑛𝑛𝑛𝑛𝑃𝑃𝑛𝑛𝑃𝑃𝑛𝑛𝑃𝑃𝑛𝑛 𝑝𝑝ℎ𝑃𝑃𝑃𝑃𝑃𝑃𝑛𝑛𝑛𝑛 𝑛𝑛𝑃𝑃𝑃𝑃𝑟𝑟𝑃𝑃 =
𝑃𝑃ℎ𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑅𝑅𝑎𝑎𝑎𝑎𝑅𝑅𝑅𝑅𝑓𝑓,𝑚𝑚
𝑥𝑥𝑓𝑓,𝑚𝑚��������
𝑠𝑠𝑝𝑝𝑓𝑓
𝑥𝑥𝑝𝑝𝑓𝑓�����
�
    (5-1), 
 
where 𝑃𝑃ℎ𝑃𝑃𝑃𝑃𝑃𝑃𝑛𝑛𝑛𝑛 𝑅𝑅𝑃𝑃𝑃𝑃𝑟𝑟𝑃𝑃𝑓𝑓,𝑎𝑎 is the range of values across the different tube voltage scans for a given 
feature f and phantom material m; 𝑥𝑥𝑓𝑓,𝑎𝑎������ is the mean of values across the different tube voltage scans 
for a given feature and phantom material; 𝑠𝑠𝑝𝑝𝑓𝑓  is the patient standard deviation for a given feature; and 
𝑥𝑥𝑝𝑝𝑓𝑓���� is the patient mean for a given feature. Larger values of the patient-normalized phantom range 
showed that the variability in feature values due to changes in tube voltage were large in comparison to 
inter-patient variation. Thus, this feature dependence on tube voltage could affect their use in 
prognostic model building.  
Paired Student’s t-tests were used to compare the results of the different pre-processing 
techniques, patient cohorts, and vendors. These tests were initially run as two-sided tests with the null 
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hypothesis that the difference between the means is 0. If a statistical difference was found, one-sided t-
tests were then run to determine which of the two subjects (the two pre-processing techniques, patient 
cohorts, or vendors in the specific t-test) in the comparison was larger. A p-value of 0.05 was used to 
determine statistical significance. 
  
5.3 Results 
5.3.1 Effective Atomic Number 
The calculated effective atomic number values are summarized in Table 5-2. In addition, this 
table contains effective atomic numbers for bone, fat, and muscle for comparison to the cartridge 
material values [133].  
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Table 5-2. Estimated Atomic Number of Phantom Cartridges and Human Tissues 
Cartridge or Tissue Effective Atomic Number 
Acrylic 6.56 
Wood 7.16 
Cork 6.86 
Dense cork 6.61 
Rubber 5.37 
Bone 12.31 [133] 
Fat 6.46 [133] 
Muscle 7.64 [133] 
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5.3.2 Spearman Correlation of Features with Tube Voltage 
The Philips scanner data only contained three data points of different tube voltages; thus, it 
was difficult to obtain statistically significant Spearman correlations. Table 5-3 summarizes the 
percentage of total features within each feature group with statistically significant (p < 0.1) Spearman 
correlations. This table only includes the GE scanner data. The material-, scanner-, and feature-specific 
Spearman rho and p-value data are provided in Appendix B. All of the feature groups (gray level co-
occurrence, gray level run length, neighborhood gray tone difference, and intensity hisogram) had 
features that were correlated with tube voltage. The gray level run length matrix features were most 
often correlated with tube voltage from the four categories.  
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Table 5-3. Percentage of Features with Significant Spearman Correlation 
Feature Group Features with Significant Spearman Correlation (%) 
GLCM 29.5 
GLRLM 55.5 
NGTDM 22.0 
IH 51.4 
GLCM: gray level co-occurrence matrix; GLRLM: gray level run length matrix; NGTDM: neighborhood 
gray tone difference matrix; IH: intensity histogram 
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The strength of the correlation was material dependent. Figure 5-1 shows axial slices of the 
acrylic and cork cartridges at each tube voltage from the GE scans analyzed using only thresholding. 
Visually, there is little to no discernable change in these images. However, the feature plots next to 
these images in the figure show that the features changed with the tube voltage. In addition, the 
change and trend with the tube voltage depended on the cartridge material. The four features in the 
figure are from different feature groups; thus, each group was represented. While the Spearman 
correlation p-value was 0.17 for all four features for acrylic, the trend is clear. Because of the limited 
number of permutations that are possible with only four distinct tube voltages, low p-values were 
difficult to achieve. In contrast, all p-values for cork were much higher. However, while the Spearman 
correlation was high for acrylic, there was always one tube voltage data point that did not follow the 
trend. The tube voltage that this occurred at was not consistent across the four features.  
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Figure 5-1: Acrylic and Cork Changes with Tube Voltage. 
Axial slices of the acrylic and cork cartridges at 80, 100, 120, and 140 kVp are shown from the data set 
on the GE scanner. In these slices it can be seen that acrylic has low texture while cork has a rough 
texture pattern. Next to the axial slices are feature plots using thresholding pre-processing, with one 
feature from each feature group. The percentage difference of the feature value relative to the feature 
value at 120 kVp is shown for acrylic (red circles) and cork (blue triangles). There was a change in the 
features with tube voltage, but it was material dependent. For busyness, acrylic has a Spearman rho of -
0.8 with a p-value of 0.17, and cork has a rho of -0.2 with a p-value of 0.73. For dissimilarity, acrylic has 
a rho of 0.8 with a p-value of 0.17, and cork has a rho of 0.2 with a p-value of 0.73. For long run 
emphasis, acrylic has a rho of -0.8 with a p-value of 0.17, and cork has a rho of 0.2 with a p-value of 
0.73. For skewness, acrylic has a rho of -0.8 with a p-value of 0.17, and cork has a rho of -0.4 with a p-
value of 0.49. Window width: 1600, window level: –300. 
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5.3.3 Patient-Normalized Phantom Range 
We computed the patient-normalized phantom range using data from both scanners as the 
phantom range not impacted by the scarcity of data unlike the Spearman correlations described above. 
Figure 5-2 shows a heat map of the patient-normalized phantom range for the GE scanner when the 
pre-processing technique was only thresholding. The patient-normalized phantom ranges, calculated 
using the two different patient populations, are shown for each material, ordered from the least to the 
most texture. The heat maps for the other pre-processing techniques and for the Philips scanner are 
provided in the Appendix B. 
According to Figure 5-2, the gray level run length matrix features performed the worst, 
indicating that they are the most sensitive to changes in tube voltage. In addition, the gray level co-
occurrence matrix features of auto correlation, sum average, and sum variance consistently had higher 
patient-normalized phantom range values across the materials than the other gray level co-occurrence 
matrix features. The intensity histogram features of mean, median, and minimum also performed 
poorly and had high patient-normalized phantom range values for all materials and patient cohorts, as 
shown in Figure 5-2. However, these three intensity histogram features had very little patient variation 
(i.e., small 𝑠𝑠𝑝𝑝𝑓𝑓 in equation 1); almost any change due to tube voltage in the phantom would cause these 
features to have high patient-normalized phantom range values. For example, kurtosis and mean both 
had very small ranges across different tube voltage scans, but the spread of kurtosis values among 
patients was large while it was small for mean; thus, kurtosis had much lower patient-normalized 
phantom range values than mean. 
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Figure 5-2: Heat map of Patient-Normalized Phantom Range Values. 
The patient-normalized phantom range values are shown for each feature on the basis of each material 
and patient population. The values are between 0 and 2; any values above 2 were mapped to the 
maximum color. The materials along the x-axis are listed in order from least to most texture on the 
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basis of the measured standard deviation of the CT numbers of the material. The patient-normalized 
phantom range that was calculated using the two patient cohorts appears together for each material. 
Each feature along the y-axis is identified first by the acronym for the feature group that it is part of. 
Each feature group is shown together with black lines separating the feature groups within the heat 
map. Textured materials have lower patient-normalized phantom range values. In addition, the gray 
level run length matrix features can be seen to have the highest values in comparison to the other 
feature groups. GLCM: gray level co-occurrence matrix; GLRLM: gray level run length matrix; NGTDM: 
neighborhood gray tone difference matrix; HNSCC: head and neck squamous cell carcinoma; NSCLC: 
non-small cell lung cancer. 
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There was also a clear difference in patient-normalized phantom range values across the 
different materials: features from low-texture materials had higher patient-normalized phantom range 
values. According to the results of one-sided paired t-tests, the order of the materials, from statistically 
higher to lower patient-normalized phantom ranges, was acrylic, rubber, cork, dense cork, and wood. 
Acrylic did not have statistically significantly (p = 0.13) higher patient-normalized phantom ranges than 
rubber, and dense cork did not have statistically significantly (p = 0.17) higher patient-normalized 
phantom ranges than wood. Interestingly, rubber, the material with the highest texture, had higher 
patient-normalized phantom ranges than cork, dense cork, and wood. This is discussed further in the 
Discussion. 
The patient-normalized phantom range values were statistically significantly (p < 0.05) different 
when bit-depth rescaling, smoothing, and thresholding were all used for pre-processing. The patient-
normalized phantom range values for this pre-processing technique were statistically significantly 
higher than were those when the other pre-processing techniques were used. The other pre-processing 
techniques did not produce patient-normalized phantom range values that were statistically 
significantly different. 
The patient-normalized phantom range values, when computed using the HNSCC patient 
cohort, were statistically significantly (p = 0.003) lower than were those using the NSCLC patient cohort. 
The patient-normalized phantom ranges were not statistically significantly (p = 0.75) different between 
the GE and Philips scanners. 
 
5.4 Discussion 
In this study, we investigated the effect of tube voltage on radiomics texture values. The tube 
voltage used in patient scans may vary because of differing protocols and scanners; thus, its effect must 
be investigated before these patients can be combined into a single cohort. The Spearman correlation 
test showed that about half of the features in several feature groups were correlated with tube voltage, 
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which was expected because of the association between HUs and tube voltage [144]. Thus, it was 
important to determine the relative impact of this change in feature values due to tube voltage 
compared to the inter-patient variation in order to evaluate if the feature value change could impact 
patient studies. Overall, radiomics features were more robust to changes in tube voltage when 
measured in materials with more texture; thus, in radiomics studies, differences in the tube voltage of 
patients’ CT scans is not an important factor.  
The cartridge materials used had effective atomic numbers close to those of human tissues. 
Acrylic, cork, rubber, and wood had effective atomic numbers close to those of fat and muscle. In 
addition, the calculated values were close to those reported in the literature. The calculated effective 
atomic number for acrylic was 6.56, which is slightly higher than that found in the literature (6.43-6.47) 
[145, 146]. The calculated effective atomic number for wood roughly agreed with the Monte Carlo 
calculations by Marashdeh et al. [135], who found that for wood particles less than 50 µm in size, the 
effective atomic number was about 7 for energies between 45 keV and 60 keV. Elias et al. showed that 
the percentage of carbon in the rubber can affect the effective atomic number, with it ranging from 
4.99 to 8.66 [147]. Our calculated value fell within this range, implying that it is a reasonable estimate. 
In addition, the cork and rubber cartridges have been previously shown to have textures similar to 
those of NSCLC tumors [132]. 
The gray level run length feature group performed the worst of the feature groups with most of 
its features consistently having high patient-normalized phantom range values. This may be due to the 
effect of tube voltage on image contrast, which would change the proportion of voxels in each gray 
level. The gray level run length matrix sums over the same range of values as the minimum and 
maximum are specified values, but the proportion of values in the lower or higher HU range may differ. 
This would affect the features that stress high or low gray levels, such as low gray level run emphasis 
(with high patient-normalized phantom range values, as shown in Figure 5-2), which is defined as 
𝐿𝐿𝐿𝐿𝑅𝑅𝐿𝐿 = 1
𝑎𝑎𝑟𝑟
∑ 𝑝𝑝𝑔𝑔(𝑖𝑖)
𝑖𝑖2
𝑀𝑀
𝑖𝑖=1   (5-2), 
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where nr is the total number of runs, i is the gray level, M is the total number of gray levels, and  
𝑝𝑝𝑅𝑅(𝑃𝑃) = ∑ 𝑝𝑝(𝑃𝑃, 𝑗𝑗)𝑁𝑁𝑗𝑗=1   (5-3) 
is the sum distribution of the number of runs with gray level i, run length j, maximum run length N, and 
run-length matrix p(i,j). It can clearly be seen how a scan at a different tube voltage in which there is a 
shift in voxels within a certain gray level would be affected in this formula: M stays the same, but pg(i) 
differs, while the emphasis of i2 in the denominator remains the same. 
The results of this study were similar to those from Mackin et al., who found that mAs did not 
affect radiomics features when measured in materials that had texture (i.e., radiomics features that 
were not measured in acrylic) [38]. Measuring features in the acrylic cartridge represents measuring 
the noise characteristics due to the different parameters. Therefore, both of these studies showed that 
the inherent texture of a material is more important than the noise created by varying acquisition 
parameters. These results are somewhat consistent with those from the study by Fave et al. [123], who 
simulated patient scans at different tube voltages and found that intra-patient variation was 
significantly lower than inter-patient variation for all features tested. In our study, the difference 
between scans at different tube voltages was not given by a HU shift applied to all voxels, which may 
explain the finding that some features changed significantly in comparison to inter-patient variation.  
These results are also somewhat consistent with Berenguer et al. [124]. They found that 43% of 
features had a coefficient of variation of less than 10% and that 55% of features had a coefficient of 
variation of less than 15% because of changes in tube voltage. In our study, 77% and 75% of the 
features measured on the GE and Philips scanners, respectively, had a coefficient of variation of less 
than 10%, and 84% and 81% of the features had a coefficient of variation of less than 15%. We 
examined 196 features (four pre-processing techniques and 49 features), while Berenguer et al. 
examined 177 features without pre-processing. In addition, we calculated gray level co-occurrence 
features and neighborhood gray tone difference features in 2D, while they calculated them in 3D. These 
differences may account for the larger number of features that had a smaller coefficient of variation in 
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our data set. Another potential cause for the difference was that we only had a few data points 
because of the limited tube voltage settings on the scanners; therefore, the coefficient of variation may 
not be a stable metric in such cases. Our results also mostly agree with Buch et al. [148]. Our specific 
additional contributions were that our study used a validated phantom that had similar features as 
patients [132] and a common, open-source radiomics tool. 
In this study, rubber had the highest texture. We had assumed that the cartridge material 
referred to as “rubber” was pure rubber when calculating the effective atomic number. However, it was 
ground-up tires; thus, less than 50% was rubber, and 17% was metal [149]. This high proportion of 
metal in the material explains why the rubber cartridge was not statistically significantly different from 
the acrylic cartridge. The high atomic number components caused the changes in the tube voltage to 
dramatically affect features measured in the rubber cartridge. 
In previous studies in which patient cohorts were used to compare to phantom results, only 
one patient cohort was typically used. In this study, we used two distinct patient cohorts and found 
them to have statistically different results. The HNSCC patient cohort likely produced smaller patient-
normalized phantom range values because these patient scans had contrast; thus, there may have been 
a larger patient spread in radiomics feature values. 
There were a few limitations to this study. First, constant CTDIvol was difficult to achieve using 
the parameters that could be changed on the Philips machine while trying to keep the pitch, rotation 
time, image thickness, and pixel size constant; thus, the variability of the CTDIvol was much larger for the 
Philips scanner than for the GE scanner. Secondly, it was conducted in a phantom; thus, the true 
implications for patient scans are not known. Conducting this study in patients would require an 
unnecessarily excessive radiation dose. The effective atomic number of the phantom cartridges was 
similar to that of human tissue; thus, reasonable conclusions can be drawn for patients’ tumor and 
normal tissues on the basis of the phantom results. In addition, because of the construction of the 
phantom, the conclusions in this study only apply to non-contrast CT scans. The effect of changing tube 
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voltage on iodine-containing tissue would be different. The phantom design was also not specific to a 
body part and did not include build-up which could affect beam hardening and scatter, which could 
consequently affect texture. Additionally, only one scan was taken at each tube voltage setting. The 
tube voltage and current can differ slightly between scans; however, in previous experiments, we found 
that the coefficient of variation of features acquired under the same settings was typically below 1%.  
Lastly, only two scanners were evaluated. Mackin et al. found that different scanners produced 
different feature values, but the features typically clustered by vendor [132]. Our study was focused on 
the magnitude of feature changes induced by altering the tube voltage; therefore, a large sample of 
scanners was not necessary as each scanner represented its vendor. The two scanners used in this 
study were from two different vendors and thus had different tube voltage settings. However, the same 
trends were found on both scanners, as shown by the t-test on the patient-normalized phantom range 
values and the heat maps. Specifically, we found that features in high-textured materials were more 
robust to tube voltage changes than were features in low-textured materials. This study and that by 
Berenguer et al. [124] found that the scanner did not affect the results. Thus, it is reasonable to 
presume that the same trend would be found for other GE and Philips scanners and scanners from 
other vendors. 
 
5.5 Conclusions 
In this study, we found that changes in the tube voltage had less effect on the measured 
radiomics feature values of phantom cartridges with high texture than on those with low texture (i.e., 
cork vs acrylic). High-texture cartridges are more representative of patient tumor tissue; thus, features 
measured in tumors are also not expected to be significantly affected by tube voltage. Several features 
had consistently high patient-normalized phantom range values, indicating that they were unreliable 
and should be used with caution in studies that include patients scanned with different tube voltages. 
Based on the results from this study, we recommend using the most common tube voltage setting for 
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the particular anatomical site of interest when conducting prospective studies, as this eliminates any 
effect of tube voltage on radiomics feature values shown by the patient-normalized phantom range 
values. However, in retrospective studies, a patient would not have to be excluded from the cohort due 
to differences in acquisition tube voltage. This is because the differences in radiomics feature values 
will be small, and therefore patient stratification will not be affected, as long as non-robust features are 
not used. 
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Chapter 6 : Impact of Head and Neck Artifacts on Computed Tomography 
Radiomics Features 
This chapter is based upon: 
Ger, RB, Craft, DF, Mackin, DS, Zhou, S, Layman, RR, Jones, AK, Elhalawani, H, Fuller, CD, Howell, RM, Li, 
H, Stafford, RJ, Court, LE. Practical Guidelines for Handling Head and Neck Computed Tomography 
Artifacts for Quantitative Image Analysis. Computerized Medical Imaging and Graphics doi: 
10.1016/j.compmedimag.2018.09.002. Volume 69, Pages 134-139. 2018. ©Elsevier. 
The permissions for reuse of these materials were obtained from Elsevier. 
 
6.1 Introduction 
 While radiomics studies have identified several imaging features that are associated with 
prognosis, these findings can be affected by a variety of factors. The impact of many characteristics of 
imaging protocols, such as voxel size, tube current, tube voltage, and kernel, has been studied 
thoroughly [32, 34, 35, 37, 38, 150]. However, the effects of factors intrinsic to the patient have not 
been investigated. For example, CT scans of the head and neck cover the oral cavity, where many 
patients have metal dental fillings that cause streak artifacts. As radiomics is based on the assumption 
that gene expression at a microscopic level is discernible on a macroscopic level in the voxels, it is likely 
that measuring the radiomics features of the structures affected by a streak artifact would not provide 
any valuable information about that structure. Another type of artifact observed in CT scans, beam 
hardening, can affect images containing bone. Because there are many bones in the area of interest in 
head and neck examinations, this area may be particularly prone to the effects of these small artifacts. 
As a result, patients whose structure of interest is affected by streak or beam-hardening artifacts are 
often excluded from the large data sets required to achieve sufficient statistical power for radiomics 
studies. Therefore, finding a way to include as many patients as possible is needed.  
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 We aimed to test the impact of these artifacts and if needed, methods for compensating for 
these artifacts in head and neck radiomics studies. First, we determined whether streak artifacts do in 
fact alter radiomics feature values, and, if so, whether the simple technique of removing the slices 
affected by the streak artifact produced feature values similar to those in regions unaffected by the 
artifact. Second, we aimed to determine whether a buffer region is needed between bone and other 
structures to ensure that the measured feature values are not affected by beam-hardening artifacts. 
 
6.2 Methods and Materials 
6.2.1 Streak Artifact 
6.2.1.1 Impact of Streak Artifacts on Feature Values 
The impact of streak artifacts on feature values was investigated using a cohort of 458 patients 
with HNSCC. All procedures were performed in accordance with the Declaration of Helsinki on Ethical 
Issues with a waiver of informed consent from the Institutional Review Board at the University of Texas 
MD Anderson Cancer Center. Only the patients whose CT images exhibited a visible streak artifact on 
slices showing the GTV were selected, resulting in the selection of 108 patients. The 108 patient cohort 
had a mean age of 58 years (range: 30-80 years), mean height of 173 cm (range: 149-191 cm), and 
mean weight of 77.9 kg (range: 46.0-136.0 kg). In order to evaluate the impact of streak artifacts on the 
radiomics features (gray-level co-occurrence matrix features, gray-level run length matrix features, 
neighborhood gray tone difference matrix features, and intensity histogram features), a new ROI was 
created from which the GTV slices with the streak artifact were removed. Radiomics features were 
extracted for the 2 ROIs: the original GTV and the modified GTV. A pairwise t-test was used to 
determine if there was a significant (p < 0.05) difference in the measured features. This difference in 
measured features would indicate the streak artifacts having an impact. Streak artifacts were identified 
manually using a window width of 400 and a window level of -200. An example of a streak artifact is 
shown in Figure 6-1.  
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Figure 6-1: Streak Artifact. 
Example of identified streak artifact using a window width of 400 and window level of -200. 
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6.2.1.2 Impact of Removing Slices 
A potential approach to removing the effect of streak artifacts on radiomics features is to 
exclude the affected slices from the feature calculations. In order to study the impact of excluding slices 
on feature values, we selected CT images for 30 HNSCC patients from the 458 patient cohort with no 
streak artifacts or with GTVs located far from the artifact and whose imaging parameters were the 
same. The 30 patients’ mean age was 64 years (range: 50-87 years), mean height, 175 cm (range: 149-
193 cm), and mean weight, 80.5 kg (range: 43.9-114.9 kg). Slices of the GTV were removed in 2 ways: 
(1) sequentially, from superior to inferior and (2) in the order given by a random number generator. A 
new ROI was created for each slice removed from the GTV until only 1 slice remained in the GTV (e.g., if 
the total GTV was 10 slices, the first ROI would consist of the full 10 slices, the next ROI would contain 9 
slices, the next ROI would contain 8 slices, etc.) 
 To determine the volume that could be removed before feature values changed, we developed 
a range variation metric based on the range of values across the volumes. First, for each feature and 
patient, the scaled range, SR, was calculated as 
𝑆𝑆𝑅𝑅𝑖𝑖 =
𝑟𝑟𝑎𝑎𝑎𝑎𝑅𝑅𝑅𝑅(𝐼𝐼𝐼𝐼𝑖𝑖)
𝐼𝐼𝐼𝐼𝐼𝐼𝑖𝑖
      (6-1), 
where i is the patient number (1 to 30), IFi is the feature value for patient i, and FIFi is the feature value 
at full volume for patient i. Next, the scaled range for each patient, SRi, was used as an input in the 
range variation metric to determine whether the given feature was robust to the removal of slices from 
the GTV: 
𝑅𝑅𝑃𝑃𝑃𝑃𝑟𝑟𝑃𝑃 𝑉𝑉𝑃𝑃𝑛𝑛𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑛𝑛𝑃𝑃 = 𝑎𝑎𝑅𝑅𝑎𝑎𝑎𝑎(𝑆𝑆𝑅𝑅𝑖𝑖)𝑆𝑆𝑆𝑆(𝐼𝐼𝐼𝐼𝐼𝐼)
𝑎𝑎𝑅𝑅𝑎𝑎𝑎𝑎(𝐼𝐼𝐼𝐼𝐼𝐼)�
    (6-2), 
where the numerator is the mean of the scaled ranges and the denominator is the standard deviation 
of the feature values at full volume across all patients divided by the mean of the feature values at full 
volume for all patients. The range variation metric thus represents the average effect of removing parts 
of the tumor divided by the variability in the patient population. 
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 To evaluate the robustness of features to the removal of slices with streak artifacts, we divided 
the data set into 4 volume range groups. In each group, all contours within a specified volume range 
were evaluated: 75%-100%, 50%-100%, 25%-100%, and 0%-100%. For example, in the 75%-100% 
group, all ROIs for a given patient that had at least 75% of the original GTV remaining after removing 
slices were evaluated. A cutoff of 0.5 was used to determine if features were robust. Features with a 
range variation above 0.5 were deemed not robust. A pairwise t-test was conducted to compare the 
feature values at 100% GTV and 50% GTV. 
 
6.2.1.3 Feature Extraction 
Images were analyzed using IBEX, an open-source radiomics tool [137, 151]. The GTV was 
contoured on patient images by a radiation oncologist (H. Elhalwani). Twenty-two gray-level co-
occurrence matrix features [139], 11 gray-level run length matrix features [140, 141], 5 neighborhood 
gray tone difference matrix features [142], and 11 intensity histogram features were calculated in IBEX. 
Each feature was calculated with 4 different preprocessing techniques because different preprocessing 
techniques have been shown to have different predictive power in non-small cell lung cancer patient 
survival for individual features [143]; therefore, we tested the following combinations of preprocessing 
techniques: (1) thresholding, (2) thresholding and Butterworth smoothing (order 2, cutoff 125), (3) 
thresholding and 8-bit depth resampling, and (4) thresholding, Butterworth smoothing, and 8-bit depth 
resampling. The lower bound of the threshold was −100 Hounsfield units, and no upper limit was used. 
The preprocessing and feature group settings were the same as those described in Fave et al.’s 
supplemental material [14]. These features and preprocessing were chosen as they have been used in 
prognostic studies and for each feature, at least one of the preprocessing techniques has been shown 
to be correlated with overall survival, local recurrence, or distant metastases [14]. Illustrations of the 
effects of each of these preprocessing techniques is demonstrated in Fave et al. [143]. 
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6.2.2 Bone Artifact 
6.2.2.1 Phantom Design and Analysis 
A modified version of the radiomics phantom described by Mackin et al. [132] was created to 
analyze the impact of bone artifacts on feature values (Figure 6-2). The phantom contained a cylindrical 
insert made up of 5 different materials: cork, dense cork, hemp seeds, rubber, and solid water. The 
hemp seeds were held in a 3D-printed cartridge made of polylactic acid (PLA). There was a central hole 
with a diameter of 2.2 cm through the insert materials. A rod of solid polyvinyl chloride (PVC) was 
placed in the hole to simulate bone [152]. A rod of 3D-printed PLA was placed in the hole to simulate 
water [153, 154]. The feature values obtained with the PLA rod in place were considered the true 
values, as this rod induced no artifact. These values were used as the reference for comparison of the 
feature values extracted with the PVC rod, which simulated bone, in place. The phantom was encased 
in a 28 × 21 × 22-cm3 buildup of high-density polystyrene; the size was based on the mean physical 
dimensions of a European female chest [155]. 
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Figure 6-2: CT Images of Bone Phantom. 
(a) Coronal slice of the full phantom with the polyvinyl chloride rod in the center of the cartridge 
materials and high-density polystyrene surrounding the cartridges. The full phantom had dimensions of 
28 × 21 × 22 cm3, the mean dimensions of a European female chest. Axial slices showing inserts of (b) 
rubber, (c) hemp seeds, (d) cork, (e) dense cork, and (f) solid water. Window width: 1600, window level: 
−300.  
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The phantom was scanned on a Philips Brilliance Big Bore CT scanner (Philips Healthcare, 
Eindhoven, The Netherlands). Scans were acquired with the following parameters: 120 kVp, 200 mAs, 
0.938 pitch, 1.0 s rotation time, 3-mm image thickness, 0.976 mm × 0.976-mm pixel size, and kernel C. 
The phantom was scanned 5 times each with the PVC and PLA inserts.  
 Wilcoxon rank sum tests were used to determine whether the feature values measured with 
the PLA insert were different from the feature values measured with the PVC insert (i.e., if contours 
next to bone were affected). For features that were significantly (p < 0.05) different, we computed the 
average absolute difference between the measurement with the PLA insert and the measurement with 
the PVC insert and compared it to the standard deviation for the feature measured in a cohort of 
HNSCC patients. The HNSCC patients were the same 30 patients as in the slice-removal study described 
in section 6.2.1.2. 
 
6.2.2.2 Feature Extraction 
 The phantom was semiautomatically contoured using the location of a radiopaque marker on 
the superior edge of the phantom. The marker location was input into an in-house MATLAB 
(MathWorks) script to create a cylindrical ROI for each material with an outer diameter of 8.2 cm, an 
inner diameter of 2.2 cm, and height of 2 cm. Additional ROIs for each material were created with inner 
diameters increasing in 2-mm steps up to 3.4 cm. The same features and preprocessing techniques 
were used as for the streak artifact study described in section 6.2.1.2; however, for the phantom 
images, no threshold bounds were applied. 
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6.3 Results 
6.3.1 Streak Artifacts 
6.3.1.1 Impact of Streak Artifacts on Feature Values 
 On average, 3.0 cm3 of GTV had to be removed to eliminate streak artifacts (standard deviation: 
4.0 cm3, range: 0.11-28 cm3). Table 6-1 shows the percentage of features for which the measured value 
in the original GTV (with artifact) and the modified GTV (without artifact) differed significantly. Only for 
gray-level run length matrix features preprocessed using thresholding and intensity features 
preprocessed using thresholding, smoothing, and 8-bit depth resampling were fewer than 70% of the 
features affected by the streak artifact. For all other feature categories and combinations of 
preprocessing techniques, at least 73% of feature values were affected by the streak artifact. 
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Table 6-1. Percentage of features with significantly different values with streak artifacts and with 
artifact slices removed 
 Preprocessing technique 
Feature category Thresholding 
Thresholding and 
8-bit depth 
resampling 
Thresholding and 
Butterworth 
smoothing 
Thresholding, 
smoothing, and 8-
bit depth 
resampling 
GLCM (N = 22) 95% 91% 95% 91% 
GLRLM (N = 11) 17% 91% 73% 91% 
NGTDM (N = 5) 80% 100% 80% 100% 
Intensity (N = 11) 82% 82% 73% 64% 
GLCM: gray-level co-occurrence matrix, GLRLM: gray-level run length matrix, NGTDM: neighborhood 
gray tone difference matrix 
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6.3.1.2 Impact of Removing Slices 
 The number of features that were not robust across the volume range for each slice removal 
and preprocessing technique is shown in Table 6-2. Almost all features were robust with removal of up 
to 50% of the original GTV. When modified GTVs were allowed to go down to only 1 slice, almost no 
features were robust. The features that were not robust are listed in the Appendix C Table C-1. The 
range variation for each feature and preprocessing for the four volume groupings is contained in 
spreadsheets in the Supplemental Material of Ger et al. [156]. 
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Table 6-2. Number of features that were not robust across the volume range for each slice removal and preprocessing technique 
 Sequential Slice Removal Random Slice Removal 
ROI Volume 
Range  
Thresholding 
Thresholding 
and 8-bit 
depth 
resampling 
Thresholding 
and 
Butterworth 
smoothing 
Thresholding, 
smoothing, 
and 8-bit 
depth 
resampling 
Thresholding 
Thresholding 
and 8-bit 
depth 
resampling 
Thresholding 
and 
Butterworth 
smoothing 
Thresholding, 
smoothing, 
and 8-bit 
depth 
resampling 
75% - 100% 0 1 0 0 0 0 0 0 
50% - 100% 4 3 4 3 2 2 2 1 
25% - 100% 20 16 22 20 9 5 9 5 
0% - 100% 48 48 48 48 47 44 47 46 
ROI, region of interest 
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The pairwise t-test between features at 100% GTV and 50% GTV showed that 76% of features 
under the sequential slice removal technique and 80% of features under the random slice removal 
technique were not significantly (p < 0.05) different. 
 
6.3.2 Bone Artifact 
Table 6-3 shows the number of features that significantly differed in the phantom with a PLA or 
PVC rod. Adding Butterworth smoothing and 8-bit depth resampling had no consistent effect on the 
differences. For example, adding smoothing reduced the number of significantly different gray-level co-
occurrence matrix features in cork but increased the number in rubber. For the features with significant 
differences, the average difference divided by the standard deviation across the 30 HNSCC patients was 
0.57 (range: 0.0044-3.6) for cork, 0.28 (range: 0.0011-1.7) for dense cork, 2.0 (range: 0.0083-36) for 
hemp seeds, 0.14 (range: 0.0014-0.93) for rubber, and 3.0 (range: 0.0031-36) for solid water. The 
results were similar for the various ROIs with different inner diameters. 
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Table 6-3. Number of features with significantly different values when measured in a phantom with a 
PLA or PVC rod 
Feature Preprocessing technique Cork 
Dense 
Cork 
Hemp 
Seeds Rubber 
Solid 
Water 
GLCM 
(N=22) 
Thresholding 12 5 7 1 13 
Thresholding, smoothing 4 4 18 11 15 
Thresholding, 8-bit depth resampling 11 7 6 1 12 
Thresholding, smoothing, 8-bit depth 
resampling 
4 3 18 10 13 
GLRLM 
(N=11) 
Thresholding 7 6 6 3 6 
Thresholding, smoothing 7 6 7 7 10 
Thresholding, 8-bit depth resampling 5 5 4 3 10 
Thresholding, smoothing, 8-bit depth 
resampling 
5 5 8 5 6 
NGTDM 
(N=5) 
Thresholding 0 0 0 0 3 
Thresholding, smoothing 0 4 1 0 1 
Thresholding, 8-bit depth resampling 0 2 0 0 1 
Thresholding, smoothing, 8-bit depth 
resampling 
0 1 1 0 3 
Intensity 
(N=11) 
Thresholding 8 3 7 3 8 
Thresholding, smoothing 5 5 11 8 9 
Thresholding, 8-bit depth resampling 7 4 5 3 7 
Thresholding, smoothing, 8-bit depth 
resampling 
6 5 9 8 9 
GLCM: gray-level co-occurrence matrix, GLRLM: gray-level run length matrix, NGTDM: neighborhood 
gray tone difference matrix 
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6.4 Discussion 
In this study, we showed that streak artifacts affect radiomics feature values, suggesting that 
regions containing such artifacts should not be included in radiomics data sets. We demonstrated that a 
simple technique, removing the slices with the artifact, can be used to remove up to 50% of the original 
GTV from the ROI while retaining similar feature values. Additionally, while the presence of bone within 
the image can affect some feature values, the effect is typically smaller than the spread in values in the 
patient population and can, therefore, be ignored. 
 The choice of 0.5 as the cutoff of the range variation metric to determine feature robustness 
was arbitrary. However, we found that using different cutoffs did not change the conclusions: feature 
values were generally robust when up to 50% of the GTV was removed, but having only a small fraction 
(less than 50%) of the GTV remaining in the ROI caused very large differences in feature values. 
Additionally, a 50% cutoff for robustness means that only a few patients would be lost from the data 
set; only 15 (3%) of 458 HNSCC patients had artifact on more than 50% of the GTV. 
 The majority of feature values were not significantly affected by the PVC rod simulating bone in 
the phantom. When features were affected, the effect was typically smaller than the standard 
deviation in values from the patient population. Interestingly, we found that the mean HU value was 
always significantly higher when the PVC rod was in the phantom than when the PLA rod was in the 
phantom, whereas the median HU was only higher for the PVC rod than the PLA rod when 8-bit depth 
resampling was not used. The presence of PVC caused this difference no matter the distance measured 
from the interface of the cartridge material and PVC. However, the average difference was typically 
one-tenth of the standard deviation of the value from the patient cohort for these features. Therefore, 
the presence of bone may cause changes in feature values, but the proximity of contours does not.  
 A method similar to that used for determining the impact of bone artifacts could have also 
been used for the streak artifacts. For example, a phantom could have been scanned with and without 
a metal bb inside of it. Since a phantom only simulates patient tissues and is not a true match and we 
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had a large sample of patients with streak artifacts within their GTV, we chose to analyze the patient 
set instead of a phantom. This gave us the most realistic scenario for implementation on patient data 
sets. We did not have a large sample for the bone artifacts and thus chose to study the impact within a 
phantom. 
 There were several limitations to this study. First, only one technique was investigated for 
dealing with streak artifacts. Metal artifact reduction techniques may also be able to solve the problem 
of streak artifacts and may be able to do so without having to exclude any patients. Second, the bone 
artifact study was conducted in a phantom. While the rubber and cork cartridges have been shown to 
produce feature values similar to those produced by non-small cell lung cancer tumors [132], the size 
and shape of the phantom simulated the dimensions of a human chest, not a head. A potential avenue 
for future investigation could be to create an anthropomorphic head and neck phantom using real 
human bone. This would allow us to investigate whether features are more susceptible to beam-
hardening artifacts right inside the skull than near a cylinder of bone-like material. Additionally, many 
of these features have been found to have some correlation with volume [143]. This may contribute to 
features becoming less robust as more volume was removed. Finally, both of these studies were 
conducted on CT scans from a single vendor so the results may not be universally applicable. 
 
6.5 Conclusion 
 We demonstrated that streak artifacts affect the measured radiomics feature values. In order 
to deal with this effect, we suggest simply removing the slices with the artifact. Using this method, 
feature values are robust when up to 50% of the original GTV is removed. Excluding patients in whom 
more than 50% of the GTV is affected by the artifact only causes about 3% of patients to be excluded. 
Additionally, we demonstrated that contours can abut bone if needed, as most features are not 
affected by the presence of nearby bone. 
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Chapter 7 : Inter-Scanner Variability of Radiomics Features on Computed 
Tomography Scanners 
This chapter is based upon: 
Ger RB, Zhou, S, Chi, PM, Lee, HJ, Layman, RR, Jones, AK, Goff, DL, Fuller, CD, Howell, RM, Li, H, 
Stafford, RJ, Court, LE, Mackin DS. Comprehensive Investigation on Controlling for CT Imaging 
Variabilities in Radiomics Studies. Scientific Reports doi: 10.1038/s41598-018-31509-z. Volume 8, Pages 
13047. ©Nature Publishing Group. 
This article is under a Creative Commons license (http://creativecommons.org/licenses/by/4.0/) which 
permits reproduction in any format. 
 
7.1 Introduction 
 Many radiomics studies are conducted at one facility. However, as the field of radiomics has 
grown, researchers have sought larger patient cohorts by combining data from multiple facilities. This 
means that patients are scanned on different CT scanners using different protocols, which may affect 
radiomics features [157]. Due to this there have been studies analyzing the uncertainty due to different 
protocol parameters. These uncertainty studies often involve only a few scanners at one facility, which 
provides valuable information about imaging variability, but these results may not be generalizable to a 
larger population of CT scanners at multiple facilities. Mackin et al. created a radiomics phantom to 
investigate the imaging variability among 17 scanners using the routine chest protocol on each [132]. 
They found that radiomics feature value differences due to the different scanners were similar to the 
inter-patient radiomics feature variability among NSCLC patients and thus recommended that these 
imaging differences be considered in future studies. 
 In this study, we aimed to obtain a large sample of CT scanners for an in-depth analysis of 
imaging variability to determine how retrospective radiomics studies should select patients and how 
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prospective radiomics studies should design CT protocols. The large sample would allow for the 
conclusions to be applied generally to all CT scanners. Local protocols were used, as many studies use 
retrospective data and it is of interest whether protocol differences will cause large radiomics feature 
value differences, thus causing patient stratification to be dominated by scan protocol and not true 
patient radiomics feature values. Also, a controlled scan was used to see whether imaging differences 
could be minimized using a harmonized protocol across different vendors. 
 
7.2 Methods 
7.2.1 Methods and Materials 
 We used an updated version of the Credence Cartridge Radiomics phantom originally described 
by Mackin et al. [132] in 2015. This version of the phantom, shown in Figure 7-1, is comprised of six 
round cartridges encased in high-density polystyrene buildup. The six cartridges were held within the 
buildup in an acrylic case with a notch designed to keep the cartridges in the same position. This case 
can be seen in Figure 7-1 as the bright line around each cartridge before the buildup. The size of the 
buildup, 28 cm × 21 cm × 22 cm, is based on the mean physical dimensions of a European woman’s 
chest [155]. The six cartridges are each comprised of different materials: 50% acrylonitrile butadiene 
styrene (ABS), 25% acrylic beads, and 25% PVC pieces (percentages are by weight); 50% ABS and 50% 
PVC pieces; 50% ABS and 50% acrylic beads; hemp seeds encased in polyurethane; shredded rubber; 
and dense cork. These materials were chosen to produce a range of radiomics feature values similar to 
those of NSCLC tumors for the original materials [132], the new materials followed the same analysis as 
the original materials. Additional details on the differences between this phantom and the original 
phantom are described in the Discussion. 
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Figure 7-1: Radiomics Phantom used for Inter-Scanner Analysis. 
Axial views from a computed tomography scan of the radiomics phantom used. The cartridges are (a) 
50% acrylonitrile butadiene styrene (ABS), 25% acrylic beads, and 25% polyvinyl chloride (PVC) pieces 
(percentages are by weight), (b) 50% ABS and 50% PVC pieces, (c) 50% ABS and 50% acrylic beads, (d) 
hemp seeds in polyurethane, (e) shredded rubber, and (f) dense cork. The high-density polystyrene 
buildup is seen outside the cartridges with dimensions of 28 cm × 21 cm × 22 cm. The cartridges had a 
diameter of 10.8 cm. Window width: 1600, window level: –300. 
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7.2.2 CT Scans 
 A controlled CT scan was acquired using the following parameters for each scanner: tube 
voltage, 120 kV(p); tube current, 200 mA∙s; helical scan type; spiral pitch factor, 1.0; 50-cm display field 
of view; and image thickness, 3 mm (except for GE scanners, which used an image thickness of 2.5 mm). 
The acquisition parameters were designed to give about 13 mGy CTDIvol (average 16 mGy, standard 
deviation 4 mGy) in order to produce the same noise characteristics. A recent study by Mackin et al. 
[38] showed that features were not affected by noise levels in the image, thus variations in CTDIvol 
should not impact the radiomics features.  The convolution kernel was standard for GE; C for Philips; 
B31f, B31s for Siemens; and FC08 for Toshiba. These kernels were chosen to minimize the difference in 
radiomics feature values across vendors as described in Mackin et al.’s abstract [158]. Also, the local 
chest protocol and local head and neck protocol were used to acquire scans of the phantom. For the 
local protocols, no parameters were changed in order to estimate the variability in protocols across 
institutions and scanners. The parameters for each of the local protocol scans is supplied in the 
Supplemental Material of Ger et al. [136]. 
 
7.2.3 Patient Scans 
 A phantom alone cannot provide insight into the impact of feature variability within a patient 
study. Thus, we have included patient cohorts to determine the size of the imaging variability with 
respect to inter-patient variability, providing an estimate on the impact of the imaging variability for 
each feature. 
 For this study, we retrospectively reviewed the images and medical records of 20 patients with 
NSCLC and 30 patients with HNSCC with a waiver of informed consent from the Institutional Review 
Board at the University of Texas MD Anderson Cancer Center. These two cohorts of patients were used 
to compare the imaging variability to inter-patient variability. Radiomics features have been shown to 
improve the patient outcome models for both of these patient types [15, 17, 20, 22, 29]. 
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The NSCLC cohort had 10 men and 10 women, mean age of 67 years (range, 52-78 years), mean 
weight of 72.9 kg (range, 41.0-97.6 kg), and mean height of 170 cm (range, 154-182 cm). The CT scans 
were acquired on a GE Discovery CT scanner (GE Healthcare) at 120 kVp, 300 mA, 0.5 s rotation time, 
2.5-mm image thickness, 1.35 pitch, and 0.976 mm × 0.976 mm pixel size.  
 The HNSCC cohort had 25 men and 5 women, mean age of 64 years (range, 50-87 years), mean 
weight of 80.5 kg (range, 43.9-114.9 kg), and mean height of 175 cm (range, 149-193 cm). The CT scans 
were acquired using a GE LightSpeed CT scanner (GE Healthcare) at 120 kVp, 220 mA, 1.0 s rotation 
time, 1.25-mm image thickness, 1.375 pitch, and 0.488 mm × 0.488 mm pixel size. For both patient 
cohorts, the tumors were contoured by a radiation oncologist. 
 
7.2.4 Radiomics Feature Extraction 
 The phantom was semi-automatically contoured using an in-house MATLAB (version 2016b, 
MathWorks) script. A cylindrical ROI was created for each cartridge. Each ROI was 8.2 cm in diameter. 
The ROIs for the cartridge with 50% ABS and 50% acrylic beads and the cartridge with hemp seeds in 
polyurethane each had a height of 1.9 cm. All other ROIs each had a height of 2 cm. Mackin et al. 
showed that the size of the ROI did not impact conclusions of a phantom study [38], therefore we 
maximized the acceptable region within each cartridge. The ROIs were automatically placed into IBEX, 
an open-source radiomics tool [137, 151], and then viewed to determine acceptability. Generated 
contours were scrutinized and edited as needed. 
 Forty-nine features were calculated using IBEX: 22 gray level co-occurrence matrix features 
[139], 11 gray level run length matrix features [140, 141], 11 intensity histogram features, and five 
neighborhood gray tone difference matrix features [142] (Table 7-1). Four different preprocessing 
techniques were used for each feature: (1) thresholding; (2) thresholding and 8-bit depth resampling; 
(3) thresholding and a Butterworth smoothing filter (order of 2, cut-off of 125); and (4) thresholding, 8-
bit depth resampling, and Butterworth smoothing [143]. The thresholds for the NSCLC patient cohort 
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were a lower threshold of –100 HU and a higher threshold of 200 HU. A lower threshold of –100 HU 
was used for the HNSCC patient cohort with no upper threshold. No thresholding was applied to the 
phantom images. The settings for each feature were the same as those listed by Fave et al. in the 
Supplemental Material [14]. For the local scans, the pixel size was resampled to 1 mm × 1 mm using 
trilinear interpolation as suggested by the results from Mackin et al. [37]. For features that have been 
previously found to correlate with volume, the updated formulae were used as described by Fave et al. 
[143]. 
  
 
98 
 
Table 7-1. Radiomics Features Analyzed 
 Gray Level Co-
occurrence Matrix 
Gray Level Run Length 
Matrix 
Intensity 
Histogram 
Neighborhood Gray 
Tone Difference Matrix 
 Auto Correlation Gray Level Nonuniformity Energy Busyness 
 Cluster Prominence* High Gray Level Run 
Emphasis 
Entropy Coarseness 
 Cluster Shade* Long Run Emphasis Kurtosis Complexity 
 Cluster Tendency Long Run High Gray Level 
Emphasis 
Maximum Contrast 
 Contrast Long Run Low Gray Level 
Emphasis 
Mean Texture Strength 
 Correlation Low Gray Level Run Emphasis Median  
 Difference Entropy Run Length Nonuniformity Minimum  
 Dissimilarity Run Percentage Skewness*  
 Energy Short Run Emphasis Standard 
Deviation 
 
 Entropy Short Run High Gray Level 
Emphasis 
Uniformity  
 Homogeneity Short Run Low Gray Level 
Emphasis 
Variance  
 Homogeneity 2    
 Information Measure 
Correlation 1 
   
 Information Measure 
Correlation 2 
   
 Inverse Difference 
Moment Norm 
   
 Inverse Difference 
Norm 
   
 Inverse Variance    
 Max Probability    
 Sum Average    
 Sum Entropy    
 Sum Variance    
 Variance    
*Indicates features that were subsequently not used due to sensitivity of region of interest placement 
within the phantom material 
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7.2.5 Statistical Methods 
7.2.5.1 Feature Stability 
 The features were tested for reproducibility by moving the ROIs on one controlled scan of the 
phantom. The ROIs were shifted 10 times within the acceptable region of the cartridges. The coefficient 
of variation was calculated for each feature. Features for which more than 50% of instances (with four 
preprocessing types and six cartridges, there were 24 total instances for each feature) had a coefficient 
of variation above 10% were removed from further analysis. It was important to remove these features 
as features that are very sensitive to the positioning of the ROI may not properly represent the imaging 
variation and may only represent placement of the ROI on the different scans. 
 
7.2.5.2 Resampling the z Dimension 
 For the local protocol scans, the image thickness was not consistent. The impact of the image 
thickness on feature value was evaluated by computing the Pearson correlation for each ROI-feature 
combination. Additionally, the impact of resampling the image thickness was investigated by 
resampling the z dimension from 1 mm to 7 mm in 1 mm increments. Features were acquired using all z 
dimension resampling values and without resampling the z dimension. The intra-class correlation 
coefficient (ICC) was computed for each feature using the eight resampling options to determine if 
resampling changed the feature values and thus reduced the correlation of feature values with image 
thickness. The ICC (2,1) (two-way random effects, absolute agreement, single rater/measurement) and 
ICC (3,1) (two-way random effects, consistency, single rater/measurement) as described by Shrout and 
Fleiss [159] were computed in R (version 3.4.3) using the psych package (version 1.7.8) [160]. For these 
tests, features were calculated with thresholding preprocessing on the local chest protocol scans. The 
other preprocessing techniques and the head protocol scans were not used as this step was simply to 
determine the relationship between image thickness and feature values, and the additional 
preprocessing and protocol scans produced redundant data. 
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7.2.5.3 Imaging Variability 
 Our goal was to determine how the manufacturer and scanner uncertainties contribute to the 
overall variability in the feature values. To determine these uncertainties, we first built a linear mixed-
effects model, which estimates the contribution of the manufacturer, the additional scanner-wise 
variability within a given manufacturer, the cartridge material, and the residual to the variability in the 
measurements. The standard deviations of the distributions are used to provide estimates of the 
variability contributed from the manufacturer, scanner, cartridge material, and residual. The term 
scanner is used here to indicate an individual scanner (e.g., multiple of the same type of scanner from 
the same manufacturer are each considered distinct). There are many factors that could affect the 
images from a particular scanner, including the quality assurance (QA) technique/periodicity, scanner 
maintenance, and scanner design. Thus, radiomics features calculated from images taken using CT 
scanners of the same manufacturer/model may be different. The term residual typically implies a small 
contribution. However, for this study the term is simply used to represent anything that is not included 
within the formula (i.e., anything that is unknown). 
 A linear mixed-effects model was created for each scan type (controlled, local chest, and local 
head and neck protocol): 
𝑓𝑓𝑎𝑎,𝑖𝑖 = 𝜇𝜇 + 𝛼𝛼𝑎𝑎 + 𝛽𝛽𝑖𝑖 + 𝑟𝑟(𝑃𝑃) + 𝜀𝜀𝑎𝑎,𝑖𝑖  (7-1), 
where f is the feature, µ is the mean, m is the cartridge material, i is the scanner, α is the material-wise 
contribution, β is the scanner-wise contribution, g(t) is the fixed effect of the impact of image thickness 
on feature value, and ε is the residual. βi is normally distributed with a mean of γv,i and a variance of 
𝜎𝜎𝛽𝛽,𝑎𝑎2 (𝜎𝜎𝛽𝛽,𝑎𝑎2 = 𝜎𝜎𝛽𝛽2 × 𝑓𝑓𝑎𝑎2). γv,i is the vendor-wise contribution which is normally distributed with a mean of 
0 and a variance of 𝜎𝜎𝛾𝛾,𝑎𝑎2 (𝜎𝜎𝛾𝛾,𝑎𝑎2 = 𝜎𝜎𝛾𝛾2 × 𝑓𝑓𝑎𝑎2). 𝑓𝑓𝑎𝑎�  is the mean feature value for the cartridge material. εm,i 
is normally distributed with a mean of 0 and variance of 𝜎𝜎𝜀𝜀,𝑎𝑎2  (𝜎𝜎𝜀𝜀,𝑎𝑎2 = 𝜎𝜎𝜀𝜀2 × 𝑓𝑓𝑎𝑎2). The model computes a 
significance test before producing the results. If the standard deviation due to one component is much 
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smaller than the others, it is set to 0 and combined into the residual. The linear mixed-effects models 
were computed in R (version 3.4.3) using the lme4 package (version 1.1-17).  
 Imaging variability was measured using the uncertainties from the linear mixed-effects models. 
Currently, most studies do not apply corrections for the manufacturer and scanner. The total imaging 
variability was calculated to estimate the impact of continuing to not apply corrections. It was 
calculated as follows: 
𝐼𝐼𝑉𝑉𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡 =
𝜎𝜎𝑡𝑡,𝑚𝑚/𝑓𝑓𝑚𝑚�
𝜎𝜎𝑝𝑝/𝜇𝜇𝑝𝑝
 (7-2), 
where σp is the standard deviation of the feature value for patients, µp is the mean feature value for 
patients, and σt,m is the total standard deviation from the model, given by 
𝜎𝜎𝑎𝑎,𝑎𝑎 = �𝜎𝜎𝛽𝛽,𝑎𝑎2 + 𝜎𝜎𝛾𝛾,𝑎𝑎2 + 𝜎𝜎𝜀𝜀,𝑎𝑎2  (7-3). 
This metric (equation 7-2) includes a comparison to the patients to gauge the impact of the imaging 
variability in a patient setting. 
 The residual imaging variability was calculated to estimate the imaging variability that would 
exist in cohorts that include CT images from different scanners even if corrections could be applied 
based on the manufacturer and individual scanner, as follows: 
 
𝐼𝐼𝑉𝑉𝑟𝑟𝑅𝑅𝑠𝑠𝑖𝑖𝑟𝑟𝑟𝑟𝑎𝑎𝑡𝑡 =
𝜎𝜎𝜀𝜀,𝑚𝑚/𝑓𝑓𝑚𝑚�
𝜎𝜎𝑝𝑝/𝜇𝜇𝑝𝑝
 (7-4). 
 We repeated this modeling process for the three scan types (controlled, local chest, and local 
head and neck protocols) and compared the results. To determine if the controlled scan significantly 
reduced the variability, we performed one-sided pairwise t-tests comparing σβ, σγ, and σε between the 
controlled protocol and both local protocols. 
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7.2.5.4 Quality Assurance Using a Radiomics Phantom 
 The feasibility of creating a credentialing phantom for radiomics studies, similar to the 
credentialing of institutions for National Institutes of Health radiation therapy studies, was investigated. 
Ideally, the credentialing phantom would be small for ease of transport and use. Therefore, the ability 
of each cartridge was tested for its use in QA checks to determine which CT scanners do not fall within 
the credentialed standard population of scanners. The spread of feature values from different scanners 
should be small relative to the inter-patient spread, therefore, the patient standard deviations were 
used to determine if scanners fell close enough to the population scanner value or not. The controlled 
scans were used for this analysis. For each feature, the patient standard deviation was scaled to 
account for differences in means between the patient and phantom populations. 
𝜎𝜎𝑠𝑠𝑠𝑠𝑎𝑎𝑡𝑡𝑅𝑅𝑟𝑟 =
𝜎𝜎𝑝𝑝
𝜇𝜇𝑝𝑝
× 𝑓𝑓  (7-5) 
For each scanner, the number of features that fell outside 1/3 of the scaled patient standard deviation 
from the mean feature value was tallied. The idea of the bounds was to determine if criteria could be 
established such that a certain number of features would fall within the bounds in order for the given 
scanner to pass the QA test. Therefore, the bounds were set as follows: 
𝐿𝐿𝑛𝑛𝐿𝐿𝑃𝑃𝑛𝑛 𝑏𝑏𝑛𝑛𝑏𝑏𝑃𝑃𝑛𝑛 =  𝑓𝑓 − 1
3
𝜎𝜎𝑠𝑠𝑠𝑠𝑎𝑎𝑡𝑡𝑅𝑅𝑟𝑟 (7-6) 
𝑈𝑈𝑝𝑝𝑝𝑝𝑃𝑃𝑛𝑛 𝑏𝑏𝑛𝑛𝑏𝑏𝑃𝑃𝑛𝑛 =  𝑓𝑓 + 1
3
𝜎𝜎𝑠𝑠𝑠𝑠𝑎𝑎𝑡𝑡𝑅𝑅𝑟𝑟 (7-7) 
 
7.3 Results 
7.3.1 Scanners 
 The phantom was scanned on 100 scanners: 51 GE scanners (GE Healthcare), 20 Philips 
scanners (Philips Healthcare), 17 Siemens scanners (Siemens Healthineers, Erlangen, Germany), 11 
Toshiba scanners (Canon Medical Systems USA, Tustin, CA, USA), and one Philips and Neusoft Medical 
System scanner (Shenyang, China). Ninety-four scanners had a controlled protocol scan that could be 
 
103 
 
used: 48 GE, 18 Philips, 17 Siemens, and 11 Toshiba scanners. However, the kernel used for the Toshiba 
scans switched from FC18 (six scanners) to FC08 (five scanners) halfway through owing to a study that 
found the FC08 kernel to match the GE standard kernel best [158]. To determine whether both Toshiba 
kernels could be used in the analysis, k-means clustering was performed. The scanners did not cluster 
by kernel type. While the best match should always be used to minimize discrepancies, in this study the 
kernel differences among the Toshiba scanners was not a driving force in the variability and therefore, 
kernel did not matter for Toshiba and all Toshiba scans were included in the analysis. Ninety-three 
scanners had a local chest protocol scan that could be used: 47 GE, 19 Philips, 17 Siemens, and 10 
Toshiba scanners. Eighty-eight scanners had a local head protocol scan that could be used: 46 GE, 18 
Philips, 14 Siemens, and 10 Toshiba scanners. The various reasons that scans could not be used were as 
follows: the field of view did not encompass all the cartridges, the scan extent did not cover the length 
of the phantom, and the scan was acquired with variable image thickness. Head and neck protocols 
could be acquired only on CT scanners used for radiation therapy purposes; on diagnostic scanners, a 
head scan, typically brain, was acquired (both head and neck and head protocols are referred to as 
“head protocols” hereafter). 
 We were able to ascertain that at least 96% of scanners followed AAPM or ACR 
recommendations for QA. Additionally, at least 49% of scanners were ACR accredited, 20% of scanners 
were in the radiation therapy department of scanners at ACR accredited facilities, and 6% of scanners 
were currently undergoing ACR accreditation. 
 The local chest protocol scans had image thicknesses ranging from 1 to 5 mm. The local head 
protocol scans had image thicknesses ranging from 0.5 to 5 mm. Histograms of the distributions are 
shown in Figure 7-2. 
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Figure 7-2: Image Thickness Histograms. 
Histograms of image thicknesses across the scans taken using (a) the local chest protocol and (b) the 
local head protocol. 
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7.3.2 Feature Stability 
 Three features had a coefficient of variation greater than 10% in more than 50% of instances 
(with 24 total instances for each feature): the features of cluster prominence, cluster shade, and 
skewness. These features were not included in subsequent analysis. The coefficient of variation 
exceeded 10% for auto correlation and sum variance in 42% of instances and for long run low gray level 
emphasis, low gray level run emphasis, short run low gray level emphasis, and the minimum in 46% of 
instances. All other features had a coefficient of variation greater than 10% in less than 25% of 
instances; the majority of features had a coefficient of variation greater than 10% in 0% of instances. 
 
7.3.3 Resample the z Dimension 
 Figure 7-3 shows the absolute value of the Pearson correlation coefficient of each ROI for the 
correlation of each feature with the image thickness. The mean absolute value of the Pearson 
correlation coefficient was 0.42. The correlation values had similar ranges for all the feature categories 
except for the gray level run length matrix category, which had lower correlation values. The mean 
absolute value of the Pearson correlation coefficient increased to 0.46 when gray level run length 
matrix features were not included. A second version of Figure 7-3 without the ABS cartridges is 
reproduced in Appendix D Figure D-1. For this analysis the mean absolute value of the Pearson 
correlation coefficient was 0.39. Without the gray level run length matrix features, the mean absolute 
value of the Pearson correlation coefficient was 0.41. 
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Figure 7-3: Pearson Correlation of Feature Value with Image Thickness. 
Absolute value of the Pearson correlation rho for the correlation between feature value and image 
thickness for each region of interest (ROI). Each ROI is a different shape. Each category of feature is a 
different color. The correlation varies between and within features depending on the ROI. COM: gray 
level co-occurrence matrix, GLCM: gray level co-occurrence (used when there are features with the 
same name in different categories to differentiate them), GLRLM: gray level run length matrix, NGTDM: 
neighborhood gray tone difference matrix, beads: acrylic beads, worms: polyvinyl chloride pieces. 
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 To determine the level of reliability based on the ICC values, the guidelines from Koo and Li 
were followed [161]. ICC values less than 0.5 signify poor reliability, those between 0.5 and 0.75 signify 
moderate reliability, those between 0.75 and 0.9 signify good reliability, and those greater than 0.9 
signify excellent reliability. When comparing feature values across different resampling techniques 
using ICC (2,1) (two-way random effects, absolute agreement, single rater/measurement), we found 
that 35 features had excellent reliability, seven features had good reliability (entropy, max probability, 
low gray level run emphasis, short run low gray level run emphasis, busyness, complexity, and 
contrast), and four features had moderate reliability (information measure correlation 1, information 
measure correlation 2, long run low gray level emphasis, and texture strength). When ICC (3,1) (two-
way random effects, consistency, single rater/measurement) was used, we found that 39 features had 
excellent reliability, five features had good reliability (information measure correlation 2, max 
probability, low gray level run emphasis, short run low gray level run emphasis, and texture strength), 
one feature had moderate reliability (long run low gray level emphasis). Thus, feature values did not 
change with resampling; therefore, for the linear mixed-effects analysis, no resampling in the z 
dimension was done for the local chest and local head protocols. Additionally, these results paired with 
the Pearson correlation results implied that there was a relationship with image thickness that needed 
to be included in the modeling. 
 
7.3.4 Imaging Variability 
 The variability due to the material was 0 in every model. The relative proportions of σβ 
(scanner-wise variability), σγ (manufacturer-wise variability), and σε (residual variability) were calculated 
for each feature. Plots of the proportion of each of these variabilities using thresholding and bit depth 
rescaling are shown in Figure 7-4 for the controlled protocol and local head protocol. All other plots 
(other preprocessing and chest protocol) are in Appendix D Figures D-2 through D-11. Figure 7-4 shows 
that the contribution from σγ is reduced when the controlled protocol is used. The mean total variability 
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for the controlled protocol was 0.43 compared with that of the local chest protocol and was 0.48 
compared with that of the local head protocol. The average proportion of total variability was 0.29, 
0.27, and 0.43 for the manufacturer, scanner, and residual respectively based on the head protocol 
scans. The average proportion of total variability was 0.30, 0.27, and 0.44 for the manufacturer, 
scanner, and residual respectively based on the chest protocol scans. The average proportion of total 
variability was 0.20, 0.25, and 0.55 for the manufacturer, scanner, and residual respectively based on 
the controlled protocol scans. The details of this are shown in Figure 7-4. 
 The residual contribution was not always small; it was often the largest component. This is 
particularly evident for the controlled protocol where the residual should have a large relative 
contribution since factors that were contributing to the variability have been accounted for in the 
design of the protocol. The manufacturer contribution was not always larger than the scanner 
contribution to the total variability, as can be seen in Figure 7-4, thus demonstrating that the variability 
among scanners of the same manufacturer can vary more than different manufacturers. 
 If it was possible to correct for the manufacturer and individual scanner, then, when using a 
controlled protocol, only the residual variability would remain. In that situation, the mean controlled 
residual variability would be 0.36 compared with the chest protocol total variability and 0.40 compared 
with the head protocol total variability. This is the theoretical best possible improvement that can be 
achieved until we have an in-depth understanding of the components hidden in the residual. In 
comparison to the controlled protocol, this is an additional 7-8% reduction in variability (100 ×
(𝑛𝑛𝑃𝑃𝑃𝑃𝑃𝑃 �𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡 𝑣𝑣𝑎𝑎𝑟𝑟𝑖𝑖𝑎𝑎𝑣𝑣𝑖𝑖𝑡𝑡𝑖𝑖𝑎𝑎𝑣𝑣 𝑠𝑠𝑎𝑎𝑎𝑎𝑎𝑎𝑟𝑟𝑎𝑎𝑡𝑡𝑡𝑡𝑅𝑅𝑟𝑟 𝑝𝑝𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎𝑠𝑠𝑎𝑎𝑡𝑡
𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡 𝑣𝑣𝑎𝑎𝑟𝑟𝑖𝑖𝑎𝑎𝑣𝑣𝑖𝑖𝑡𝑡𝑖𝑖𝑎𝑎𝑣𝑣 𝑡𝑡𝑎𝑎𝑠𝑠𝑎𝑎𝑡𝑡 𝑝𝑝𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎𝑠𝑠𝑎𝑎𝑡𝑡
� − 𝑛𝑛𝑃𝑃𝑃𝑃𝑃𝑃(𝑟𝑟𝑅𝑅𝑠𝑠𝑖𝑖𝑟𝑟𝑟𝑟𝑎𝑎𝑡𝑡 𝑣𝑣𝑎𝑎𝑟𝑟𝑖𝑖𝑎𝑎𝑣𝑣𝑖𝑖𝑡𝑡𝑖𝑖𝑎𝑎𝑣𝑣 𝑠𝑠𝑎𝑎𝑎𝑎𝑎𝑎𝑟𝑟𝑎𝑎𝑡𝑡𝑡𝑡𝑅𝑅𝑟𝑟 𝑝𝑝𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎𝑠𝑠𝑎𝑎𝑡𝑡
𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡 𝑣𝑣𝑎𝑎𝑟𝑟𝑖𝑖𝑎𝑎𝑣𝑣𝑖𝑖𝑡𝑡𝑖𝑖𝑎𝑎𝑣𝑣 𝑡𝑡𝑎𝑎𝑠𝑠𝑎𝑎𝑡𝑡 𝑝𝑝𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎𝑠𝑠𝑎𝑎𝑡𝑡
)). 
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Figure 7-4: Bar Plots of Variation from Head and Controlled Protocols. 
Bar plots of the relative contributions of the scanner-wise variability (green), manufacturer-wise 
variability (blue), and residual variability (red) for each feature using thresholding and bit depth 
rescaling calculated on (a) the local head protocol and (b) the controlled protocol. The contribution of 
the manufacturer was much larger for many features in the local head protocol than in the controlled 
protocol. The total variability for the controlled protocol compared with that of the head protocol was 
0.48.  
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The linear mixed-effects models produced a spectrum of variabilities, from high to low. For 
ease of summary, a cutoff has been established. Spreadsheets with the data are in the Supplemental 
Material of Ger et al. to allow for different cutoffs to be used in future studies [136]. For IVtotal and 
IVresidual (equations 7-2 and 7-4), a cutoff of 1/3 was used to create a binary of significance (i.e. 
significant or not). This was done for each feature to indicate that the imaging variation was negligible 
relative to inter-patient variability or imaging variability was significant relative to inter-patient 
variability. The total numbers of features in each category that had IVtotal or IVresidual values greater than 
1/3 are displayed in Table 7-2.  
 Two gray level run length matrix features and one intensity feature were always above the 
cutoff: long run low gray level emphasis, low gray level run emphasis, and the minimum. Short run low 
gray level emphasis was also often above the cutoff. While only features that passed the feature 
stability test were included in the analysis, we were interested in examining if these features’ poor 
performance in the IVtotal and IVresidual tests could be attributed to other causes. Therefore, we re-
examined the feature stability and found that these features were not as stable as many of the other 
features that also passed the test. There was no clear way to determine the cutoff for the feature 
stability test, but this indicates that the poor performance in the IVtotal and IVresidual tests could be due to 
sensitivity of these features to the ROI placement.  
 Overall, there was very little to no improvement in the number of features above the cutoff 
when IVresidual was computed compared with IVtotal. There were fewer features above the cutoff for the 
controlled protocol compared with the local protocols except when thresholding, smoothing, and bit 
depth rescaling were used.  
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Table 7-2. Number of features for each protocol and preprocessing type that have imaging variability 
compared to inter-patient variability from linear mixed-effects models above the cutoff 
Protocol 
Feature 
Group 
Thresholding Thresholding and Smoothing 
Total Variability Residual Variability Total Variability Residual Variability 
NSCLC 
Patients 
HNSCC 
Patients 
NSCLC 
Patients 
HNSCC 
Patients 
NSCLC 
Patients 
HNSCC 
Patients 
NSCLC 
Patients 
HNSCC 
Patients 
Controlled 
Protocol 
GLCM 
(N = 20) 
1 1 1 1 0 2 0 2 
GLRLM 
(N = 11) 
3 3 3 3 2 2 2 2 
Intensity 
(N = 10) 
1 1 1 1 1 1 1 1 
NGTDM 
(N = 5) 
0 0 0 0 0 0 0 0 
Local 
Chest 
Protocol 
GLCM 
(N = 20) 
3 4 2 3 3 3 2 3 
GLRLM 
(N = 11) 
3 3 3 3 3 3 3 3 
Intensity 
(N = 10) 
1 1 1 1 1 1 1 1 
NGTDM 
(N = 5) 
0 0 0 0 0 0 0 0 
Local 
Head 
Protocol 
GLCM 
(N = 20) 
2 4 1 3 2 3 2 3 
GLRLM 
(N = 11) 
3 3 3 3 3 3 3 3 
Intensity 
(N = 10) 
1 1 1 1 1 1 1 1 
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NGTDM 
(N = 5) 
0 0 0 0 0 0 0 0 
 
 
Protocol 
Feature 
Group 
Thresholding and Bit Depth Rescaling Thresholding, Smoothing, and Bit Depth Rescaling 
Total Variability Residual Variability Total Variability Residual Variability 
NSCLC 
Patients 
HNSCC 
Patients 
NSCLC 
Patients 
HNSCC 
Patients 
NSCLC 
Patients 
HNSCC 
Patients 
NSCLC 
Patients 
HNSCC 
Patients 
Controlled 
Protocol 
GLCM 
(N = 20) 
0 0 0 0 1 3 1 3 
GLRLM 
(N = 11) 
3 3 3 3 3 3 3 3 
Intensity 
(N = 10) 
1 1 1 1 1 1 1 1 
NGTDM 
(N = 5) 
0 0 0 0 0 0 0 0 
Local 
Chest 
Protocol 
GLCM 
(N = 20) 
2 4 2 2 2 2 2 2 
GLRLM 
(N = 11) 
3 3 3 3 2 2 2 2 
Intensity 
(N = 10) 
1 1 1 1 1 1 1 1 
NGTDM 
(N = 5) 
0 0 0 0 0 0 0 0 
Local 
Head 
Protocol 
GLCM 
(N = 20) 
1 4 0 2 1 2 1 2 
GLRLM 
(N = 11) 
3 3 3 3 1 1 1 1 
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Intensity 
(N = 10) 
1 1 1 1 1 1 1 1 
NGTDM 
(N = 5) 
0 0 0 0 0 0 0 0 
 
GLCM: gray level co-occurrence matrix, GLRLM: gray level run length matrix, NGTDM: neighborhood gray tone 
difference matrix, NSCLC: non–small cell lung cancer, HNSCC: head and neck squamous cell carcinoma. Total 
variability: 𝐼𝐼𝑉𝑉𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡 =
𝜎𝜎𝑡𝑡,𝑚𝑚/𝑓𝑓𝑚𝑚�
𝜎𝜎𝑝𝑝/𝜇𝜇𝑝𝑝
, residual variability: 𝐼𝐼𝑉𝑉𝑟𝑟𝑅𝑅𝑠𝑠𝑖𝑖𝑟𝑟𝑟𝑟𝑎𝑎𝑡𝑡 =
𝜎𝜎𝜀𝜀,𝑚𝑚/𝑓𝑓𝑚𝑚�
𝜎𝜎𝑝𝑝/𝜇𝜇𝑝𝑝
, with a cutoff of 1/3.
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 Twenty of the 24 pairwise t-tests of σβ, σγ, and σε between the controlled protocol and local 
chest protocol and between the controlled protocol and local head protocol were significant (p < 0.05). 
All comparisons between the controlled and local head protocol were not significant when thresholding 
and smoothing were applied as the preprocessing. Additionally, σε was not significantly different 
between the controlled and local head protocol when thresholding, smoothing, and bit depth rescaling 
were applied as the preprocessing. Appendix D Table D-1 shows the p-values for all comparisons.  
 Since there was a disproportionately high number of GE scanners, the linear mixed-effects 
models were also run with only the GE scanners. A pairwise t-test was run on σβ and σε between the 
models with all of the scanners and the models with only the GE scanners. There was a significant 
difference (p < 0.05) for 11 of the 24 comparisons between variabilities calculated from linear mixed-
effects models with all scanners and models with GE scanners only. Appendix D Table D-2 shows the p-
values for all comparisons. 
 
7.3.5 Quality Assurance Using a Radiomics Phantom 
 The three cartridges with ABS had noticeable changes over the course of the study. The mean 
values of the cartridges over time are shown in Appendix D Figure D-12. The three cartridges with ABS 
displayed a downward trend in mean value over time, while the other cartridges did not show any 
trend with time. Therefore, the three ABS cartridges were excluded from the QA analysis with a 
radiomics phantom. 
 The gray level run length matrix features had a disproportionately high number of scanners 
outside the established bounds; therefore, these features were not included in the QA analysis. Thus, 
35 features with four preprocessing types were included in the QA test. Histograms of the number of 
scanners with the percentage of features outside the bounds set using the scaled patient standard 
deviation showed that many scanners had more than 20% of features outside the bounds, as shown in 
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Appendix D Figure D-13 for each of the rubber, dense cork, and hemp seed cartridges using the HNSCC 
and NSCLC patient cohorts.  
 Not all features may be useful, as not all features have been correlated with patient outcomes. 
Therefore, a subset of features with associated preprocessing type were selected on the basis of 
studies by Fave et al. and Fried et al. [14, 22]. The features and the preprocessing types that were 
correlated with patient survival on univariate analysis were included, which resulted in 26 features. Like 
the gray level run length matrix features, the features of auto correlation, correlation, sum average, 
sum variance, and the median had a disproportionately high number of scanners outside the bounds. 
Excluding the features that were shown to not be robust and excluding the gray level run length matrix 
features reduced the feature set to 16 features with their associated preprocessing types. These 16 
features are listed in the Appendix D Table D-3. Figure 7-5 shows histograms for percentages of 
features outside the bounds (similar to Appendix D Figure D-13, but with the reduced set of features). 
More scanners had low percentage of features outside 1/3 of the scaled patient standard deviation in 
the NSCLC patient cohort than in the HNSCC patient cohort; this is discussed further in the Discussion 
section. One scanner consistently had the highest percentage of features outside the bounds. However, 
aside from this scanner, the scanners with the highest percentages of features outside the bounds were 
not consistent across the different materials. 
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Figure 7-5: Histograms of Number of Scanners that have a Percentage of features outside of patient 
bounds. 
The percentages of features outside 1/3 of the scaled patient standard deviation for rubber, dense 
cork, and hemp seeds in the head and neck squamous cell carcinoma (HNSCC) patient cohort and the 
non-small cell lung cancer (NSCLC) patient cohort using the features correlated with patient survival in 
previous studies without non-robust features. More scanners had fewer features outside 1/3 of the 
patient standard deviation in the NSCLC patient cohort than the HNSCC patient cohort.  
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7.4 Discussion 
 This study showed that imaging variability exists but is not large compared with inter-patient 
variability for most features. A controlled scan can be helpful for reducing these uncertainties in 
prospective studies, as there was statistically significantly less variability in the controlled protocol 
scans than in the local protocol scans. The controlled protocol reduced the total variability by over 50% 
compared with both local chest and local head protocol scans. It is theoretically possible to correct for 
the manufacturer and the individual scanner. One possible way to do this is to use a phantom on each 
scanner to correct for all the factors that could impact the output of a scanner. If this were done 
perfectly, the imaging variability could be reduced by an additional 7-8% compared with the reduction 
due to implementing a controlled protocol.  
 The controlled protocol implemented in this study specified kernels for each manufacturer. 
Solomon et al. and Winslow et al. compared kernels on Siemens and GE [162, 163]. Both found that the 
GE standard kernel was the closest match to the B31f or B31s kernel on Siemens, which agrees with our 
controlled protocol. Additionally, Shafiq-ul-Hassan et al. recently demonstrated the feasibility of 
correcting for the different kernels, achieving improvements in feature robustness by 30-78% [164]. 
Our goal in this study was to harmonize the kernels across manufacturers such that the kernel did not 
affect the imaging variability. However, including this new correction technique may reduce imaging 
variability further.  
 Gray level run length matrix features had high feature variability when ROIs were moved. 
Additionally, these features had the highest imaging variability. We believe that these results are due to 
the current construction of these features. Examining low gray level run emphasis demonstrates this 
issue. Low gray level run emphasis is defined as 
 𝐿𝐿𝐿𝐿𝑅𝑅𝐿𝐿 =  1
𝑎𝑎𝑟𝑟
∑ 𝑝𝑝𝑔𝑔(𝑖𝑖)
𝑖𝑖2
𝑀𝑀
𝑖𝑖=1   (7-8) 
where nr is the total number of runs, M is the total number of gray levels, i is the gray level, and  
𝑝𝑝𝑅𝑅(𝑃𝑃) = ∑ 𝑝𝑝(𝑃𝑃, 𝑗𝑗)𝑁𝑁𝑗𝑗=1   (7-9) 
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is the sum distribution of the number of runs with gray level i, run length j, maximum run length N, and 
run-length matrix p(i,j). A slight shift in the distribution of gray levels within the ROI can significantly 
impact the feature value as the range of the summations remain the same but p(i,j) changes, thus 
impacting the feature value. Thus we recommend that these features not be used until these issues can 
be resolved. This problem may be why gray level run length matrix features have not come out in the 
final models in many studies. 
 Many of the features showed a correlation between feature value and image thickness that 
must be considered. Also, the slope of the fixed-effects term for the image thickness was generally the 
same for a given feature across all models, even in the controlled protocol scans where there were only 
two image thickness values, indicating the strength of this relationship. This agrees with several studies 
that have demonstrated the relationship between radiomics features and image thickness [32-34, 165]. 
However, the high ICC values indicate that the feature value correlation with image thickness cannot be 
fixed by resampling the image and thus cannot be fixed for retrospective scans for this particular 
phantom study. When the range of resampled image thickness values was decreased (i.e. not including 
thicknesses above 5mm), the ICC values remained high. Noise characteristics were not included in this 
part of the study which can affect feature values as thicker slices can introduce less noise than thinner 
slices. Even given the limitations of this study, these results indicate that this effect cannot be 
compensated for after reconstruction with resampling for this phantom study. This is in contrast to the 
studies by Shafiq-ul-Hassan et al. and Larue et al. who found that resampling an arbitrarily chosen 
standard voxel size improved feature reproducibility [32, 36]. Therefore, in this study there is a need to 
control the image thickness as resampling to a variety of image thickness values did not change the 
feature value, and thus, we recommend controlling image thickness in prospective studies to eliminate 
this feature value dependence. If the image thickness cannot be completely controlled, the range of 
image thicknesses used within a study cohort should be limited to reduce this effect. 
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 The importance of a controlled protocol for prospective studies was also demonstrated through 
the linear mixed-effects models. There was significantly less variability in the controlled protocol scans 
compared with the local protocol scans. Furthermore, the total variability (Table 7-2) does not include 
the contribution from the fixed-effect term for image thickness, which would increase imaging 
variability. Reducing the uncertainty is a crucial step in moving forward with radiomics studies, as 
reduced uncertainty allows more levels of stratification in prognostic models and enables the 
movement towards individual prognostic models instead of sorting patients into groups. The 
manufacturer-wise variation was reduced when a controlled scan was implemented because imaging 
parameters were harmonized. Many local protocols use the standard kernel, but this kernel is not the 
best match across different manufacturers. The controlled scan also demonstrated more benefit than 
post-processing correction for the manufacturer and individual scanner. Radiomics has traditionally 
been conducted on standard of care imaging, but the large improvements of a controlled protocol 
demonstrated in this study show the potential importance of such a controlled scan. Thus, efforts 
should be made to implement a controlled protocol for prospective radiomics studies, and only patients 
whose imaging parameters match the controlled protocol should be selected in retrospective studies. 
Studies by Mackin et al. [38] and Fave et al. [150] have shown that tube current and tube voltage do 
not significantly impact the majority of radiomics features. Therefore, the reconstruction settings 
dominate the imaging variability and most of the benefit of the controlled scan can be achieved using 
an additional radiomics reconstruction resulting in no extra dose to the patient. 
 This study uses the second version of the radiomics phantom. The lessons learned from the first 
phantom, used in several studies [38, 132], led to this new, improved phantom. The buildup was one 
considerable difference between the phantoms. Buildup was added to make the phantom more 
realistic. Also, only the rubber and cork cartridges were kept from the first phantom, as features 
measured from these cartridges more closely matched NSCLC patient features than did features from 
other cartridges in the first phantom. In this phantom, we added hemp seed and ABS cartridges, and we 
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have learned that for future phantoms, ABS cartridges should not be used, as they change over time. 
The cartridges that were added matched features calculated from patients better and produced a more 
realistic range of textures. While three of the cartridges changed over time and thus are not optimal 
options for future work, removing these from the linear mixed-effects models did not change 
conclusions. 
 Almost all of the scanners in this study followed established QA protocols. However, in spite of 
this there were still large imaging variabilities. Therefore, there may be a need for radiomics QA and we 
demonstrated the potential for a radiomics QA process. The different materials identified different 
scanners with large percentage of features outside the established bounds, which indicates that a 
radiomics QA phantom may not be feasible with only one material. The choice of 1/3 in establishing the 
bounds was arbitrary. The cutoff for the percentage of features failed that would be acceptable to pass 
the QA process depends on the bounds chosen. When the features found to be correlated with patient 
survival by Fave et al. and Fried et al. [14, 22] were used, the histograms of the number of scanners 
with features outside the bounds was reduced, likely because those features are more robust. While 
studies have found that a radiomics signature developed from NSCLC patients can be used to predict 
survival in head and neck cancer patients [19, 26], there are distinct feature clusters for the lung and 
the head and neck cancer patient cohorts [20]. Our patient sets also showed different feature 
distributions for lung and head and neck patient cohorts, which contributed to the difference in QA 
results. Therefore, for QA purposes, a distinct radiomics signature should be selected for each cancer 
site to be credentialed. 
 There are several limitations to this study. First, the phantom was not imaged by a single user; 
therefore, there may be some added variability due to different users. Secondly, the phantom materials 
are not the same as human tissue. Dense cork and rubber have been previously shown to have 
radiomics feature spectrums similar to those of NSCLC patients [132], and these cartridges have 
effective atomic numbers close to those of human tissues [133, 134, 147]. Using patients for these 
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studies is not feasible; therefore, these materials are a close match to human tissues, and results 
derived from them can be applied to patient CT scans. Additionally, the same phantom was used for 
chest and head scans. The dimensions of the phantom were designed for chest imaging. Visual 
inspection of the images did not yield any artifacts specific to the head protocols. While not optimized 
for head imaging, this phantom still provides valuable information on the radiomics feature variability 
of these protocols. 
 Also, there was not an even distribution of scanners by manufacturer. There was a 
disproportionately high number of GE CT scanners, and it is unknown whether our sample of scanners 
accurately represents the distribution of scanners in clinical use, as these data are not available. When 
GE scanners alone were run through the linear mixed-effects model, some variabilities were statistically 
significantly different between the GE scanners alone and between all scanners. This difference may 
point to there being scanner-wise variability differences between manufacturers which was not 
accounted. This was due to the limited number of scanners outside GE which is a limitation of this 
study. The sample of scanners selected were acquired in Dallas, San Antonio, Houston, Galveston, 
Baton Rouge, and New Orleans thru proximity and personal contacts. As this sample only constitutes 
scanners from Texas and Louisiana, the manufacturer distribution may look different in other parts of 
the USA or in other countries. Additionally, the patient scans used were from selected scanners using 
well-specified imaging parameters. This may not represent the true inter-patient variation that may 
exist in a large radiomics study. However, as these patient scans were well controlled, this provides a 
conservative estimate of the imaging variability effect within patient cohorts. The results from IVtotal 
and IVresidual are promising given that this may be a conservative estimate and within a larger patient 
cohort even fewer features may be adversely affected due to larger inter-patient variation. 
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7.5 Conclusion 
 A controlled protocol substantially reduces imaging variability compared with local protocols, 
as the controlled protocol can reduce the total variability by more than 50%. Thus, controlled protocols 
should be used for radiomics studies. Most of this benefit can be achieved by an extra radiomics 
reconstruction resulting in no additional dose to the patient. Correcting for the manufacturer and 
individual scanner can also yield an additional benefit. 
  
 
124 
 
Chapter 8 : PET Imaging Protocol Effect on Radiomics Feature Values 
8.1 Introduction 
 Variability in imaging protocols can add noise to radiomics data in patient studies. For PET 
images, acquisition and reconstruction parameters have been shown to affect radiomics features. In 
particular, the number of iterations, matrix size, and smoothing filter produce variability in radiomics 
features [39-49]. In general, these studies have been performed using only one scanner and have 
investigated only a few of the parameters that can be altered in the imaging protocol. Those studies 
that used a phantom often used one with uniform spheres, such as the National Electrical 
Manufacturers Association phantom, which may not be representative of the texture within patients’ 
tumors. Thus, although these studies have provided valuable insight into particular issues, they may not 
be generalizable. 
 In this study, we aimed to fill this gap by using a phantom that provided radiomics feature 
values similar to those found in patients. We used scanners from several different vendors and 
investigated the effects of changing all of the parameters that could be changed for reconstructions. 
Filling this gap allows for more precise inclusion criteria in patient studies in order to reduce the noise 
in radiomics features to produce the best possible prediction studies. 
 
8.2 Methods 
8.2.1 Phantom Scans 
PET images of a 3-dimensional Hoffman brain phantom were acquired on GE Discovery 710 (GE 
Healthcare, Chicago, IL), Siemens mCT (Siemens Healthineers, Forchheim, Germany), and Philips Vereos 
(Philips Healthcare, Eindhoven, The Netherlands) PET scanners. A standard-protocol scan was acquired 
on each machine, and then each parameter that could be changed was altered individually. For 
example, to assess the impact of time per bed position, the other standard-protocol parameters were 
held constant while the time per bed position was set to 2 minutes for one reconstruction, 3 minutes 
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for another reconstruction, 4 minutes for another reconstruction, and 5 minutes for another 
reconstruction. The parameters that could be changed and the settings investigated for each scanner 
are listed in Table 8-1. 
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Table 8-1. Parameters Changed to Investigate Impact on Radiomics Features 
 Scanner 
Parameters GE Discovery 710 Siemens mCT Philips Vereos 
Field of view (cm) 25, 50, 70   
Filter cutoff (mm) 1, 3, 5, 8, 10 1, 3, 5, 8, 10 None, 1, 3, 5, 8, 10 
Iterations × subsets 1 × 4, 2 × 8, 4 × 8, 2 × 
18, 4 × 32 
Non-TOF: 1 × 4, 2 × 8, 
4 × 8, 2 × 12, 4 × 24 
TOF: 1 × 21, 2 × 21, 3 
× 21, 4 × 21 
1 × 4, 2 × 8, 4 × 8, 2 × 
20, 3 × 15, 4 × 32 
Matrix size 128, 192, 256 128, 200, 256, 400, 
512 
 
Time per bed position 
(min) 
2, 3, 4, 5 2, 3, 4, 5 2, 3, 4, 5 
Type of reconstruction VPFX, VPFX-S, VPHD, 
VPHD-S, QCFX-S, 
QCHD-S 
Backprojection, 
backprojection TOF, 
iterative, iterative 
TOF, TRUEX, TRUEX 
TOF 
 
Z smoothing None, light, standard, 
heavy 
  
 
TOF: time of flight 
Types of reconstruction are proprietary names used by each vendor. 
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The standard-protocol settings for the GE scanner were 70 cm field of view, 5 mm filter cutoff, 
2 iterations and 18 subsets, 192 matrix size, standard z smoothing, 6 minutes per bed position, and 
VPFX-S reconstruction. The standard-protocol settings for the Siemens scanner were 82 cm field of 
view, 5 mm filter cutoff, 2 iterations and 21 subsets, 200 matrix size, 5 minutes per bed position, and 
TRUEX time-of-flight (TOF) reconstruction. As the Siemens scanner also allows for continuous bed 
motion, this type of acquisition was also explored and treated as an additional scanner. The standard-
protocol settings were the same as the fixed number of bed positions acquisition but with 0.4 mm/s as 
the bed speed. The standard-protocol settings for the Philips scanner were 60 cm field of view, 3 
iterations and 15 subsets, 128 matrix size, no smoothing filter, and 5 minutes per bed position. The 
term “standard protocol” here means that it was the baseline acquisition. The time per bed position 
was longer than that used clinically and for the Siemens scanner, the standard acquisition used at MD 
Anderson is continuous bed motion. The phantom was injected with 2.53-2.75 mCi of F-18 
fluorodeoxyglucose for each scan and then imaged about 30 minutes later. The weight was set to 20 kg 
to obtain standardized uptake values (SUVs) in the phantom that were similar to the SUVs in patient 
tumors. 
 
8.2.2 Patients 
Data from a patient cohort were used to provide context to the variability observed between 
scanners. For example, an interscanner variation of 0.4 for a given feature with a phantom does not 
necessarily represent the impact of interscanner variation in a patient study. However, if the 
interscanner variation is computed relative to interpatient variation, the impact on patient studies can 
be directly observed. In order to make interscanner comparisons that were relative to interpatient 
variation in this study, PET studies of 224 patients with non-small cell lung cancer (NSCLC) were 
retrospectively analyzed. The requirement for informed consent was waived by the Institutional Review 
Board at The University of Texas MD Anderson Cancer Center. This cohort consisted of 84 women and 
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140 men with an average age of 65 years (range, 39–89 years), average height of 171 cm (range, 147–
195 cm), average weight of 82 kg (range, 39–151 kg), and average tumor volume of 90 cm3 (range, 0.4–
920 cm3).   
 
8.2.3 Feature Extraction 
Each phantom scan was semiautomatically contoured with 10 cylindrical regions of interest 
(ROIs) using in-house developed MATLAB (MathWorks, Natick, MA) scripts. Each ROI had a diameter of 
19.4 cm and a height of 1 cm. Some slices of the phantom with contours are shown in Figure 8-1. A 
threshold of 0.4 SUV was used before feature calculation on the phantom images to remove 
background noise or activity that had leaked to the edges of the phantom container. The patient 
images were contoured using PET Edge in MIM (MIM Software Inc., Cleveland, OH). Forty-five features 
were extracted using 2 preprocessing methods: (1) a fixed-bin-width of 0.5 SUV, as suggested by 
Leijenaar et al. [166], and (2) rescaling to 64 levels, as suggested by Hatt et al. [167]. Radiomics features 
were calculated using IBEX, a freely available radiomics tool [137, 138]. The features used are listed in 
Table 8-2. More information about these features can be found in a publication by Zhang et al. [137]. 
The settings for each of the features were the same as those listed in Fave et al.’s Supplemental 
Material [14], except for neighborhood gray tone difference matrix, where we set the neighborhood to 
3 owing to the large voxel size in PET images. 
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Figure 8-1: Slices of Hoffman Phantom. 
Four slices of the Hoffman phantom are shown. Each slice is from a different ROI among the 10 ROIs 
that were drawn in the phantom. The example slices shown here are from different regions within the 
phantom: (a) near the bottom of the phantom, (b) between the bottom and the middle of the 
phantom, (c) between the middle and the top of the phantom, and (d) near the top of the phantom. 
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Table 8-2. Radiomics Features Used in PET Analysis 
 Gray Level Co-occurrence Matrix Gray Level Run Length Matrix Intensity Histogram Neighborhood Gray Tone Difference Matrix 
 Auto Correlation Gray Level Nonuniformity Energy Busyness 
 Cluster Prominence High Gray Level Run Emphasis Entropy Coarseness 
 Cluster Shade Long Run Emphasis Kurtosis Complexity 
 Cluster Tendency Long Run High Gray Level Emphasis Skewness Contrast 
 Contrast Long Run Low Gray Level Emphasis Standard Deviation Texture Strength 
 Correlation Low Gray Level Run Emphasis Uniformity  
 Difference Entropy Run Length Nonuniformity Variance  
 Dissimilarity Run Percentage   
 Energy Short Run Emphasis   
 Entropy Short Run High Gray Level Emphasis   
 Homogeneity Short Run Low Gray Level Emphasis   
 Homogeneity 2    
 Information Measure Correlation 1    
 Information Measure Correlation 2    
 Inverse Difference Moment Norm    
 Inverse Difference Norm    
 Inverse Variance    
 Max Probability    
 Sum Average    
 Sum Entropy    
 Sum Variance    
 Variance    
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8.2.4 Statistical Analysis 
The intraclass correlation coefficient (ICC) was used to determine whether changes in each 
parameter affected the measured radiomics features. This was done separately for each adjustable 
parameter on each scanner, with the ROIs as the subjects and the different parameter values as the 
raters. The 2-way random effects, consistency, single rater/measurement ICC as described by Shrout 
and Fleiss [159] was computed in R (version 3.4.3) using the psych package (version 1.7.8) [160]. To 
determine the level of reliability indicated by the ICC values, the guidelines published by Koo and Li 
[161] were followed: ICC values lower than 0.5 signified poor reliability, those between 0.5 and 0.75 
signified moderate reliability, those between 0.75 and 0.9 signified good reliability, and those greater 
than 0.9 signified excellent reliability. 
 Interscanner analysis was performed using the standard-protocol image from each scanner. 
The standard deviation across the ROIs from the four scanners (GE, Philips, Siemens, and Siemens using 
continuous bed motion) was compared to the standard deviation from the NSCLC patient cohort. This 
was done separately for each feature and preprocessing technique. Additionally, the mean value for 
each feature and preprocessing technique combination from the phantom standard-protocol images 
was compared to the mean value from the patient images for the same combination. If the phantom 
mean was not within two standard deviations of the patient mean for a given feature, the feature was 
not included when calculating the interscanner variation metric. 
 
8.3 Results 
For all scanners, most features had good (ICC > 0.75) to excellent (ICC > 0.9) reliability when reasonable 
parameter choices were used. Here, “reasonable” refers to parameter values that are used in clinics. 
For example, extremely low or extremely high effective iteration values (iterations × subsets) were 
excluded, as these are not actually used in clinics. The following paragraphs summarize the results 
obtained using the reasonable parameters and give the percentage of features in each of the reliability 
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classifications described in the Statistical Analysis section. The specific ICC values for each feature using 
all parameter values and the subset of parameter values that were deemed reasonable are presented 
in Appendix E. 
 For the GE scanner, when the pixel size was resampled, all features had excellent reliability with 
both preprocessing types for field of view and matrix size. When only filter cutoff values below 6 mm 
were included, 96% of features had excellent reliability, 3% of features had good reliability, and 1% of 
features had moderate reliability (busyness calculated using fixed-bin-width preprocessing). For 
iterations and subsets, when only effective iterations between 16 and 36 were included, 87% of 
features had excellent reliability, 12% of features had good reliability, and 1% of features had poor 
reliability (complexity calculated using 64-level preprocessing). When time per bed position was 
altered, all features had excellent reliability with both preprocessing types. For the type of 
reconstruction, when Q.Clear was not included (reconstruction types QCFX-S and QCHD-S), 92% of 
features had excellent reliability and 8% of features had good reliability. For z smoothing, 89% and 11% 
of features had excellent and good reliability, respectively. 
 For the Siemens scanner, when only filter cutoff values below 6 mm were included, 80% of 
features had excellent reliability, 19% of features had good reliability, and 1% of features had moderate 
reliability (busyness calculated using fixed-bin-width preprocessing). For matrix size, when the pixel size 
was resampled, 94% and 6% of features had excellent and good reliability, respectively. For iterations 
and subsets using TOF, 83% of features had excellent reliability, 12% of features had good reliability, 
and 4% of features had moderate reliability. For iterations and subsets using non-TOF, when only 
effective iterations between 16 and 24 were included, 76% of features had excellent reliability, 18% of 
features had good reliability, and 7% of features had moderate reliability. For the time per bed position, 
all features had excellent reliability with both preprocessing types. Similar results were found using 
continuous bed motion. 
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For the Philips scanner, when only filter cutoff values below 6 mm were included, 71% and 29% 
of features had excellent and good reliability, respectively. For iterations and subsets, when only 
effective iterations between 16 and 45 were included, 92% and 8% of features had excellent and good 
reliability, respectively. For the time per bed position, all features had excellent reliability with both 
preprocessing types. The distribution of features in each reliability grouping for each imaging protocol 
parameter and preprocessing technique for the Philips scanner is shown in Figure 8-2. The data used to 
create this figure, as well as the data for the other scanners, are detailed in Appendix E. 
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Figure 8-2: Bar Plots of Features by Reliability Level. 
For each imaging-protocol parameter using each of the 2 preprocessing techniques (fixed bin width and 
64 levels), the number of features in each ICC reliability level is shown: excellent reliability (green) is ICC 
> 0.9, good reliability (yellow) is 0.75 < ICC < 0.9, moderate reliability (orange) is 0.5 < ICC < 0.75, and 
poor reliability (red) is ICC < 0.5. When parameters were limited to values seen in clinics, most features 
had excellent reliability, regardless of preprocessing technique. The subset for filter cutoff contains 
reconstructions for which the filter cutoff was below 6 mm. The subset for iterations and subsets 
contains reconstructions for which the effective number of iterations was between 16 and 45. 
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Across all scanners, the average ICC was typically higher with fixed-bin preprocessing than with 
64-level preprocessing. This was the case for all of the imaging parameters on the Siemens (both for the 
step-and-shoot and the continuous-bed-motion acquisition) and Philips scanners. 
For the interscanner analysis, the average ratio of the standard deviation across all features 
from the standard-protocol phantom scans to the standard deviation from the NSCLC patient scans was 
0.73 using fixed-bin-width preprocessing and 1.0 using 64-level preprocessing. With 64-level 
preprocessing, 7 features on the phantom scans had a mean value more than 2 standard deviations 
from the patient-scan mean value for that feature. Excluding these features, the mean ratio of the 
phantom-scan standard deviation to the patient-scan standard deviation was reduced to 0.92. We 
changed the weight on the GE standard-protocol scan to 35 kg to make the mean SUVs more similar to 
the mean SUVs on the other scanners. The average ratio of the standard deviation across all features 
from the standard-protocol phantom scans to the standard deviation from the NSCLC patient scans was 
0.76 using fixed-bin-width preprocessing and 1.1 using 64-level preprocessing. With 64-level 
preprocessing, 8 features on the phantom scans had a mean value more than 2 standard deviations 
from the patient-scan mean value for that feature. Excluding these features, the mean ratio of the 
phantom-scan standard deviation to the patient-scan standard deviation was reduced to 0.96. These 
results demonstrated that scaling the SUVs was not a factor in interscanner variability. 
 
8.4 Discussion 
In this study, we investigated the impact on the variability of radiomics feature values of the 
imaging protocol parameters that could be retrospectively changed on GE, Philips, and Siemens PET 
scanners. We found that as long as reasonable parameter values were used (i.e., parameter values that 
are actually used in clinics), almost all features had at least good reliability. These results demonstrate 
that on a given scanner, radiomics data for patients scanned using different imaging protocols can be 
combined without adding significant noise. 
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However, interscanner variability was about equal to interpatient variability. This implies that 
caution should be used when combining data for patients scanned on equipment from different 
vendors for radiomics analysis as the observed stratification in a patient cohort may be due to 
differences in scanners and not true patient differences. A phantom with radiomics feature values 
similar to those of patients, such as the one used here, should be used to verify which features can be 
used in the patient analysis. If a phantom cannot be acquired, our full interscanner analysis, which is 
provided in Appendix E, can serve as a reference on which features are robust enough to be included in 
the analysis and which features are too variable and should be excluded. 
We found that there was less variability in features when using the fixed-bin-width 
preprocessing method than with the 64-level preprocessing method. Leijenaar et al. [166] also found 
that using a fixed-bin-width was preferable in their interpatient and intrapatient comparisons of two 
preprocessing techniques (fixed-bin-width and fixed number of levels) in 35 lung cancer patients. 
When we included a large range of parameter values, our results agreed with those of previous 
studies that found that the parameters of filter cutoff, matrix size, and iterations and subsets affect 
feature values [39-49]. We were also able to show that resampling the image in our radiomics software 
prior to feature extraction removed the impact of matrix size on feature values. Additionally, the 
impact of variations in filter cutoffs and iterations and subsets could be removed if only parameter 
values that are commonly used in clinics were included. 
This study has several limitations. First, only one scanner from each vendor was used; 
therefore, the variability of different models from a given vendor could not be explored. Second, only 
one acquisition per scanner was used for this study. We previously found the repeatability of a 
particular acquisition on a scanner to be very high; thus, we do not believe acquisition-level variability 
affected the results of this study. Third, this study was conducted using a phantom, which allowed for 
consistency in subject material across scanners, but the phantom is only a representation of patient 
texture. For this particular study, most features were within two standard deviations of the NSCLC 
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patient cohort average, showing that the phantom features were a good representation of the features 
of this patient cohort. However, the activity concentration was higher in our phantom than that seen in 
typical patient PET scans. This could affect the convergence rate of the reconstruction algorithms. To 
assess the impact of convergence rates, many scans with different activity levels would have to be 
acquired and the whole analysis repeated, which is outside the scope of this paper. Another limitation 
is that, for practical reasons, we only examined a subset of the entire parameter space. For example, 
the voxel size relative to the filter cutoff values may also have affected the results. For the standard-
protocol scan, the voxel size was 0.36 × 0.36 × 0.33 cm on the GE scanner, 0.41 × 0.41 × 0.2 cm on the 
Siemens scanner, and 0.2 × 0.2 × 0.2 cm on the Philips scanner. The small values of the cutoff value 
investigated (particularly 1 mm) would only represent part of a voxel and, would therefore, not affect 
the image. Smaller voxel sizes could be affected more by these filter cutoff values and could result in 
lower ICC values. Finally, this study used an adult NSCLC patient cohort; different adult patient cohorts 
may have different interpatient variability levels and different ratios of the standard deviation of the 
phantom measurements to that of the patients’ measurements. Results may be different in pediatric 
patient cohorts where the average weight is much less than the average weight of the cohort in this 
study. 
 
8.5 Conclusion 
We found that all imaging-protocol parameters had good reliability across feature values when 
the parameter values were within limits typically used in clinics. However, interscanner variability was 
about equal to interpatient variability. Therefore, caution must be used when combining patients 
scanned using equipment from different vendors into single radiomics data sets. 
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Chapter 9 : CT- and PET-Based Radiomics Survival Modeling of HNSCC Patients 
9.1 Introduction  
Studies have shown that imaging protocol differences, such as pixel size can increase 
uncertainties in patient datasets [32, 37, 38, 132, 136]. A recent phantom study showed that inter-
scanner variability can be reduced by more than 50% when a controlled imaging protocol is used for CT 
imaging [136]. For PET images, acquisition and reconstruction parameters have been shown to affect 
radiomics features; particularly, the number of iterations, matrix size, and smoothing filter have 
demonstrated variability [42, 46-48, 168]. 
Based on these uncertainty studies, our hypothesis is that outcome models built with data from 
patients on controlled imaging protocols should perform better than models built with data from a 
varied patient cohort since the noise from imaging variability is removed in the former model. We 
aimed to test this hypothesis in large cohorts of CT and PET head and neck cancer patients. 
 
9.2 Materials and Methods  
9.2.1 CT Patients 
Patients who were treated with definitive radiotherapy for head and neck squamous cell 
carcinoma (HNSCC) at least five years ago, had pre-treatment CT images available, did not have a tumor 
stage of Tx (primary tumor could not be assessed), T0 (no evidence of primary tumor), or Tis (carcinoma 
in situ), and did not have a nodal stage of Nx (regional lymph nodes could not be assessed) were 
considered eligible. We retrospectively reviewed contrast-enhanced pretreatment CT images and 
medical records of 652 patients with oropharyngeal HNSCC that were treated between March 2004 and 
November 2013 with a waiver of informed consent from the Institutional Review Board at The 
University of Texas MD Anderson Cancer Center. All patients were scanned on GE scanners (GE 
Healthcare, Chicago, IL). The primary gross tumor volume (GTV) was contoured by two radiation 
oncologists specific for this study. In addition, 156 HNSCC patients from Aerts et al.’s data set from 
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MAASTRO were included [26]. Fifty patients were excluded from this data set due to no contoured GTV, 
other missing data elements, or issues with importing data into our radiomics software.  
Patients whose GTV was more than 50% affected by streak artifacts were excluded from our 
study. Our previous work has shown that this cutoff was useful for including only those patients whose 
features from GTV not affected by streak artifacts represented features from the whole GTV [156]. 
Removing all patients with any streak artifact within their GTV would have removed 215 patients. 
Therefore, this method allows many more patients to be included in the study, as this resulted in the 
removal of only 32 patients from the study, while not impacting feature values. The remaining 726 
patients were divided into training and testing cohorts by medical record number (MRN): those with an 
odd MRN were placed into the training cohort (377 patients), and those with an even MRN were placed 
into the testing cohort (349 patients). The patient demographics for each cohort are summarized in 
Table 9-1.  
Our previous work has shown that inter-scanner variability can be significantly reduced when 
using a controlled protocol [136]. To investigate this impact on the prognostic ability of patient 
outcome models, we included in these cohorts only patients who had been scanned on a GE scanner 
with a standard kernel, 1.25-mm image thickness, and 25-cm field of view because the largest subset 
cohort could be created from the original cohort using these settings. Most of the acquisition 
parameters have been shown to not impact features, while these reconstruction parameters (kernel, 
image thickness, and field of view) have been shown to affect features [32, 34, 37, 38, 150]. Thus we 
focused reconstruction parameters for selecting the subset of patients. These patients were only from 
MD Anderson as the MAASTRO data was not on a GE scanner. 
 
9.2.2 PET Patients 
Patients who were treated with definitive radiotherapy for HNSCC at least four years ago, had 
pre-treatment PET images available, did not have a tumor stage of Tx (primary tumor could not be 
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assessed), T0 (no evidence of primary tumor), or Tis (carcinoma in situ), and did not have a nodal stage 
of Nx (regional lymph nodes could not be assessed) were considered eligible. We retrospectively 
reviewed the images and medical records of 445 patients with oropharyngeal HNSCC that were treated 
between March 2004 and November 2013 with a waiver of informed consent from the Institutional 
Review Board at The University of Texas MD Anderson Cancer Center. In addition, we used images, 
patient survival data, and demographics from the Head-Neck-PET-CT TCIA collection [169, 170]. This 
collection contained 298 patients, 241 of whom were included; those excluded had lesions with no F18-
FDG PET radiotracer uptake or there were issues with importing data into our radiomics software. Each 
patient’s primary GTV was contoured using MIM PET Edge (MIM Software Inc, Cleveland, OH). 
The 686 patients were divided into training and testing cohorts by MRN: those with an odd 
MRN were placed into the training cohort (345 patients), and those with an even MRN were placed into 
the testing cohort (341 patients). The patient demographics for each cohort are summarized in Table 9-
1.  
To investigate the effect of reducing inter-scanner variability on the predictive performance of 
patient outcome models, we included in these cohorts only patients who had been scanned on a GE 
scanner with two iterations and 20 or 21 subsets; these reconstruction settings were chosen to enable 
the largest subset cohort to be created from the original cohort. Additionally, in our unpublished work 
we have found that iterations and subsets can cause the largest discrepancies in radiomics features 
from the reconstruction parameters that can be changed. However, inter-vendor variances can be 
large, thus restricting this subset to only patients imaged on a GE scanner is the main driving force in 
reducing the uncertainty for this study. 
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Table 9-1. Patient Demographics 
 CT Patients PET Patients 
 Training Cohort Testing Cohort Training Cohort Testing Cohort 
Number of patients 377 349 345 341 
Number of events 97 75 76 51 
Age (years)* 59 (21-87) 57 (30-80) 60 (34-87) 58 (35-90) 
HPV status     
     Positive 224 189 207 206 
     Negative/unknown 153 160 138 135 
Tumor stage     
     T1 71 78 52 63 
     T2 143 142 131 142 
     T3 88 72 111 75 
     T4 75 57 51 61 
Nodal stage     
     N0 47 40 47 38 
     N1 34 34 39 40 
     N2 286 260 248 245 
     N3 10 15 11 18 
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AJCC stage     
     I-II 20 20 18 21 
     III 48 45 57 52 
     IV 309 284 270 268 
Primary Gross Tumor 
Volume (cm3)* 
9 (0.3-326) 8 (0.3-150) 9 (0.8-81) 9 (0.4-123) 
* median; range in parentheses 
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9.2.3 Feature Extraction 
The radiomics features were calculated using IBEX, an open-source radiomics tool [137, 138]. 
Tables of the extracted features are provided in the Supplemental Material. The settings for each 
feature were the same as those listed in Fave et al.’s Supplemental Material [14]. All of the features 
were calculated by using four different preprocessing techniques for the CT images: (1) thresholding 
(lower limit -100 HU, no upper limit), (2) thresholding and a Butterworth smoothing filter (order of 2, 
cut-off of 125), (3) thresholding and 8-bit depth resampling, and (4) thresholding, 8-bit depth 
resampling, and Butterworth smoothing. Different features have been shown to be most prognostic 
with different preprocessing techniques, which is why this assortment of preprocessing techniques was 
chosen [143]. For the PET images, all of these features were preprocessed using two methods: (1) a 
fixed bin width of 0.5 SUV, as suggested by Leijenaar et al. [166], and (2) rescaling to 64 levels, as 
suggested by Hatt et al. [167]. The volume of each GTV was also extracted. 
 
9.2.4 Model Building 
The modeling process used here is based on that used for several of our previous, successful 
radiomics studies [14, 15, 22]. The overall survival was defined as the time interval from the end of 
definitive radiotherapy to death, and was censored at the last follow-up for patients who were alive. 
The end point of overall survival was selected for this study because the number of events were higher 
than events using locoregional control or freedom from distant metastases as an end point. The model 
was built by using the training data and then receiver operator curve statistics were obtained by using 
the trained model on the testing data. The radiomics features and volume of the training data were 
scaled by subtracting the mean and dividing by the standard deviation for each since Lasso penalizes 
larger values more (R version 3.5.1).  Tumor volume and HPV status were the only clinical variables 
used in order to focus on the effect of the radiomics features. 
To begin building the model, we first used univariate Cox proportional hazards models to select 
 
144 
 
the one preprocessing technique for each feature that had the most significant association with overall 
survival. Clinical variables were used in forward selection, keeping only those that reduced the Akaike 
information criteria (AIC) by more than 2. Next, the selected clinical variable(s) were held constant in a 
univariate Cox proportional hazards model with the prescreened radiomics features to further reduce 
the dimensionality of the data (R survival package version 2.42-6). The features that had a p-value less 
than 0.01 were kept. One thousand bootstrap iterations of Lasso regression, using the selected 
radiomics features and clinical variables, were conducted (R glmnet package version 2.0-16). For these 
1000 iterations, the Lasso was fit by using the minimum lambda determined from a 10-fold cross-
validation with a maximum of 1000 iterations. The covariates selected in more than 50% of the 1000 
bootstrap iterations were kept. Due to the minimum lambda under penalizing the regression, a final 
forward selection was performed. Those covariates that reduced the AIC by more than 2 were selected. 
A final Cox model was fit by using these covariates and the non-scaled training data. 
The area under the curve (AUC) of the final Cox model when predicting overall survival in the 
testing data was calculated at 3 years (R survivalROC package version 1.0.3). Patients were assigned to 
the “High Risk” group if their prediction score was higher than the median; otherwise they were 
assigned to the “Low Risk” group. The survival probability curve of each group was estimated by the 
Kaplan-Meier method. The separation between these groups was evaluated by the log-rank test and 
determined to be significant if the p-value was less than 0.05 (R survival package). Models were built 
separately for the whole patient cohort and the subset of patients with the same imaging protocol. 
We also examined the HPV positive and negative/unknown patients separately because HPV 
status is a strong known predictor of overall survival. Additionally, most of the patients in our original 
patient cohort had oropharyngeal cancer, therefore, we analyzed the data using only these patients as 
well. For these subgroups, the whole modeling process was repeated, including modeling with only 
those patients with the same imaging protocol to allow for comparisons. 
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9.3 Results  
9.3.1 CT Patients 
When using the whole patient cohort, volume and HPV status were selected from the forward 
selection of the clinical variables. Twelve radiomics features had a p-value < 0.01 when tumor volume 
and HPV status were held within the Cox proportional hazards model. Five covariates were selected 
from the bootstrap Lasso. The final selected model contained the following four covariates: tumor 
volume, HPV status, gray level nonuniformity calculated using thresholding and bit depth resampling, 
and inverse difference norm calculated using thresholding. The AUC of this model on the testing data 
was 0.72. The High Risk and Low Risk groups were statistically separated (p=5x10-4). Survival plots are 
shown in Figure 9-1. However, when a Cox model with these covariates was fit on the testing data, 
volume, gray level nonuniformity, and inverse difference norm were just under the significance 
threshold (p=0.027, p=0.024, and p=0.017, respectively), and HPV status was not significant (p=0.18). 
Volume alone or volume and HPV status fit in a Cox model on the training data and evaluated on the 
testing data provided an AUC of 0.73. Adding any radiomics features to this reduced the AUC. 
The CT imaging protocol is also known to affect radiomics features measured from CT images 
[32, 37, 38, 132, 136]. Therefore, to reduce the noise in the data sets, only those patients scanned on a 
GE scanner with the same imaging protocol were included. This reduced the training data to 260 
patients and the testing data to 251 patients. The final model using this data included two covariates 
and had an AUC of 0.55 on the testing data. However, neither covariate was significant (p=0.90, p=0.79) 
in the testing data, so this attempt to control for imaging parameters was not effective. The High Risk 
and Low Risk groups were not statistically separated, and the survival curves for these risk groups are 
shown in Figure 9-1 alongside the survival curves using all of the patients. 
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Figure 9-1: Patient survival curves for CT radiomics models. 
Patient survival curves using CT patient data for the cohort using all patients and the subset of patients 
that had the same imaging protocol. For the cohort using all patients, the testing data were from 349 
patients who were assigned to High Risk or Low Risk groups according to prediction scores from the Cox 
model fit using the training data and the four covariates: volume, HPV status, gray level nonuniformity 
calculated using thresholding and bit depth resampling, and inverse difference norm calculated using 
thresholding. The separation between the curves was statistically significant (p=5x10-4). These patient 
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curves are called “All” and are in red and orange. For the subset of patients with the same imaging 
protocol, the testing data were from 251 patients who were assigned to High Risk or Low Risk groups 
according to prediction scores from the Cox model fit using the training data and the two covariates: 
HPV status and cluster tendency calculated using thresholding, smoothing, and bit depth resampling. 
The separation between the curves was not statistically significant. These patient curves are called 
“Subset” and are in blue and light blue. 
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When analyzing the CT data, inclusion of data from Aerts et al. [26] substantially affected the 
results. Although the MD Anderson data set was large, no radiomics feature was produced from the 
modeling process that was also significant in the testing data. However, inclusion of Aerts et al. [26] 
data produced two radiomics features that were also significant in the testing data and an AUC above 
0.7, as discussed at the beginning of the results presented here. 
Examining subgroups of only HPV positive, HPV negative/unknown, or oropharyngeal cancer 
patients did not improve these results. The information on the covariates selected and the AUC for 
these patient cohorts can be found in Appendix F. 
 
9.3.2 PET Patients 
When using the whole patient cohort, HPV status was selected from the forward selection of 
the clinical variables. Four radiomics features had a p-value < 0.01 when HPV status was held within the 
Cox proportional hazards model. Three covariates were selected from the bootstrap Lasso. The final 
selected model contained two covariates: HPV status and coarseness calculated using 64 gray levels. 
The AUC of this model on the testing data was 0.59. However, neither of the covariates was significant 
(p=0.69, p=0.16) when the Cox model was fit using the testing data or when selecting only one 
covariate. The High Risk and Low Risk groups were not statistically separated, as shown by the survival 
plots for these patients in Figure 9-2 where the curves overlap. 
The subsets and iterations in a PET imaging protocol are known to affect radiomics features 
measured from PET images [42, 46-48, 168]. Therefore, including only patients scanned on a GE 
scanner with 20 or 21 subsets and two iterations reduced the training data to 144 patients and the 
testing data to 168 patients. These patients were imaged on Discovery ST, Discovery STE, or Discovery 
RX PET scanners which are all non-time of flight and did not model point spread function. The final 
model included no covariates, even when relaxing the p-value for passing the additional prescreening 
univariate Cox analysis, so this attempt to control for imaging parameters was not effective. 
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Figure 9-2: Patient survival curves for PET radiomics models. 
Patient survival curves using PET patient data. The testing data were from 341 patients who were 
assigned to High Risk or Low Risk groups according to prediction scores from the Cox model fit using the 
training data and two covariates: HPV status and coarseness calculated with use of using 64 gray levels. 
The High Risk and Low Risk groups were not statistically separated as shown by the overlap of the 
survival curves. These patient curves are called “All” and are in red and orange. For the subset of 
patients with the same imaging protocol, no covariates were selected, therefore, the patients could not 
be separated into High Risk and Low Risk and no curves are displayed for the subset patient group. 
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Examining subgroups of only HPV positive, HPV negative/unknown, or oropharyngeal cancer 
patients did not improve these results. The information on the covariates selected and the AUC for 
these patient cohorts is in Appendix F. 
 
9.4 Discussion  
In this study, we investigated radiomics features for HNSCC patients by using CT and PET 
images. Both studies included more than 600 patients. A recent study published by Orlhac et al. found 
that since the first published PET radiomics study in 2009, almost 80% of studies have included fewer 
than 100 patients [168]. Similarly, CT head and neck cancer studies often include about 200 patients. 
Our study included more than three times this amount for both CT and PET analyses. 
While some features selected were significant in both the training and testing cohorts, none of 
our analyses in CT or PET studies could find a reliable radiomics feature that correlated with overall 
survival that was better than tumor volume. Our negative results are in contrast to other radiomics 
studies of head and neck cancer patients. Other studies have found radiomics features that correlated 
with overall survival, locoregional control, and freedom from distant metastases [17, 18, 26, 31, 171, 
172]. We investigated these other outcomes as well and found similar results to the overall survival 
results presented here. We chose to focus on overall survival since there were more events which 
typically results in better model building. However, most of our patients had oropharyngeal cancer, 
whereas most other radiomics studies included patients with general head and neck cancers that 
included sites such as the larynx. Foy et al. also showed that there are differences in implementation of 
the various radiomics software tools [173]. All of these differences could contribute to the differences 
in results found in other studies compared to our study. 
We attempted many manipulations of the data, including making the patient cohorts all one 
HPV status (e.g., positive), which removed the issue of HPV status having different rates of survival, and 
radiomics features were not consistently correlated with survival. Different splitting techniques of the 
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training and testing cohorts yielded similar, negative, results. The data between the training and testing 
was similar in patient number, HPV status composition, event rate, and other patient demographics. 
The positive results from the inclusion of the Aerts et al. data is consistent with the positive 
results found by Aerts et al. [26] in their original study with these data. Patient demographics (e.g., age, 
stage) were similar between the Aerts et al. [26] data set and the MD Anderson data set; however, 
there was a difference in event rate. This, in addition to the substantially different radiomics results 
between the two patient cohorts, indicated that there may have been differences in the patient 
population that we cannot understand through this study, such as differences in the patient population 
as it relates to the overall health care system. This suggests that radiomics signatures may not always 
be transferrable due to unseen differences in patient populations. 
These discrepancies were not observed with the PET data. The MD Anderson and TCIA data sets 
were similar in patient demographics and event rate. These data sets produced no AUC above 0.6, even 
when sources of noise, such as imaging protocol or HPV status, were removed. Some of these models 
resulted in no covariates selected, which meant that even the two included clinical variables in the first 
stages of the modeling were not good predictors of survival. Since PET scans are not part of the 
standard of care for HNSCC patients, the patient cohort in this study that underwent PET scans may not 
be representative of HNSCC patients in general. This could explain why the traditional strong clinical 
correlates of survival, tumor volume and HPV status, were not selected or significant. 
There are several limitations to this study. First, there are known clinical factors that affect 
survival that were not included in the analysis, such as smoking pack-years. The focus of this study was 
to demonstrate improvement in patient outcome models when imaging protocols are controlled, not to 
build the best possible outcome model that would include these clinical factors. Also, in common with 
other radiomics studies, only the primary GTV was analyzed. In patients with HNSCC, often nodes are 
involved, and some nodes may be irradiated due to suspected tumor involvement without definitive 
confirmation on images. It is difficult to determine how to best include these data in a conventional 
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radiomics study such as this one. Deep learning approaches have shown promising results as a different 
technique to radiomics studies and may handle these challenges better [174, 175]. 
 While the results of this particular study are negative, they highlight the areas that radiomics 
research should go towards in head and neck cancer patients. Our large CT study showed that the noise 
due to different imaging protocols can be overshadowed by noise due to differences between patient 
cohorts. This needs to be considered and investigated when applying radiomics signatures to patient 
groups from different regions with potentially different characteristics. Additionally, for PET, the lack of 
any texture signature correlation with overall survival outweighed the noise due to different imaging 
protocols. This again identifies an avenue for future studies as alternative approaches are needed, for 
example, deep learning or development of PET-specific features. Lastly, we showed that harmonizing 
imaging protocols does reduce some uncertainties in radiomics features. Reducing this source of 
uncertainty should make it easier to investigate other sources of uncertainty (such as differences in 
patient cohorts) that impact the results of radiomics studies. If these additional sources of uncertainty 
can also be reduced, then this harmonization of imaging protocols could result in more precise 
radiomics studies. 
 
9.5 Conclusion  
This is one of the largest radiomics studies in head and neck cancer patients and one of the 
largest PET radiomics studies in general. CT and PET-based radiomics features failed to improve survival 
models for head and neck cancer patients. Controlling the imaging protocol to minimize image 
uncertainties did not improve the radiomics models. The inconsistent CT findings here demonstrate 
that radiomics signatures for head and neck cancer patients may not be transferable, even when 
patient cohorts appear to be very similar. Head and neck cancer patient images may not have enough 
PET texture to be used in conventional radiomics studies.  
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Chapter 10 : Discussion 
In this dissertation we examined uncertainties in MRI, CT, and PET that could add noise to 
quantitative metrics used in patient analysis and then determined if controlling these uncertainties 
could improve prediction accuracy in models for salivary gland function and overall survival. For each 
modality we identified uncertainties and were able to control for several of these and then apply 
patient prediction models. However, for each aim we were unable to demonstrate that there was an 
improvement in modeling when controlling for the uncertainties due to the imaging. The individual 
studies are discussed in detail in the discussion section for each respective chapter above. 
For Aim 1 (MRI), the porcine phantom and synthetic images, showed that both Velocity and the 
in-house demons-based image registration system performed well, with all RMSEs below 3 mm. 
Therefore, the image registration uncertainty was quantified and we attempted to use this information 
in a longitudinal study that utilized deformable image registration. A cohort of 15 HNSCC patients 
imaged with DCE-MRI pre-, mid-, and post-treatment were used to quantify inter-algorithm reliability. 
Algorithms were able to determine high values from low values on DROs, but workflow differences may 
obscure the ability to discern values across algorithms in patients. Specifically, trends among algorithms 
from the same institution (institution supplied both Tofts-Kermode and extended Tofts algorithms) 
were consistent, but not across institutions. Therefore, translatability of DCE-MRI across algorithms is 
not currently feasible. Due to this and non-physiological values output from algorithms, voxel based 
tracking for prediction of salivary gland function was not pursued further. Thus, the Aim 1 hypothesis 
that “DCE-MRI parameters at pre- and mid-treatment time points are associated with normal tissue 
outcomes” was not proven. 
For Aim 2 (CT), we identified several potential noise sources that could impact radiomics 
studies: artifacts, imaging protocols, and inter-scanner variability. We showed that streak artifacts 
affect radiomics feature values, suggesting that regions containing such artifacts should not be included 
in radiomics data sets. We demonstrated that a simple technique, removing the slices with the artifact, 
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can be used to remove up to 50% of the original GTV from the ROI while retaining similar feature 
values. Additionally, while the presence of bone within the image can affect some feature values, the 
effect is typically smaller than the spread in values in the patient population and can, therefore, be 
ignored. We then showed that a controlled scan can be helpful for reducing uncertainties in 
prospective studies, as there was statistically significantly less variability in the controlled protocol 
scans than in the local protocol scans. The controlled protocol reduced the total variability by over 50% 
compared with both local chest and local head protocol scans. It is theoretically possible to correct for 
the manufacturer and the individual scanner. If this were done perfectly, the imaging variability could 
be reduced by an additional 7-8% compared with the reduction due to implementing a controlled 
protocol. We also demonstrated that tube voltage did not impact most features when measured in 
high-textured phantom cartridges which are more representative of patient tumors. This, in 
conjunction with other studies [32, 34, 35, 37, 38, 150], showed that the majority of the benefit of the 
controlled protocols can be achieved using the reconstruction parameters. Therefore, a radiomics 
reconstruction can be established that reduces noise of radiomics features for patient studies, while 
adding no extra dose to the patient for an additional CT scan. 
We then tested this reduction of noise of the radiomics features for patient studies by 
modeling overall survival with 726 HNSCC patients with CT images and then repeating the modeling 
with a subset of the patients with the same imaging protocol. While some features selected were 
significant in both the training and testing cohorts, none of our analyses could find a reliable radiomics 
feature that correlated with overall survival that was better than tumor volume. Positive results were 
found when Aerts et al. [26] data set was included. Patient demographics (e.g., age, stage) were similar 
between this data set and the MD Anderson data set; however, there was a difference in event rate. 
This, in addition to the substantially different radiomics results between the two patient cohorts, 
indicated that there may have been differences in the patient population that we cannot understand 
through this study, such as differences in the patient population as it relates to the overall health care 
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system. This suggests that radiomics signatures may not always be transferrable due to unseen 
differences in patient populations. Therefore, the noise due to underlying differences in patient 
populations from different institutions was found to be larger than the noise due to differences in 
imaging protocols. Thus, the Aim 2 hypothesis that “reducing the variability in CT-based radiomics 
features due to imaging protocols improves prediction accuracy when these features are used in HNSCC 
patient outcome models” was not proven. 
For Aim 3 (PET), we identified imaging protocols as a potential noise source. We found that as 
long as reasonable parameter values were used (i.e. parameter values that are actually used in clinics), 
almost all features had good reliability. This shows that on a given scanner, patients scanned using 
different imaging protocols can be combined without adding significant noise to the patient cohort. 
However, inter-scanner variability was about equal to inter-patient variability. This implies that patients 
scanned on different vendors should be combined with caution. Then, we tested this in 686 HNSCC 
patients with PET images. Cox proportional hazards models were created for overall survival using all 
patients and a subset of patients that had the same imaging protocol on the same vendor. No 
significant stratification of patients into Low and High Risk was achieved for any patient cohort. The MD 
Anderson and TCIA data sets were similar in patient demographics and event rate. These data sets 
produced no AUC above 0.6, even when sources of noise, such as imaging protocol or HPV status, were 
removed. Some of these models resulted in no covariates selected, which meant that even the two 
included clinical variables in the first stages of the modeling were not good predictors of survival. Since 
PET scans are not part of the standard of care for HNSCC patients, the patient cohort in this study that 
underwent PET scans may not be representative of HNSCC patients in general. This could explain why 
the traditional strong clinical correlates of survival, tumor volume and HPV status, were not selected or 
significant. As no patient cohort demonstrated a correlation of radiomics features with survival, PET 
radiomics studies such as this may not be suitable for these patients. Thus, the Aim 3 hypothesis that 
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“reducing the variability in PET-based radiomics features due to imaging protocols improves prediction 
accuracy when these features are used in HNSCC patient outcome models” was not proven. 
Overall, we investigated noise sources in each imaging modality that could contribute to 
uncertainties in patient analysis. For each modality we were able to quantify the uncertainty and 
determine a method to minimize its impact on the patient analysis. However, for each modality larger 
sources of noise were identified that caused each aim’s hypothesis to not be proven. 
 
Future Applications 
Potential future directions for each study were discussed in the respective chapter for that 
study.  Additional potential future studies are discussed here.  
For DCE-MRI, besides development of algorithms that are more robust to noise, there are 
several potential inter-institution and inter-algorithm studies that could be conducted based on the 
results from this work. First, similar studies comparing the output from different algorithms could be 
evaluated for different anatomical sites or different DCE-MRI metrics. A study in breast DCE-MRI was 
able to find some agreement between algorithms [94]. Therefore, investigating other sites provides 
valuable information into the issues discovered in this dissertation work. There could be large 
discrepancies in output for most anatomical sites or head and neck could be a difficult site for reliable 
results from DCE-MRI due to the many air cavities within the imaging space. If head and neck was found 
to be a more challenging site than others and this caused the inter-algorithm variability observed in this 
work to be much higher than for other sites, research into development of different sequences for 
quantitative analysis would be a productive avenue. Otherwise, development of consensus algorithms 
or standardization of algorithms by organizations such as QIBA would be a productive research path. In 
order to determine which path, however, additional inter-algorithm studies into other anatomical sites 
are needed. 
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Additionally, semi-quantitative metrics, such as area under the curve, could be more robust 
across algorithms and should be investigated. In this study we only investigated two quantitative 
metrics. Semi-quantitative metrics are more robust and thus, may have less inter-algorithm variability. 
These metrics have been found to correlate with outcomes in DCE-MRI studies before demonstrating 
that they are also useful [176-179]. Determination of the inter-algorithm variability of these metrics 
could lead to multi-institutional DCE-MRI research that can currently be conducted until such time that 
quantitative metrics are consistent across algorithms. 
For the radiomics studies, there are several potential future applications of this research. First, 
the modeling structure defined here was developed with close collaboration with a biostatistician and 
is therefore a strong statistical approach. This modeling structure can be used for studying outcomes in 
other patient cohorts. NSCLC has shown better prediction accuracy in the literature than HNSCC and is 
one possible avenue. Using a NSCLC cohort may enable demonstration of the impact of minimizing 
imaging uncertainties in patient studies.  
Another potential future application is the use of larger patient cohorts from more institutions 
and more head and neck sites. The current work was mostly composed of patients from MD Anderson. 
There was a demonstrable difference between patient cohorts from the two institutions in the CT 
analysis. Having data from more institutions from additional places in the United States and Europe can 
help elucidate if these are differences due to each institution or if they are regional differences. This 
can be expanded to other areas as well, such as Canada. The more institutions involved the easier it will 
be to determine if there are subregions that produce the same results, such as if all southern states in 
the United States had similar results. HNSCC encompasses a heterogeneous group of malignancies with 
HPV associated SCC involving only certain anatomical sites [180]. With the decline of tobacco use in the 
United States and other developed countries, there has been a decrease in oral cavity and laryngeal 
SCC incidence, but an increase in oropharyngeal SCC incidence with the increase in HPV incidence [180]. 
In Europe the overall mortality rates for HNSCC are higher with an annual incidence of 43 per 100,000 
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persons, where in the United States this is 15 per 100,000 persons [181]. This difference could be due 
different proportions HNSCC anatomical sites. Even within Europe there was a 14% difference in 5-year 
survival of head and neck cancer in 2004 across five countries: France, Italy, Spain, Switzerland, 
Belgium, and Portugal [182]. This difference was larger than the 6% difference in 1992 [182], indicating 
that discrepancies between areas may be growing and it may be possible to distinguish these using a 
large study. 
Beyond elucidating the differences between institutions, a large patient cohort could allow 
evaluation of the different head and neck sites. The patients in the study here mostly had 
oropharyngeal cancer. The oropharynx may be a particularly difficult site for radiomics studies. Using a 
larger cohort with more diverse head and neck cancer sites could allow for studies to determine if there 
are differences when predicting on patients with different anatomical head and neck cancer sites, such 
as larynx compared to oropharynx. 
Further, the conventional radiomics analysis that was conducted here may not be the best 
option. The studies here used features that were created for satellite images and applied them to 
medical images as many radiomics studies have also done. Feature generation specific for medical 
images is a potential research option that would allow for classical machine learning and statistical 
approaches, such as those used in this study. In this case the feature space and weighting of each 
feature is defined by the user. Creating new features could be useful as the hand-crafted methodology 
allows for interpretability of the modeling. Additionally, deep learning, where the feature space is not 
defined by the user, is a potential future research option. Deep learning has shown potential for 
radiomics applications [183-186]. This approach allows for inputting the whole 3D volume which may 
work better for head and neck patients as there is often large nodal involvement. The current work did 
not include analysis of the nodal involvement as it is difficult to include in conventional radiomics 
studies. Additionally, in head and neck treatments whole nodal levels are irradiated due to suspicion of 
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involvement which is difficult to include. Deep learning may allow for this information to be included 
due to the non-defined feature space that is used to create the model. 
Lastly, the identified controlled protocol for CT scans could be established as an additional 
reconstruction for patients. This would allow for accrual of consistent patient images that could be 
assessed in several years after outcome data has been recorded for these patients. Establishing this 
protocol would not result in immediate studies, but provides valuable data for future studies that 
eliminates the imaging protocol variabilities. While reduction of this variability did not improve 
performance of survival models in this work, reduction of this variability improves any study. Therefore, 
a move toward establishing this reconstruction at different institutions allows for high-quality data in 
the future. 
 
Conclusion 
We were able to quantify and control for the impact of several identified imaging uncertainties 
that could add noise to the analysis of quantitative imaging metrics in patient cohorts. However, 
prediction accuracy in head and neck patient cohorts was not improved by this noise reduction due to 
other noise sources. Therefore, the central hypothesis that DCE-MRI parameter changes during 
treatment are associated with salivary gland toxicity and pre-treatment CT and PET-based radiomics 
features are predictive of patient outcome in HNSCC was not shown within this work. 
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Appendix A: Supplemental Material for Chapter 4 
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Figure A-1: Heat Maps of No Noise DRO Error. 
Heat maps of the percentage error for Ktrans (left) and ve (right) in the DRO without noise. 
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Figure A-2: Heat Maps of Noisy DRO Error. 
Heat maps of the error for Ktrans (left) and ve (right) in the 28 DROs with noise. Maximum error is defined 
as 0.5, and minimum error is defined as -0.5. Any differences between the measured and simulated 
values greater than 0.5 are mapped to 0.5 and any differences less than -0.5 are mapped to -0.5. (See 
the inset in Fig. 2 for all Ktrans and SNR values.) 
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Figure A-3: Sorting of Patients Above and Below Median. 
Demonstration of the Krippendorff’s alpha test for pretreatment GTV-P. Red indicates that a patient’s 
pretreatment GTV-P Ktrans value is above the median pretreatment GTV-P Ktrans value for that algorithm. 
Blue indicates that a patient’s pretreatment GTV-P Ktrans value is below the median pretreatment GTV-P 
Ktrans value for that algorithm. Gray indicates that the patient’s pretreatment GTV-P Ktrans value was 
outside the bounds of the threshold. Overall, algorithms do not agree in classifying if a patient’s 
pretreatment GTVP Ktrans value is above or below the median for all patients. 
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Description of MDA Model 
Pre-contrast T1 maps were generated from the variable flip angle patient data. T1 values were 
calculated for each voxel in MATLAB (R2013a; MathWorks, Natick, MA) by performing a nonlinear curve 
fit (using “lsqcurvefit”) between signal intensity and the steady state signal equation for fast spoiled 
gradient echo sequences. Voxels with nonphysiological T1 values for soft tissue (T1<0.3s or T1>3.3s) 
were flagged and excluded from further analysis. Dynamic gadolinium concentration was calculated for 
the population AIF and each voxel of dynamic data which exceeded a minimum signal intensity 
threshold, assuming a relaxivity of 3.3/mM/s for Gd-DTPA and a baseline T1 value of 1600ms for blood 
at 3T. A hematocrit value of 41% was assumed in these analyses. 
All dynamic Gd concentration curves were trimmed to align the beginning of enhancement in AIF and 
tissue concentration curves and to ensure a consistent number of dynamic frames. Voxels that yielded 
negative or complex Gd concentration were flagged and excluded from further analysis. DCE-MRI 
vascular parameters were calculated by fitting dynamic data to the Tofts and extended Tofts models.  
 
Description of MGH Model 
The method for the DRO images and patient images were similar. The mri_ms_fitparms command from 
Freesurfer (https://surfer.nmr.mgh.harvard.edu/fswiki/mri_ms_fitparms) was used to create T1 maps 
from the provided variable flip angle files. These T1 maps then had a 2D Gaussian blur applied on each 
axial slice, or on just the one slice in the case of the DROs. For the patients, a population AIF was used 
from the AIF spreadsheet provided. For the DROs, AIFs were averaged from the provided AIF ROIs. 
All images except for the noiseless DRO were subject to a 2D Gaussian filter applied to axial slices. 
Signal intensity was converted into Gd concentration using the provided parameters for repetition 
time, flip angle and relaxivity. Hematocrit was assumed at 45%. T1 parameters were determined voxel-
by-voxel from the T1 map. Ktrans and ve values were fit using the two-parameter Tofts model. Fitting was 
achieved via the Nelder-Mead Simplex algorithm in Matlab, with a cost-function determined by 
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subtracting the AUC between expected signal intensity and observed signal intensity. AUCs were 
determined by piecewise linear integration across the entire timespan of the scan. Voxels that fit to 
unreasonable Ktrans or ve values were set to -.01. 
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R code for Permutation Test 
ord <- function(x){ 
  n.row <- length(x) 
  res <- NULL 
  for (i in 1:(n.row-1)){ 
    for (j in (i+1):n.row){ 
      res <- c(res, ifelse(x[i]<x[j], 0, 1))  
    } 
  } 
  return(sum(res))   
} 
 
#for k-trans which differs down columns 
perm.test <- function(mat, n.sim=1000, seed=1){ 
  set.seed(seed) 
  res <- numeric(n.sim) 
  for (i in 1:n.sim){ 
    res[i] <- sum(apply(mat, 2, function(x){ord(sample(x))})) 
  } 
  res.obs <- sum(apply(mat, 2, function(x){ord(x)})) 
  p.value <- mean(res < res.obs) + mean(res == res.obs)/2 
}  
 
p.value <- matrix(data=NA, nrow=noise,ncol=inst) 
for (i in 1:inst){ 
  for (j in 1:noise){ 
    data.sub <- data1[data1$institution==i&data1$noise==j,] 
    datasub.mat <- matrix(data.sub$measured.ktrans, nrow=length(table(data.sub$ktrans))) 
    p.value[j,i] <- perm.test(datasub.mat) 
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  } #institution is to identify algorithm 1 thru 11, noise is a value of 1 to 28 to identify the different noisy 
DROs 
} 
 
#for ve which is compared across rows 
perm.testrows <- function(mat, n.sim=1000, seed=1){ 
  set.seed(seed) 
  res <- numeric(n.sim) 
  for (i in 1:n.sim){ 
    res[i] <- sum(apply(mat, 1, function(x){ord(sample(x))})) 
  } 
  res.obs <- sum(apply(mat, 1, function(x){ord(x)})) 
  p.value <- mean(res < res.obs) + mean(res == res.obs)/2 
}  
 
p.valueve <- matrix(data=NA, nrow=noise,ncol=inst) 
for (i in 1:inst){ 
  for (j in 1:noise){ 
    data.sub <- data1[data1$institution==i&data1$noise==j,] 
    datasub.mat <- matrix(data.sub$measured.ve, nrow=length(table(data.sub$ktrans))) 
    p.valueve[j,i] <- perm.testrows(datasub.mat) 
  } 
} 
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Appendix B: Supplemental Material for Chapter 5 
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Figure B-1: Heat map of Patient-Normalized Phantom Range Values with Bit Depth Rescaling and 
Thresholding on GE.  
The patient-normalized phantom range values are shown for each feature on the basis of each material 
and patient population. The values are between 0 and 2; any values above 2 were mapped to the 
maximum color. Gray implies that the standard deviation among the patients was 0, therefore, the 
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denominator of the patient-normalized phantom range was 0. The materials along the x-axis are listed 
in order from least to most texture on the basis of the measured standard deviation of the CT numbers 
of the material. The patient-normalized phantom range that was calculated using the two patient 
cohorts appears together for each material. Each feature along the y-axis is identified first by the 
acronym for the feature group that it is part of. Each feature group is shown together with black lines 
separating the feature groups within the heat map. Textured materials have lower patient-normalized 
phantom range values. In addition, the gray level run length matrix features can be seen to have the 
highest values in comparison to the other feature groups. GLCM: gray level co-occurrence matrix; 
GLRLM: gray level run length matrix; NGTDM: neighborhood gray tone difference matrix; HNSCC: head 
and neck squamous cell carcinoma; NSCLC: non-small cell lung cancer. 
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Figure B-2: Heat map of Patient-Normalized Phantom Range Values with Smoothing and 
Thresholding on GE. 
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Figure B-3: Heat map of Patient-Normalized Phantom Range Values with Bit Depth Rescaling, 
Smoothing, and Thresholding on GE. 
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Figure B-4: Heat map of Patient-Normalized Phantom Range Values with Thresholding on Philips. 
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Figure B-5: Heat map of Patient-Normalized Phantom Range Values with Bit Depth Rescaling and 
Thresholding on Philips. 
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Figure B-6: Heat map of Patient-Normalized Phantom Range Values with Smoothing and 
Thresholding on Philips. 
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Figure B-7: Heat map of Patient-Normalized Phantom Range Values with Bit Depth Rescaling, 
Smoothing, and Thresholding on Philips. 
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Table B-1. Acrylic Spearman Rho and P Values 
   Acrylic 
   GE Philips 
Preprocessing Category Feature Rho P Value Rho P Value 
Thresholding GLCM Auto Correlation 0.80 0.17 -0.50 0.48 
Thresholding GLCM ClusterProminence 0.80 0.17 -0.50 0.48 
Thresholding GLCM Cluster Shade -0.40 0.49 -1.00 0.16 
Thresholding GLCM Cluster Tendendcy 0.80 0.17 -0.50 0.48 
Thresholding GLCM Contrast 0.80 0.17 -0.50 0.48 
Thresholding GLCM Correlation 0.40 0.49 -1.00 0.16 
Thresholding GLCM Difference Entropy 0.80 0.17 -0.50 0.48 
Thresholding GLCM Dissimilarity 0.80 0.17 -0.50 0.48 
Thresholding GLCM Energy -0.80 0.17 0.50 0.48 
Thresholding GLCM Entropy 0.80 0.17 -0.50 0.48 
Thresholding GLCM Homogeneity -0.80 0.17 0.50 0.48 
Thresholding GLCM Homogeneity2 -0.80 0.17 0.50 0.48 
Thresholding GLCM 
Information 
Measure Correlation 
1 -0.40 0.49 1.00 0.16 
Thresholding GLCM 
Information 
Measure Correlation 
2 0.40 0.49 -1.00 0.16 
Thresholding GLCM 
Inverse Difference 
Moment Norm 0.80 0.17 0.50 0.48 
Thresholding GLCM 
Inverse Difference 
Norm 0.80 0.17 0.50 0.48 
Thresholding GLCM Inverse Variance -0.80 0.17 0.50 0.48 
Thresholding GLCM Max Probability -0.80 0.17 0.50 0.48 
Thresholding GLCM Sum Average 0.80 0.17 -0.50 0.48 
Thresholding GLCM Sum Entropy 0.80 0.17 -0.50 0.48 
Thresholding GLCM Sum Variance 0.80 0.17 -0.50 0.48 
Thresholding GLCM Variance 0.80 0.17 -0.50 0.48 
Thresholding GLRLM 
Gray Level 
Nonuniformity -0.80 0.17 0.50 0.48 
Thresholding GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding GLRLM Long Run Emphasis -0.80 0.17 0.50 0.48 
Thresholding GLRLM 
Long Run High Gray 
Level Emphasis 0.80 0.17 0.50 0.48 
Thresholding GLRLM 
Long Run Low Gray 
Level Emphasis -1.00 0.08 0.50 0.48 
Thresholding GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding GLRLM 
Run Length 
Nonuniformity 0.80 0.17 -0.50 0.48 
Thresholding GLRLM Run Percentage 0.80 0.17 -0.50 0.48 
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Thresholding GLRLM Short Run Emphasis 0.80 0.17 -0.50 0.48 
Thresholding GLRLM 
Short Run High Gray 
Level Emphasis 1.00 0.08 0.50 0.48 
Thresholding GLRLM 
Short Run Low Gray 
Level Emphasis -1.00 0.08 -0.50 0.48 
Thresholding NGTDM Busyness -0.80 0.17 -0.50 0.48 
Thresholding NGTDM Coarseness -0.80 0.17 0.50 0.48 
Thresholding NGTDM Complexity 0.80 0.17 -0.50 0.48 
Thresholding NGTDM Contrast -0.40 0.49 -0.50 0.48 
Thresholding NGTDM TextureStrength 1.00 0.08 -1.00 0.16 
Thresholding IH Energy 1.00 0.08 1.00 0.16 
Thresholding IH Entropy -0.80 0.17 -0.50 0.48 
Thresholding IH Max 1.00 0.08 1.00 0.16 
Thresholding IH Mean 1.00 0.08 1.00 0.16 
Thresholding IH Median 1.00 0.08 1.00 0.16 
Thresholding IH Min 1.00 0.08 1.00 0.16 
Thresholding IH Standard Deviation 0.80 0.17 -0.50 0.48 
Thresholding IH Uniformity 0.80 0.17 0.50 0.48 
Thresholding IH Kurtosis -0.40 0.49 1.00 0.16 
Thresholding IH Skewness -0.80 0.17 -1.00 0.16 
Thresholding IH Variance 0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Auto Correlation -0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM ClusterProminence 0.00 1.00 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Cluster Shade -0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Cluster Tendendcy 0.00 1.00 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Contrast 0.00 1.00 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Correlation -0.40 0.49 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Difference Entropy 0.00 1.00 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Dissimilarity 0.00 1.00 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Energy 0.00 1.00 0.50 0.48 
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Thresholding 
and Bit Depth 
Resampling GLCM Entropy 0.00 1.00 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Homogeneity 0.00 1.00 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Homogeneity2 0.00 1.00 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
1 0.40 0.49 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
2 0.00 1.00 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Moment Norm 0.00 1.00 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Norm 0.00 1.00 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Inverse Variance 0.00 1.00 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Max Probability 0.00 1.00 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Sum Average -0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Sum Entropy 0.00 1.00 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Sum Variance -0.20 0.73 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Variance 0.00 1.00 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Gray Level 
Nonuniformity 0.00 1.00 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM Long Run Emphasis 0.00 1.00 0.50 0.48 
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Thresholding 
and Bit Depth 
Resampling GLRLM 
Long Run High Gray 
Level Emphasis 0.40 0.49 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Long Run Low Gray 
Level Emphasis 0.00 1.00 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Run Length 
Nonuniformity 0.00 1.00 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM Run Percentage 0.00 1.00 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM Short Run Emphasis 0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Short Run High Gray 
Level Emphasis 1.00 0.08 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Short Run Low Gray 
Level Emphasis 0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling NGTDM Busyness -0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling NGTDM Coarseness 0.80 0.17 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling NGTDM Complexity -0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling NGTDM Contrast -0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling NGTDM TextureStrength 0.80 0.17 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling IH Energy 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Entropy #N/A #N/A #N/A #N/A 
Thresholding 
and Bit Depth 
Resampling IH Max 0.89 0.12 #N/A #N/A 
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Thresholding 
and Bit Depth 
Resampling IH Mean 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Median 0.95 0.10 0.87 0.22 
Thresholding 
and Bit Depth 
Resampling IH Min 0.95 0.10 0.87 0.22 
Thresholding 
and Bit Depth 
Resampling IH Standard Deviation 0.00 1.00 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling IH Uniformity #N/A #N/A #N/A #N/A 
Thresholding 
and Bit Depth 
Resampling IH Kurtosis 0.00 1.00 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling IH Skewness -0.80 0.17 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling IH Variance 0.00 1.00 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Auto Correlation 0.40 0.49 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM ClusterProminence 1.00 0.08 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Cluster Shade -0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Cluster Tendendcy 1.00 0.08 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Contrast 0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Correlation 0.20 0.73 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Difference Entropy 0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Dissimilarity 0.80 0.17 -0.50 0.48 
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Thresholding 
and 
Smoothing GLCM Energy -1.00 0.08 0.50 0.48 
Thresholding 
and 
Smoothing GLCM Entropy 1.00 0.08 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Homogeneity -0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing GLCM Homogeneity2 -0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing GLCM 
Information 
Measure Correlation 
1 -0.20 0.73 0.50 0.48 
Thresholding 
and 
Smoothing GLCM 
Information 
Measure Correlation 
2 0.20 0.73 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM 
Inverse Difference 
Moment Norm 0.80 0.17 1.00 0.16 
Thresholding 
and 
Smoothing GLCM 
Inverse Difference 
Norm 0.80 0.17 1.00 0.16 
Thresholding 
and 
Smoothing GLCM Inverse Variance -0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing GLCM Max Probability -0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing GLCM Sum Average 0.40 0.49 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Sum Entropy 1.00 0.08 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Sum Variance 0.40 0.49 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Variance 1.00 0.08 -0.50 0.48 
Thresholding 
and 
Smoothing GLRLM 
Gray Level 
Nonuniformity -1.00 0.08 0.50 0.48 
Thresholding 
and 
Smoothing GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
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Thresholding 
and 
Smoothing GLRLM Long Run Emphasis -0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing GLRLM 
Long Run High Gray 
Level Emphasis 0.20 0.73 0.50 0.48 
Thresholding 
and 
Smoothing GLRLM 
Long Run Low Gray 
Level Emphasis -1.00 0.08 0.50 0.48 
Thresholding 
and 
Smoothing GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Run Length 
Nonuniformity 0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing GLRLM Run Percentage 0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing GLRLM Short Run Emphasis 0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing GLRLM 
Short Run High Gray 
Level Emphasis 1.00 0.08 -0.50 0.48 
Thresholding 
and 
Smoothing GLRLM 
Short Run Low Gray 
Level Emphasis -1.00 0.08 -0.50 0.48 
Thresholding 
and 
Smoothing NGTDM Busyness -1.00 0.08 0.50 0.48 
Thresholding 
and 
Smoothing NGTDM Coarseness -0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing NGTDM Complexity 1.00 0.08 -0.50 0.48 
Thresholding 
and 
Smoothing NGTDM Contrast -0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing NGTDM TextureStrength 1.00 0.08 -0.50 0.48 
Thresholding 
and 
Smoothing IH Energy 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Entropy -0.80 0.17 -0.50 0.48 
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Thresholding 
and 
Smoothing IH Max 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Mean 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Median 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Min 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Standard Deviation 1.00 0.08 -0.50 0.48 
Thresholding 
and 
Smoothing IH Uniformity 0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing IH Kurtosis 0.80 0.17 1.00 0.16 
Thresholding 
and 
Smoothing IH Skewness -0.40 0.49 -1.00 0.16 
Thresholding 
and 
Smoothing IH Variance 1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Auto Correlation 0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM ClusterProminence 0.00 1.00 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Cluster Shade -0.80 0.17 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Cluster Tendendcy 0.00 1.00 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Contrast 0.00 1.00 -1.00 0.16 
Thresholding, 
Smoothing, GLCM Correlation 0.00 1.00 -1.00 0.16 
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and Bit Depth 
Resampling 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Difference Entropy 0.00 1.00 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Dissimilarity 0.00 1.00 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Energy 0.00 1.00 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Entropy 0.00 1.00 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Homogeneity 0.00 1.00 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Homogeneity2 0.00 1.00 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
1 0.00 1.00 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
2 0.00 1.00 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Moment Norm 0.00 1.00 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Norm 0.00 1.00 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Inverse Variance 0.00 1.00 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Max Probability 0.00 1.00 1.00 0.16 
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Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Sum Average 0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Sum Entropy 0.00 1.00 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Sum Variance 0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Variance 0.00 1.00 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Gray Level 
Nonuniformity 0.00 1.00 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM Long Run Emphasis 0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Long Run High Gray 
Level Emphasis 0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Long Run Low Gray 
Level Emphasis 0.00 1.00 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Run Length 
Nonuniformity -0.40 0.49 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM Run Percentage 0.00 1.00 -1.00 0.16 
Thresholding, 
Smoothing, GLRLM Short Run Emphasis 0.80 0.17 -1.00 0.16 
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and Bit Depth 
Resampling 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Short Run High Gray 
Level Emphasis 0.80 0.17 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Short Run Low Gray 
Level Emphasis 0.80 0.17 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Busyness -0.80 0.17 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Coarseness 0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Complexity -0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Contrast -0.80 0.17 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM TextureStrength 0.80 0.17 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Energy 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Entropy #N/A #N/A #N/A #N/A 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Max 0.95 0.10 0.87 0.22 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Mean 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Median 0.95 0.10 0.87 0.22 
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Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Min 0.89 0.12 #N/A #N/A 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Standard Deviation 0.00 1.00 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Uniformity #N/A #N/A #N/A #N/A 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Kurtosis 0.00 1.00 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Skewness -0.80 0.17 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Variance 0.00 1.00 -1.00 0.16 
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Table B-2. Cork Spearman Rho and P Values 
   Cork 
   GE Philips 
Preprocessing Category Feature Rho P Value Rho P Value 
Thresholding GLCM Auto Correlation -0.20 0.73 0.50 0.48 
Thresholding GLCM ClusterProminence 0.80 0.17 -0.50 0.48 
Thresholding GLCM Cluster Shade 0.60 0.30 -0.50 0.48 
Thresholding GLCM Cluster Tendendcy 0.80 0.17 -1.00 0.16 
Thresholding GLCM Contrast 0.20 0.73 -0.50 0.48 
Thresholding GLCM Correlation -0.20 0.73 -1.00 0.16 
Thresholding GLCM Difference Entropy 0.20 0.73 -0.50 0.48 
Thresholding GLCM Dissimilarity 0.20 0.73 -0.50 0.48 
Thresholding GLCM Energy -0.80 0.17 0.50 0.48 
Thresholding GLCM Entropy 0.80 0.17 -0.50 0.48 
Thresholding GLCM Homogeneity -0.40 0.49 0.50 0.48 
Thresholding GLCM Homogeneity2 -0.20 0.73 0.50 0.48 
Thresholding GLCM 
Information 
Measure Correlation 
1 0.20 0.73 1.00 0.16 
Thresholding GLCM 
Information 
Measure Correlation 
2 -0.20 0.73 -1.00 0.16 
Thresholding GLCM 
Inverse Difference 
Moment Norm -0.20 0.73 0.50 0.48 
Thresholding GLCM 
Inverse Difference 
Norm -0.20 0.73 0.50 0.48 
Thresholding GLCM Inverse Variance -0.80 0.17 1.00 0.16 
Thresholding GLCM Max Probability -0.80 0.17 0.00 1.00 
Thresholding GLCM Sum Average -0.20 0.73 0.50 0.48 
Thresholding GLCM Sum Entropy 0.80 0.17 -1.00 0.16 
Thresholding GLCM Sum Variance -0.20 0.73 0.50 0.48 
Thresholding GLCM Variance 0.80 0.17 -1.00 0.16 
Thresholding GLRLM 
Gray Level 
Nonuniformity -0.80 0.17 1.00 0.16 
Thresholding GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding GLRLM Long Run Emphasis 0.20 0.73 0.50 0.48 
Thresholding GLRLM 
Long Run High Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding GLRLM 
Long Run Low Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding GLRLM 
Run Length 
Nonuniformity 0.40 0.49 -0.50 0.48 
Thresholding GLRLM Run Percentage 0.11 0.86 -0.50 0.48 
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Thresholding GLRLM Short Run Emphasis 0.40 0.49 -0.50 0.48 
Thresholding GLRLM 
Short Run High Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding GLRLM 
Short Run Low Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding NGTDM Busyness -0.20 0.73 -0.50 0.48 
Thresholding NGTDM Coarseness -0.20 0.73 1.00 0.16 
Thresholding NGTDM Complexity 0.40 0.49 0.50 0.48 
Thresholding NGTDM Contrast 0.40 0.49 -0.50 0.48 
Thresholding NGTDM TextureStrength 0.20 0.73 0.50 0.48 
Thresholding IH Energy 1.00 0.08 1.00 0.16 
Thresholding IH Entropy 0.80 0.17 -0.50 0.48 
Thresholding IH Max 0.40 0.49 0.50 0.48 
Thresholding IH Mean 1.00 0.08 1.00 0.16 
Thresholding IH Median 0.95 0.10 1.00 0.16 
Thresholding IH Min 1.00 0.08 1.00 0.16 
Thresholding IH Standard Deviation 0.80 0.17 -0.50 0.48 
Thresholding IH Uniformity -0.80 0.17 0.50 0.48 
Thresholding IH Kurtosis -0.80 0.17 0.50 0.48 
Thresholding IH Skewness -0.40 0.49 0.50 0.48 
Thresholding IH Variance 0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Auto Correlation -0.60 0.30 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM ClusterProminence 0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Cluster Shade 0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Cluster Tendendcy 1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Contrast 0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Correlation -0.20 0.73 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Difference Entropy 0.20 0.73 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Dissimilarity 0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Energy -1.00 0.08 1.00 0.16 
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Thresholding 
and Bit Depth 
Resampling GLCM Entropy 1.00 0.08 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Homogeneity -1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Homogeneity2 -1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
1 0.40 0.49 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
2 -0.40 0.49 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Moment Norm -0.60 0.30 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Norm -0.60 0.30 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Inverse Variance -0.20 0.73 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Max Probability -0.80 0.17 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Sum Average -0.60 0.30 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Sum Entropy 1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Sum Variance -0.60 0.30 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Variance 1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Gray Level 
Nonuniformity -0.80 0.17 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM Long Run Emphasis -0.80 0.17 -0.50 0.48 
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Thresholding 
and Bit Depth 
Resampling GLRLM 
Long Run High Gray 
Level Emphasis -0.20 0.73 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Long Run Low Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Run Length 
Nonuniformity 0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM Run Percentage 0.80 0.17 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM Short Run Emphasis 0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Short Run High Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Short Run Low Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling NGTDM Busyness 0.80 0.17 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling NGTDM Coarseness -0.40 0.49 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling NGTDM Complexity -0.20 0.73 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling NGTDM Contrast 0.80 0.17 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling NGTDM TextureStrength -0.40 0.49 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Energy 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Entropy 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Max 0.77 0.18 0.87 0.22 
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Thresholding 
and Bit Depth 
Resampling IH Mean 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Median #N/A #N/A #N/A #N/A 
Thresholding 
and Bit Depth 
Resampling IH Min 0.89 0.12 0.87 0.22 
Thresholding 
and Bit Depth 
Resampling IH Standard Deviation 1.00 0.08 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling IH Uniformity -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Kurtosis -0.80 0.17 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling IH Skewness -0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling IH Variance 1.00 0.08 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Auto Correlation 0.40 0.49 0.50 0.48 
Thresholding 
and 
Smoothing GLCM ClusterProminence 0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Cluster Shade 0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Cluster Tendendcy 1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Contrast 0.40 0.49 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Correlation -0.40 0.49 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Difference Entropy 0.40 0.49 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Dissimilarity 0.40 0.49 -1.00 0.16 
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Thresholding 
and 
Smoothing GLCM Energy -0.40 0.49 1.00 0.16 
Thresholding 
and 
Smoothing GLCM Entropy 0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Homogeneity -0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing GLCM Homogeneity2 -0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing GLCM 
Information 
Measure Correlation 
1 0.20 0.73 0.50 0.48 
Thresholding 
and 
Smoothing GLCM 
Information 
Measure Correlation 
2 -0.20 0.73 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM 
Inverse Difference 
Moment Norm -0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing GLCM 
Inverse Difference 
Norm -0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing GLCM Inverse Variance -0.20 0.73 1.00 0.16 
Thresholding 
and 
Smoothing GLCM Max Probability 0.74 0.20 0.50 0.48 
Thresholding 
and 
Smoothing GLCM Sum Average 0.40 0.49 0.50 0.48 
Thresholding 
and 
Smoothing GLCM Sum Entropy 1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Sum Variance 0.40 0.49 0.50 0.48 
Thresholding 
and 
Smoothing GLCM Variance 1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Gray Level 
Nonuniformity -0.40 0.49 0.50 0.48 
Thresholding 
and 
Smoothing GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
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Thresholding 
and 
Smoothing GLRLM Long Run Emphasis -0.40 0.49 -1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Long Run High Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Long Run Low Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Run Length 
Nonuniformity 0.40 0.49 1.00 0.16 
Thresholding 
and 
Smoothing GLRLM Run Percentage 0.40 0.49 1.00 0.16 
Thresholding 
and 
Smoothing GLRLM Short Run Emphasis 0.40 0.49 1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Short Run High Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Short Run Low Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing NGTDM Busyness -0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing NGTDM Coarseness -0.40 0.49 1.00 0.16 
Thresholding 
and 
Smoothing NGTDM Complexity 0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing NGTDM Contrast -0.60 0.30 -0.50 0.48 
Thresholding 
and 
Smoothing NGTDM TextureStrength 0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing IH Energy 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Entropy 1.00 0.08 -1.00 0.16 
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Thresholding 
and 
Smoothing IH Max 0.00 1.00 0.87 0.22 
Thresholding 
and 
Smoothing IH Mean 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Median 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Min 0.60 0.30 0.87 0.22 
Thresholding 
and 
Smoothing IH Standard Deviation 0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing IH Uniformity -0.80 0.17 1.00 0.16 
Thresholding 
and 
Smoothing IH Kurtosis 0.60 0.30 0.50 0.48 
Thresholding 
and 
Smoothing IH Skewness -0.20 0.73 0.50 0.48 
Thresholding 
and 
Smoothing IH Variance 0.80 0.17 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Auto Correlation 0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM ClusterProminence 0.80 0.17 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Cluster Shade 0.40 0.49 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Cluster Tendendcy 1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Contrast 0.40 0.49 -0.50 0.48 
Thresholding, 
Smoothing, GLCM Correlation -0.40 0.49 -0.50 0.48 
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and Bit Depth 
Resampling 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Difference Entropy 0.40 0.49 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Dissimilarity 0.40 0.49 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Energy -0.80 0.17 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Entropy 1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Homogeneity -0.80 0.17 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Homogeneity2 -0.80 0.17 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
1 0.40 0.49 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
2 -0.40 0.49 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Moment Norm -0.60 0.30 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Norm -0.80 0.17 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Inverse Variance 0.20 0.73 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Max Probability -0.20 0.73 1.00 0.16 
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Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Sum Average 0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Sum Entropy 1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Sum Variance 0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Variance 1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Gray Level 
Nonuniformity -0.40 0.49 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM Long Run Emphasis -0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Long Run High Gray 
Level Emphasis 0.60 0.30 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Long Run Low Gray 
Level Emphasis -0.80 0.17 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Run Length 
Nonuniformity 1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM Run Percentage 0.80 0.17 -0.50 0.48 
Thresholding, 
Smoothing, GLRLM Short Run Emphasis 1.00 0.08 -0.50 0.48 
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and Bit Depth 
Resampling 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Short Run High Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Short Run Low Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Busyness 0.40 0.49 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Coarseness -0.80 0.17 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Complexity 0.00 1.00 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Contrast 0.80 0.17 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM TextureStrength -0.80 0.17 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Energy 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Entropy 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Max 0.00 1.00 0.87 0.22 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Mean 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Median #N/A #N/A #N/A #N/A 
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Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Min 0.26 0.65 #N/A #N/A 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Standard Deviation 1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Uniformity -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Kurtosis 0.40 0.49 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Skewness -0.80 0.17 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Variance 1.00 0.08 -0.50 0.48 
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Table B-3. Dense Cork Spearman Rho and P Values 
   Dense Cork 
   GE Philips 
Preprocessing Category Feature Rho P Value Rho P Value 
Thresholding GLCM Auto Correlation 0.40 0.49 1.00 0.16 
Thresholding GLCM ClusterProminence 0.40 0.49 -1.00 0.16 
Thresholding GLCM Cluster Shade -1.00 0.08 -1.00 0.16 
Thresholding GLCM Cluster Tendendcy 0.20 0.73 -1.00 0.16 
Thresholding GLCM Contrast 0.20 0.73 -1.00 0.16 
Thresholding GLCM Correlation -0.20 0.73 -1.00 0.16 
Thresholding GLCM Difference Entropy 0.20 0.73 -1.00 0.16 
Thresholding GLCM Dissimilarity 0.20 0.73 -1.00 0.16 
Thresholding GLCM Energy -0.40 0.49 1.00 0.16 
Thresholding GLCM Entropy 0.20 0.73 -1.00 0.16 
Thresholding GLCM Homogeneity -1.00 0.08 0.50 0.48 
Thresholding GLCM Homogeneity2 -1.00 0.08 -0.50 0.48 
Thresholding GLCM 
Information 
Measure Correlation 
1 0.20 0.73 1.00 0.16 
Thresholding GLCM 
Information 
Measure Correlation 
2 -0.20 0.73 -1.00 0.16 
Thresholding GLCM 
Inverse Difference 
Moment Norm -0.40 0.49 -0.50 0.48 
Thresholding GLCM 
Inverse Difference 
Norm -0.40 0.49 -0.50 0.48 
Thresholding GLCM Inverse Variance -0.40 0.49 0.50 0.48 
Thresholding GLCM Max Probability -0.32 0.58 -0.50 0.48 
Thresholding GLCM Sum Average 0.40 0.49 1.00 0.16 
Thresholding GLCM Sum Entropy 0.20 0.73 -1.00 0.16 
Thresholding GLCM Sum Variance 0.40 0.49 1.00 0.16 
Thresholding GLCM Variance 0.20 0.73 -1.00 0.16 
Thresholding GLRLM 
Gray Level 
Nonuniformity -0.20 0.73 1.00 0.16 
Thresholding GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding GLRLM Long Run Emphasis -0.40 0.49 -1.00 0.16 
Thresholding GLRLM 
Long Run High Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding GLRLM 
Long Run Low Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding GLRLM 
Run Length 
Nonuniformity 0.80 0.17 1.00 0.16 
Thresholding GLRLM Run Percentage 0.40 0.49 1.00 0.16 
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Thresholding GLRLM Short Run Emphasis 0.80 0.17 1.00 0.16 
Thresholding GLRLM 
Short Run High Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding GLRLM 
Short Run Low Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding NGTDM Busyness -0.80 0.17 1.00 0.16 
Thresholding NGTDM Coarseness -0.20 0.73 1.00 0.16 
Thresholding NGTDM Complexity 0.40 0.49 -1.00 0.16 
Thresholding NGTDM Contrast 0.40 0.49 1.00 0.16 
Thresholding NGTDM TextureStrength 0.80 0.17 -1.00 0.16 
Thresholding IH Energy 1.00 0.08 1.00 0.16 
Thresholding IH Entropy 0.40 0.49 -1.00 0.16 
Thresholding IH Max 0.40 0.49 -0.50 0.48 
Thresholding IH Mean 1.00 0.08 1.00 0.16 
Thresholding IH Median 1.00 0.08 1.00 0.16 
Thresholding IH Min 0.60 0.30 1.00 0.16 
Thresholding IH Standard Deviation 0.20 0.73 -1.00 0.16 
Thresholding IH Uniformity -0.40 0.49 1.00 0.16 
Thresholding IH Kurtosis -0.80 0.17 -0.50 0.48 
Thresholding IH Skewness -1.00 0.08 -1.00 0.16 
Thresholding IH Variance 0.20 0.73 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Auto Correlation 0.40 0.49 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM ClusterProminence 1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Cluster Shade -1.00 0.08 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Cluster Tendendcy 0.40 0.49 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Contrast 0.20 0.73 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Correlation -0.20 0.73 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Difference Entropy 0.20 0.73 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Dissimilarity 0.20 0.73 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Energy -0.20 0.73 1.00 0.16 
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Thresholding 
and Bit Depth 
Resampling GLCM Entropy 0.20 0.73 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Homogeneity -0.20 0.73 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Homogeneity2 -0.20 0.73 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
1 0.20 0.73 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
2 -0.20 0.73 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Moment Norm -0.40 0.49 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Norm -0.40 0.49 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Inverse Variance -0.40 0.49 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Max Probability -0.80 0.17 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Sum Average 0.40 0.49 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Sum Entropy 0.20 0.73 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Sum Variance 0.40 0.49 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Variance 0.40 0.49 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Gray Level 
Nonuniformity -0.20 0.73 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM Long Run Emphasis -1.00 0.08 1.00 0.16 
 
204 
 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Long Run High Gray 
Level Emphasis 0.80 0.17 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Long Run Low Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Run Length 
Nonuniformity 1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM Run Percentage 1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM Short Run Emphasis 1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Short Run High Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Short Run Low Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling NGTDM Busyness 0.40 0.49 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling NGTDM Coarseness -0.20 0.73 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling NGTDM Complexity 0.20 0.73 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling NGTDM Contrast 0.40 0.49 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling NGTDM TextureStrength -0.40 0.49 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Energy 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Entropy -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Max 0.00 1.00 #N/A #N/A 
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Thresholding 
and Bit Depth 
Resampling IH Mean 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Median 0.89 0.12 0.87 0.22 
Thresholding 
and Bit Depth 
Resampling IH Min 0.26 0.65 #N/A #N/A 
Thresholding 
and Bit Depth 
Resampling IH Standard Deviation 0.20 0.73 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Uniformity 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Kurtosis -0.20 0.73 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling IH Skewness -1.00 0.08 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling IH Variance 0.20 0.73 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Auto Correlation 0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM ClusterProminence 1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Cluster Shade -1.00 0.08 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Cluster Tendendcy 1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Contrast 0.40 0.49 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Correlation -0.20 0.73 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Difference Entropy 0.20 0.73 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Dissimilarity 0.20 0.73 -1.00 0.16 
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Thresholding 
and 
Smoothing GLCM Energy -0.80 0.17 1.00 0.16 
Thresholding 
and 
Smoothing GLCM Entropy 0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Homogeneity -0.40 0.49 1.00 0.16 
Thresholding 
and 
Smoothing GLCM Homogeneity2 -0.40 0.49 0.50 0.48 
Thresholding 
and 
Smoothing GLCM 
Information 
Measure Correlation 
1 1.00 0.08 0.50 0.48 
Thresholding 
and 
Smoothing GLCM 
Information 
Measure Correlation 
2 -0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM 
Inverse Difference 
Moment Norm 0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM 
Inverse Difference 
Norm 0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Inverse Variance -0.40 0.49 1.00 0.16 
Thresholding 
and 
Smoothing GLCM Max Probability -0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Sum Average 0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Sum Entropy 1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Sum Variance 0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Variance 1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Gray Level 
Nonuniformity -0.20 0.73 1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
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Thresholding 
and 
Smoothing GLRLM Long Run Emphasis -0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing GLRLM 
Long Run High Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Long Run Low Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Run Length 
Nonuniformity 0.40 0.49 -0.50 0.48 
Thresholding 
and 
Smoothing GLRLM Run Percentage 0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing GLRLM Short Run Emphasis 0.40 0.49 -0.50 0.48 
Thresholding 
and 
Smoothing GLRLM 
Short Run High Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Short Run Low Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing NGTDM Busyness -0.60 0.30 -0.50 0.48 
Thresholding 
and 
Smoothing NGTDM Coarseness -0.20 0.73 1.00 0.16 
Thresholding 
and 
Smoothing NGTDM Complexity 0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing NGTDM Contrast -0.60 0.30 -0.50 0.48 
Thresholding 
and 
Smoothing NGTDM TextureStrength 0.60 0.30 -0.50 0.48 
Thresholding 
and 
Smoothing IH Energy 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Entropy 1.00 0.08 -1.00 0.16 
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Thresholding 
and 
Smoothing IH Max 0.95 0.10 -0.50 0.48 
Thresholding 
and 
Smoothing IH Mean 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Median 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Min 0.32 0.58 1.00 0.16 
Thresholding 
and 
Smoothing IH Standard Deviation 1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing IH Uniformity -0.80 0.17 1.00 0.16 
Thresholding 
and 
Smoothing IH Kurtosis 0.40 0.49 1.00 0.16 
Thresholding 
and 
Smoothing IH Skewness -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing IH Variance 1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Auto Correlation 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM ClusterProminence 1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Cluster Shade -1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Cluster Tendendcy 1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Contrast 0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, GLCM Correlation -0.40 0.49 -0.50 0.48 
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and Bit Depth 
Resampling 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Difference Entropy 0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Dissimilarity 0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Energy -0.20 0.73 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Entropy 0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Homogeneity -0.80 0.17 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Homogeneity2 -0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
1 0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
2 -0.40 0.49 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Moment Norm -0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Norm -0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Inverse Variance 0.60 0.30 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Max Probability -0.40 0.49 1.00 0.16 
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Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Sum Average 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Sum Entropy 1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Sum Variance 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Variance 1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Gray Level 
Nonuniformity -0.40 0.49 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM Long Run Emphasis -0.80 0.17 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Long Run High Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Long Run Low Gray 
Level Emphasis -1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Run Length 
Nonuniformity 0.20 0.73 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM Run Percentage 0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, GLRLM Short Run Emphasis 0.20 0.73 -1.00 0.16 
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and Bit Depth 
Resampling 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Short Run High Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Short Run Low Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Busyness 0.80 0.17 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Coarseness -0.80 0.17 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Complexity -0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Contrast 1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM TextureStrength -0.80 0.17 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Energy 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Entropy -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Max #N/A #N/A #N/A #N/A 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Mean 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Median 0.77 0.18 0.87 0.22 
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Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Min #N/A #N/A #N/A #N/A 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Standard Deviation 1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Uniformity 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Kurtosis 0.20 0.73 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Skewness -1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Variance 1.00 0.08 -1.00 0.16 
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Table B-4. Rubber Spearman Rho and P Values 
   Rubber 
   GE Philips 
Preprocessing Category Feature Rho P Value Rho P Value 
Thresholding GLCM Auto Correlation -1.00 0.08 -1.00 0.16 
Thresholding GLCM ClusterProminence -1.00 0.08 -1.00 0.16 
Thresholding GLCM Cluster Shade -1.00 0.08 -1.00 0.16 
Thresholding GLCM Cluster Tendendcy -1.00 0.08 -1.00 0.16 
Thresholding GLCM Contrast -1.00 0.08 -1.00 0.16 
Thresholding GLCM Correlation -1.00 0.08 -1.00 0.16 
Thresholding GLCM Difference Entropy -1.00 0.08 -1.00 0.16 
Thresholding GLCM Dissimilarity -1.00 0.08 -1.00 0.16 
Thresholding GLCM Energy 1.00 0.08 1.00 0.16 
Thresholding GLCM Entropy -1.00 0.08 -1.00 0.16 
Thresholding GLCM Homogeneity 1.00 0.08 1.00 0.16 
Thresholding GLCM Homogeneity2 1.00 0.08 1.00 0.16 
Thresholding GLCM 
Information 
Measure Correlation 
1 1.00 0.08 1.00 0.16 
Thresholding GLCM 
Information 
Measure Correlation 
2 -1.00 0.08 -1.00 0.16 
Thresholding GLCM 
Inverse Difference 
Moment Norm -0.80 0.17 -1.00 0.16 
Thresholding GLCM 
Inverse Difference 
Norm -0.80 0.17 -1.00 0.16 
Thresholding GLCM Inverse Variance 1.00 0.08 1.00 0.16 
Thresholding GLCM Max Probability 0.63 0.27 1.00 0.16 
Thresholding GLCM Sum Average -1.00 0.08 -1.00 0.16 
Thresholding GLCM Sum Entropy -1.00 0.08 -1.00 0.16 
Thresholding GLCM Sum Variance -1.00 0.08 -1.00 0.16 
Thresholding GLCM Variance -1.00 0.08 -1.00 0.16 
Thresholding GLRLM 
Gray Level 
Nonuniformity 1.00 0.08 1.00 0.16 
Thresholding GLRLM 
High Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding GLRLM Long Run Emphasis -0.60 0.30 -1.00 0.16 
Thresholding GLRLM 
Long Run High Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding GLRLM 
Long Run Low Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding GLRLM 
Low Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding GLRLM 
Run Length 
Nonuniformity 0.80 0.17 0.50 0.48 
Thresholding GLRLM Run Percentage 0.74 0.20 0.50 0.48 
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Thresholding GLRLM Short Run Emphasis 0.80 0.17 0.50 0.48 
Thresholding GLRLM 
Short Run High Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding GLRLM 
Short Run Low Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding NGTDM Busyness 1.00 0.08 1.00 0.16 
Thresholding NGTDM Coarseness 1.00 0.08 1.00 0.16 
Thresholding NGTDM Complexity -1.00 0.08 -1.00 0.16 
Thresholding NGTDM Contrast -1.00 0.08 -1.00 0.16 
Thresholding NGTDM TextureStrength -1.00 0.08 -1.00 0.16 
Thresholding IH Energy -1.00 0.08 -1.00 0.16 
Thresholding IH Entropy -1.00 0.08 -1.00 0.16 
Thresholding IH Max -1.00 0.08 -1.00 0.16 
Thresholding IH Mean -1.00 0.08 -1.00 0.16 
Thresholding IH Median -1.00 0.08 -1.00 0.16 
Thresholding IH Min -0.20 0.73 -0.50 0.48 
Thresholding IH Standard Deviation -1.00 0.08 -1.00 0.16 
Thresholding IH Uniformity 1.00 0.08 1.00 0.16 
Thresholding IH Kurtosis 1.00 0.08 1.00 0.16 
Thresholding IH Skewness -1.00 0.08 -1.00 0.16 
Thresholding IH Variance -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Auto Correlation -0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM ClusterProminence -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Cluster Shade -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Cluster Tendendcy -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Contrast -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Correlation -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Difference Entropy -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Dissimilarity -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Energy 1.00 0.08 1.00 0.16 
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Thresholding 
and Bit Depth 
Resampling GLCM Entropy -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Homogeneity 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Homogeneity2 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
1 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
2 -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Moment Norm -0.80 0.17 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Norm -0.80 0.17 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Inverse Variance 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Max Probability 0.40 0.49 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Sum Average -0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Sum Entropy -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Sum Variance -0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Variance -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Gray Level 
Nonuniformity 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
High Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM Long Run Emphasis 1.00 0.08 1.00 0.16 
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Thresholding 
and Bit Depth 
Resampling GLRLM 
Long Run High Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Long Run Low Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Low Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Run Length 
Nonuniformity -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM Run Percentage -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM Short Run Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Short Run High Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Short Run Low Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling NGTDM Busyness 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling NGTDM Coarseness 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling NGTDM Complexity -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling NGTDM Contrast -0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling NGTDM TextureStrength -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Energy -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Entropy 0.80 0.17 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Max -1.00 0.08 -1.00 0.16 
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Thresholding 
and Bit Depth 
Resampling IH Mean -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Median -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Min -0.20 0.73 0.00 1.00 
Thresholding 
and Bit Depth 
Resampling IH Standard Deviation -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Uniformity -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Kurtosis 1.00 0.08 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling IH Skewness -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Variance -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Auto Correlation -0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM ClusterProminence -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Cluster Shade -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Cluster Tendendcy -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Contrast -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Correlation -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Difference Entropy -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Dissimilarity -1.00 0.08 -1.00 0.16 
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Thresholding 
and 
Smoothing GLCM Energy 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing GLCM Entropy -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Homogeneity 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing GLCM Homogeneity2 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing GLCM 
Information 
Measure Correlation 
1 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing GLCM 
Information 
Measure Correlation 
2 -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM 
Inverse Difference 
Moment Norm -0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM 
Inverse Difference 
Norm -0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Inverse Variance 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing GLCM Max Probability 0.80 0.17 1.00 0.16 
Thresholding 
and 
Smoothing GLCM Sum Average -0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Sum Entropy -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Sum Variance -0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Variance -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Gray Level 
Nonuniformity 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
High Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
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Thresholding 
and 
Smoothing GLRLM Long Run Emphasis 0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing GLRLM 
Long Run High Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Long Run Low Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Low Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Run Length 
Nonuniformity -0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing GLRLM Run Percentage -0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing GLRLM Short Run Emphasis -0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing GLRLM 
Short Run High Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Short Run Low Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing NGTDM Busyness 1.00 0.08 0.50 0.48 
Thresholding 
and 
Smoothing NGTDM Coarseness 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing NGTDM Complexity -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing NGTDM Contrast -0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing NGTDM TextureStrength -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing IH Energy -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing IH Entropy -1.00 0.08 -1.00 0.16 
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Thresholding 
and 
Smoothing IH Max -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing IH Mean -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing IH Median -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing IH Min -0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing IH Standard Deviation -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing IH Uniformity 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Kurtosis 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Skewness -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing IH Variance -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Auto Correlation -1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM ClusterProminence -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Cluster Shade -1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Cluster Tendendcy -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Contrast -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, GLCM Correlation -1.00 0.08 -1.00 0.16 
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and Bit Depth 
Resampling 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Difference Entropy -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Dissimilarity -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Energy 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Entropy -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Homogeneity 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Homogeneity2 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
1 0.40 0.49 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
2 -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Moment Norm -1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Norm -1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Inverse Variance 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Max Probability 1.00 0.08 1.00 0.16 
 
222 
 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Sum Average -1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Sum Entropy -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Sum Variance -1.00 0.08 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Variance -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Gray Level 
Nonuniformity 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
High Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM Long Run Emphasis 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Long Run High Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Long Run Low Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Low Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Run Length 
Nonuniformity -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM Run Percentage -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, GLRLM Short Run Emphasis -1.00 0.08 -1.00 0.16 
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and Bit Depth 
Resampling 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Short Run High Gray 
Level Emphasis -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Short Run Low Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Busyness 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Coarseness 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Complexity -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Contrast -0.40 0.49 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM TextureStrength -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Energy -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Entropy 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Max -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Mean -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Median -1.00 0.08 -1.00 0.16 
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Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Min -0.95 0.10 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Standard Deviation -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Uniformity -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Kurtosis 1.00 0.08 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Skewness -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Variance -1.00 0.08 -1.00 0.16 
 
  
 
225 
 
Table B-5. Wood Spearman Rho and P Values 
   Wood 
   GE Philips 
Preprocessing Category Feature Rho P Value Rho P Value 
Thresholding GLCM Auto Correlation 0.80 0.17 -1.00 0.16 
Thresholding GLCM ClusterProminence 1.00 0.08 -1.00 0.16 
Thresholding GLCM Cluster Shade -0.40 0.49 0.50 0.48 
Thresholding GLCM Cluster Tendendcy 1.00 0.08 -1.00 0.16 
Thresholding GLCM Contrast 0.40 0.49 -0.50 0.48 
Thresholding GLCM Correlation -0.40 0.49 0.50 0.48 
Thresholding GLCM Difference Entropy 0.80 0.17 -0.50 0.48 
Thresholding GLCM Dissimilarity 0.80 0.17 -0.50 0.48 
Thresholding GLCM Energy -1.00 0.08 0.50 0.48 
Thresholding GLCM Entropy 0.80 0.17 -0.50 0.48 
Thresholding GLCM Homogeneity -0.80 0.17 0.50 0.48 
Thresholding GLCM Homogeneity2 -1.00 0.08 0.50 0.48 
Thresholding GLCM 
Information 
Measure Correlation 
1 0.80 0.17 -0.50 0.48 
Thresholding GLCM 
Information 
Measure Correlation 
2 -0.80 0.17 0.50 0.48 
Thresholding GLCM 
Inverse Difference 
Moment Norm 0.20 0.73 0.50 0.48 
Thresholding GLCM 
Inverse Difference 
Norm 0.00 1.00 0.50 0.48 
Thresholding GLCM Inverse Variance -1.00 0.08 0.50 0.48 
Thresholding GLCM Max Probability -0.40 0.49 1.00 0.16 
Thresholding GLCM Sum Average 0.80 0.17 -1.00 0.16 
Thresholding GLCM Sum Entropy 0.20 0.73 -1.00 0.16 
Thresholding GLCM Sum Variance 0.80 0.17 -1.00 0.16 
Thresholding GLCM Variance 1.00 0.08 -1.00 0.16 
Thresholding GLRLM 
Gray Level 
Nonuniformity -0.40 0.49 1.00 0.16 
Thresholding GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding GLRLM Long Run Emphasis -0.80 0.17 0.50 0.48 
Thresholding GLRLM 
Long Run High Gray 
Level Emphasis 0.20 0.73 1.00 0.16 
Thresholding GLRLM 
Long Run Low Gray 
Level Emphasis -0.80 0.17 0.50 0.48 
Thresholding GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding GLRLM 
Run Length 
Nonuniformity 0.80 0.17 -0.50 0.48 
Thresholding GLRLM Run Percentage 0.80 0.17 -0.50 0.48 
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Thresholding GLRLM Short Run Emphasis 0.80 0.17 -0.50 0.48 
Thresholding GLRLM 
Short Run High Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding GLRLM 
Short Run Low Gray 
Level Emphasis -0.80 0.17 -1.00 0.16 
Thresholding NGTDM Busyness 0.80 0.17 -1.00 0.16 
Thresholding NGTDM Coarseness -0.40 0.49 0.50 0.48 
Thresholding NGTDM Complexity 0.40 0.49 -0.50 0.48 
Thresholding NGTDM Contrast 0.80 0.17 -0.50 0.48 
Thresholding NGTDM TextureStrength -0.80 0.17 -0.50 0.48 
Thresholding IH Energy 1.00 0.08 1.00 0.16 
Thresholding IH Entropy 0.20 0.73 -1.00 0.16 
Thresholding IH Max 0.63 0.27 1.00 0.16 
Thresholding IH Mean 1.00 0.08 1.00 0.16 
Thresholding IH Median 1.00 0.08 1.00 0.16 
Thresholding IH Min -0.63 0.27 1.00 0.16 
Thresholding IH Standard Deviation 1.00 0.08 -1.00 0.16 
Thresholding IH Uniformity -0.40 0.49 1.00 0.16 
Thresholding IH Kurtosis -0.40 0.49 -0.50 0.48 
Thresholding IH Skewness -0.40 0.49 -0.50 0.48 
Thresholding IH Variance 1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Auto Correlation 1.00 0.08 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM ClusterProminence 0.80 0.17 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Cluster Shade -0.40 0.49 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Cluster Tendendcy 1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Contrast 0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Correlation -0.40 0.49 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Difference Entropy 0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Dissimilarity 0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Energy -0.80 0.17 0.50 0.48 
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Thresholding 
and Bit Depth 
Resampling GLCM Entropy 0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Homogeneity -0.80 0.17 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Homogeneity2 -0.80 0.17 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
1 0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
2 -0.40 0.49 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Moment Norm -0.40 0.49 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Norm -0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Inverse Variance 1.00 0.08 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Max Probability -0.40 0.49 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Sum Average 1.00 0.08 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Sum Entropy 0.80 0.17 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLCM Sum Variance 1.00 0.08 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLCM Variance 1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Gray Level 
Nonuniformity 0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM Long Run Emphasis -1.00 0.08 0.50 0.48 
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Thresholding 
and Bit Depth 
Resampling GLRLM 
Long Run High Gray 
Level Emphasis -1.00 0.08 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Long Run Low Gray 
Level Emphasis -1.00 0.08 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Run Length 
Nonuniformity 0.80 0.17 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM Run Percentage 1.00 0.08 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM Short Run Emphasis 0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Short Run High Gray 
Level Emphasis 0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling GLRLM 
Short Run Low Gray 
Level Emphasis 0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling NGTDM Busyness 0.40 0.49 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling NGTDM Coarseness -0.40 0.49 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling NGTDM Complexity 0.40 0.49 -0.50 0.48 
Thresholding 
and Bit Depth 
Resampling NGTDM Contrast 0.80 0.17 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling NGTDM TextureStrength -0.40 0.49 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Energy 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Entropy #N/A #N/A #N/A #N/A 
Thresholding 
and Bit Depth 
Resampling IH Max #N/A #N/A #N/A #N/A 
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Thresholding 
and Bit Depth 
Resampling IH Mean 1.00 0.08 1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Median #N/A #N/A 0.87 0.22 
Thresholding 
and Bit Depth 
Resampling IH Min #N/A #N/A 0.87 0.22 
Thresholding 
and Bit Depth 
Resampling IH Standard Deviation 1.00 0.08 -1.00 0.16 
Thresholding 
and Bit Depth 
Resampling IH Uniformity #N/A #N/A #N/A #N/A 
Thresholding 
and Bit Depth 
Resampling IH Kurtosis 0.00 1.00 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling IH Skewness -0.40 0.49 0.50 0.48 
Thresholding 
and Bit Depth 
Resampling IH Variance 1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Auto Correlation 0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM ClusterProminence 1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Cluster Shade -0.40 0.49 0.50 0.48 
Thresholding 
and 
Smoothing GLCM Cluster Tendendcy 1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Contrast 0.40 0.49 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM Correlation -0.40 0.49 0.50 0.48 
Thresholding 
and 
Smoothing GLCM Difference Entropy 0.40 0.49 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Dissimilarity 0.40 0.49 -0.50 0.48 
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Thresholding 
and 
Smoothing GLCM Energy -0.80 0.17 1.00 0.16 
Thresholding 
and 
Smoothing GLCM Entropy 0.40 0.49 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Homogeneity -1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing GLCM Homogeneity2 -1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing GLCM 
Information 
Measure Correlation 
1 0.40 0.49 -0.50 0.48 
Thresholding 
and 
Smoothing GLCM 
Information 
Measure Correlation 
2 -0.40 0.49 0.50 0.48 
Thresholding 
and 
Smoothing GLCM 
Inverse Difference 
Moment Norm -0.20 0.73 0.50 0.48 
Thresholding 
and 
Smoothing GLCM 
Inverse Difference 
Norm -0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing GLCM Inverse Variance -0.80 0.17 1.00 0.16 
Thresholding 
and 
Smoothing GLCM Max Probability 0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Sum Average 0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Sum Entropy 0.20 0.73 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Sum Variance 0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing GLCM Variance 1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Gray Level 
Nonuniformity 0.40 0.49 1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
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Thresholding 
and 
Smoothing GLRLM Long Run Emphasis -1.00 0.08 0.50 0.48 
Thresholding 
and 
Smoothing GLRLM 
Long Run High Gray 
Level Emphasis -0.80 0.17 0.50 0.48 
Thresholding 
and 
Smoothing GLRLM 
Long Run Low Gray 
Level Emphasis -1.00 0.08 0.50 0.48 
Thresholding 
and 
Smoothing GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Run Length 
Nonuniformity 1.00 0.08 -0.50 0.48 
Thresholding 
and 
Smoothing GLRLM Run Percentage 1.00 0.08 -0.50 0.48 
Thresholding 
and 
Smoothing GLRLM Short Run Emphasis 1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Short Run High Gray 
Level Emphasis 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing GLRLM 
Short Run Low Gray 
Level Emphasis -0.80 0.17 -1.00 0.16 
Thresholding 
and 
Smoothing NGTDM Busyness 0.40 0.49 -0.50 0.48 
Thresholding 
and 
Smoothing NGTDM Coarseness -0.40 0.49 0.50 0.48 
Thresholding 
and 
Smoothing NGTDM Complexity 0.40 0.49 -1.00 0.16 
Thresholding 
and 
Smoothing NGTDM Contrast 0.80 0.17 -0.50 0.48 
Thresholding 
and 
Smoothing NGTDM TextureStrength -0.40 0.49 -0.50 0.48 
Thresholding 
and 
Smoothing IH Energy 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Entropy 0.20 0.73 -1.00 0.16 
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Thresholding 
and 
Smoothing IH Max 0.63 0.27 1.00 0.16 
Thresholding 
and 
Smoothing IH Mean 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Median 1.00 0.08 1.00 0.16 
Thresholding 
and 
Smoothing IH Min 0.26 0.65 1.00 0.16 
Thresholding 
and 
Smoothing IH Standard Deviation 1.00 0.08 -1.00 0.16 
Thresholding 
and 
Smoothing IH Uniformity -0.40 0.49 1.00 0.16 
Thresholding 
and 
Smoothing IH Kurtosis -0.40 0.49 -0.50 0.48 
Thresholding 
and 
Smoothing IH Skewness -0.40 0.49 -0.50 0.48 
Thresholding 
and 
Smoothing IH Variance 1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Auto Correlation 0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM ClusterProminence 0.80 0.17 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Cluster Shade -0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Cluster Tendendcy 0.80 0.17 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Contrast 0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, GLCM Correlation -0.40 0.49 -1.00 0.16 
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and Bit Depth 
Resampling 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Difference Entropy 0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Dissimilarity 0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Energy -0.80 0.17 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Entropy 0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Homogeneity -0.80 0.17 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Homogeneity2 -0.80 0.17 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
1 0.40 0.49 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Information 
Measure Correlation 
2 -0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Moment Norm -0.60 0.30 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM 
Inverse Difference 
Norm -0.60 0.30 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Inverse Variance 0.80 0.17 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Max Probability -0.40 0.49 -0.50 0.48 
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Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Sum Average 0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Sum Entropy 1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Sum Variance 0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLCM Variance 0.80 0.17 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Gray Level 
Nonuniformity 0.80 0.17 -0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
High Gray Level Run 
Emphasis 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM Long Run Emphasis -0.80 0.17 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Long Run High Gray 
Level Emphasis -0.80 0.17 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Long Run Low Gray 
Level Emphasis -1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Low Gray Level Run 
Emphasis -1.00 0.08 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Run Length 
Nonuniformity 0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM Run Percentage 0.80 0.17 -1.00 0.16 
Thresholding, 
Smoothing, GLRLM Short Run Emphasis 0.40 0.49 -0.50 0.48 
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and Bit Depth 
Resampling 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Short Run High Gray 
Level Emphasis 0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling GLRLM 
Short Run Low Gray 
Level Emphasis -0.20 0.73 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Busyness 0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Coarseness -0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Complexity 0.20 0.73 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM Contrast 0.40 0.49 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling NGTDM TextureStrength -0.40 0.49 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Energy 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Entropy #N/A #N/A #N/A #N/A 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Max #N/A #N/A #N/A #N/A 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Mean 1.00 0.08 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Median #N/A #N/A 0.87 0.22 
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Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Min 0.26 0.65 #N/A #N/A 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Standard Deviation 0.80 0.17 -1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Uniformity #N/A #N/A #N/A #N/A 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Kurtosis 0.20 0.73 1.00 0.16 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Skewness -0.40 0.49 0.50 0.48 
Thresholding, 
Smoothing, 
and Bit Depth 
Resampling IH Variance 0.80 0.17 -1.00 0.16 
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Appendix C: Supplemental Material for Chapter 6 
 
Table C-1. Features that were not robust across the volume range for each slice removal and 
preprocessing technique 
ROI Volume 
Range 
Preprocessing 
technique 
Sequential Slice Removal Random Slice Removal 
75%-100% 
Thresholding n/a n/a 
Thresholding and 8-
bit depth resampling 
• Contrast n/a 
Thresholding and 
Butterworth 
smoothing 
n/a n/a 
Thresholding, 
smoothing, and 8-bit 
depth resampling 
n/a n/a 
50%-100% 
Thresholding • Information measure 
correlation 1 
• Busyness 
• Texture strength 
• Skewness 
• Texture strength 
• Skewness 
Thresholding and 8-
bit depth resampling 
• Busyness 
• Contrast 
• Texture strength 
• Skewness 
• Texture strength 
• Skewness 
Thresholding and 
Butterworth 
smoothing 
• Information measure 
correlation 1 
• Information measure 
correlation 2 
• Busyness 
• Texture strength 
• Information measure 
correlation 1 
• Texture strength 
Thresholding, 
smoothing, and 8-bit 
depth resampling 
• Busyness 
• Contrast 
• Texture strength 
• Texture strength 
 
25%-100% 
Thresholding • Auto correlation 
• Cluster tendency 
• Contrast (GLCM) 
• Correlation 
• Information measure 
correlation 1 
• Correlation 
• Information measure 
correlation 1 
• Information measure 
correlation 2 
• Max probability 
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• Information measure 
correlation 2 
• Max probability 
• Sum average 
• Sum variance 
• Variance (GLCM) 
• Long run high gray level 
emphasis 
• Short run low gray level 
emphasis 
• Busyness 
• Contrast 
• Texture strength 
• Median 
• Minimum 
• Uniformity 
• Skewness 
• Variance 
• Busyness 
• Contrast 
• Texture strength 
• Minimum 
• Skewness 
Thresholding and 8-
bit depth resampling 
• Auto correlation 
• Cluster tendency 
• Contrast (GLCM) 
• Correlation 
• Information measure 
correlation 1 
• Information measure 
correlation 2 
• Sum average 
• Sum variance 
• Variance (GLCM) 
• Gray level nonuniformity 
• Busyness 
• Contrast 
• Texture strength 
• Entropy 
• Median 
• Skewness 
• Correlation 
• Busyness 
• Contrast 
• Texture strength 
• Skewness 
Thresholding and 
Butterworth 
smoothing 
• Auto correlation 
• Cluster shade 
• Cluster tendency 
• Contrast (GLCM) 
• Correlation 
• Information measure 
correlation 1 
• Correlation 
• Information measure 
correlation 1 
• Information measure 
correlation 2 
• Max probability 
• Busyness 
• Contrast 
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• Information measure 
correlation 2 
• Max probability 
• Sum average 
• Sum variance 
• Variance (GLCM) 
• Gray level nonuniformity 
• Long run high gray level 
emphasis 
• Short run low gray level 
emphasis 
• Busyness 
• Contrast 
• Texture strength 
• Median 
• Minimum 
• Uniformity 
• Skewness 
• Variance 
• Texture strength 
• Minimum 
• Skewness 
Thresholding, 
smoothing, and 8-bit 
depth resampling 
• Auto correlation 
• Cluster shade 
• Cluster tendency 
• Contrast (GLCM) 
• Correlation 
• Information measure 
correlation 1 
• Information measure 
correlation 2 
• Max probability 
• Sum average 
• Sum variance 
• Variance (GLCM) 
• Gray level nonuniformity 
• Busyness 
• Contrast 
• Texture strength 
• Entropy 
• Median 
• Minimum 
• Skewness 
• Variance 
• Correlation 
• Busyness 
• Contrast 
• Texture strength 
• Skewness 
0%-100% 
Thresholding All features fail except: 
• Complexity 
All features fail except: 
• Complexity 
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• Maximum 
Thresholding and 8-
bit depth resampling 
All features fail except: 
• Complexity 
All features fail except: 
• Long run emphasis 
• Long run low gray level 
emphasis 
• Complexity 
• Maximum 
• Uniformity 
Thresholding and 
Butterworth 
smoothing 
All features fail except: 
• Complexity 
All features fail except: 
• Complexity 
• Maximum 
Thresholding, 
smoothing, and 8-bit 
depth resampling 
All features fail except: 
• Complexity 
All features fail except: 
• Complexity 
• Maximum 
• Uniformity 
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Appendix D: Supplemental Material Chapter 7 
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Figure D-1: Pearson Correlation of Features with Image Thickness with Only Robust Cartridges. 
Absolute value of the Pearson correlation rho for the correlation between feature value and image 
thickness for each region of interest (ROI). Each ROI is a different shape. Each category of feature is a 
different color. The correlation varies between and within features depending on the ROI. COM: gray 
level co-occurrence matrix, GLCM: gray level co-occurrence (used when there are features with the 
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same name in different categories to differentiate them), GLRLM: gray level run length matrix, NGTDM: 
neighborhood gray tone difference matrix. 
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Figure D-2: Bar Plots of Variability in Controlled Protocol with Thresholding. 
Bar plots of the relative contribution of the scanner wise variability, manufacturer wise variability, and 
residual variability for each feature using thresholding calculated on the controlled protocol. 
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Figure D-3: Bar Plots of Variability in Controlled Protocol with Thresholding and Smoothing. 
Bar plots of the relative contribution of the scanner wise variability, manufacturer wise variability, and 
residual variability for each feature using thresholding and smoothing calculated on the controlled 
protocol. 
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Figure D-4: Bar Plots of Variability in Controlled Protocol with Thresholding, Smoothing, and Bit 
Depth Rescaling. 
Bar plots of the relative contribution of the scanner wise variability, manufacturer wise variability, and 
residual variability for each feature using thresholding, smoothing, and bit depth rescaling calculated on 
the controlled protocol. 
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Figure D-5: Bar Plots of Variability in Head Protocol with Thresholding. 
Bar plots of the relative contribution of the scanner wise variability, manufacturer wise variability, and 
residual variability for each feature using thresholding calculated on the local head protocol. 
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Figure D-6: Bar Plots of Variability in Head Protocol with Thresholding and Smoothing. 
Bar plots of the relative contribution of the scanner wise variability, manufacturer wise variability, and 
residual variability for each feature using thresholding and smoothing calculated on the local head 
protocol. 
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Figure D-7: Bar Plots of Variability in Head Protocol with Thresholding, Smoothing, and Bit Depth 
Rescaling. 
Bar plots of the relative contribution of the scanner wise variability, manufacturer wise variability, and 
residual variability for each feature using thresholding, smoothing, and bit depth rescaling calculated on 
the local head protocol. 
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Figure D-8: Bar Plots of Variability in Thoracic Protocol with Thresholding. 
Bar plots of the relative contribution of the scanner wise variability, manufacturer wise variability, and 
residual variability for each feature using thresholding calculated on the local chest protocol. 
  
 
251 
 
  
Figure D-9: Bar Plots of Variability in Thoracic Protocol with Thresholding and Bit Depth Rescaling. 
Bar plots of the relative contribution of the scanner wise variability, manufacturer wise variability, and 
residual variability for each feature using thresholding and bit depth rescaling calculated on the local 
chest protocol. 
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Figure D-10: Bar Plots of Variability in Thoracic Protocol with Thresholding and Smoothing. 
Bar plots of the relative contribution of the scanner wise variability, manufacturer wise variability, and 
residual variability for each feature using thresholding and smoothing calculated on the local chest 
protocol. 
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Figure D-11: Bar Plots of Variability in Thoracic Protocol with Thresholding, Smoothing, and Bit Depth 
Rescaling. 
Bar plots of the relative contribution of the scanner wise variability, manufacturer wise variability, and 
residual variability for each feature using thresholding, smoothing, and bit depth rescaling calculated on 
the local chest protocol.   
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Table D-1. P-values for One Sided Pairwise T-tests between Control and Local Protocol Scans 
 
 
 
 
 
 
 
σβ: scanner-wise variability, σγ: manufacturer-wise variability, σε: residual variability 
  
 Control vs Chest Protocol Control vs Head Protocol 
 Thresholding 
Thresholding 
and Smoothing 
Thresholding 
and Bit Depth 
Rescaling 
Thresholding, 
Smoothing, and 
Bit Depth 
Rescaling 
Thresholding 
Thresholding 
and Smoothing 
Thresholding 
and Bit Depth 
Rescaling 
Thresholding, 
Smoothing, and 
Bit Depth 
Rescaling 
σβ 0.037 0.032 0.00073 0.0042 0.035 0.54 0.0015 0.0024 
σγ 0.027 0.018 0.00022 0.00049 0.0072 0.90 0.0000093 0.000097 
σε 0.038 0.046 0.0050 0.0049 0.036 0.42 0.0014 0.073 
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Table D-2. P-values for Pairwise T-tests between Variability from Model with All Manufacturers vs GE Only 
   
 Scanner-wise Variability Residual variability 
 Control Protocol Local Chest Protocol Local Head Protocol Control Protocol Local Chest Protocol Local Head Protocol 
Thresholding 0.088 0.084 0.076 0.29 0.070 0.071 
Thresholding and 
Smoothing 
0.45 0.0078 0.0024 0.051 0.13 0.48 
Thresholding and Bit 
Depth Resampling 
0.93 0.21 0.025 0.0022 0.028 0.0081 
Thresholding, 
Smoothing, and Bit 
Depth Resampling 
0.049 0.00022 0.0016 0.0024 0.083 0.0014 
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Figure D-12: Mean Value of Radiomics Cartridges Over Time. 
Mean value over time for each ROI, shown as a different colored and shaped point. The three cartridges 
with ABS demonstrated a downward trend with time while the other cartridges did not demonstrate 
any trend with time. 
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Percentage of Features Outside 1/3 Scaled Patient Standard Deviation Using All Robust Features 
Figure D-13: Percentage of Features Outside Patient Bounds. 
The percentage of features outside 1/3 scaled patient standard deviation for rubber, dense cork, and 
hemp seeds using the head and neck squamous cell carcinoma (HNSCC) patient cohort and the non-
small cell lung cancer (NSCLC) patient cohort. For all plots, there are a large percentage of features 
outside of a third of the scaled patient standard deviation. 
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Table D-3. Preprocessing and Features From Previous Studies Used for QA Analysis 
Preprocessing Feature Group Feature 
Thresholding and Smoothing NGTDM Texture Strength 
Thresholding and Smoothing IH Variance 
Thresholding and Smoothing IH Standard Deviation 
Thresholding and Smoothing IH Mean 
Thresholding and Smoothing IH Kurtosis 
Thresholding, Smoothing, and Bit 
Depth Resampling 
IH Entropy 
Thresholding and Smoothing IH Energy 
Thresholding and Smoothing GLCM Inverse Difference Norm 
Thresholding and Smoothing GLCM Inverse Difference Moment 
Norm 
Thresholding GLCM Information Measure 
Correlation 1 
Thresholding GLCM Information Measure 
Correlation 2 
Thresholding and Smoothing GLCM Dissimilarity 
Thresholding, Smoothing, and Bit 
Depth Resampling 
GLCM Difference Entropy 
Thresholding and Smoothing GLCM Contrast 
Thresholding NGTDM Busyness 
Thresholding IH Kurtosis 
NGTDM: neighborhood gray tone difference matrix; IH: intensity histogram; GLCM: gray level co-
occurrence matrix 
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Appendix E: Supplemental Material for Chapter 8 
 
Table E-1. Philips Scanner ICC Values for Protocol Parameters Changed 
  
Time per bed 
position Filter cutoff 
Filter cutoff 
(subset) 
Iterations and 
subsets 
Iterations and 
subsets 
(subset) 
Feature Category 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
AutoCorrelation GLCM 0.99 1.00 0.91 0.99 0.92 1.00 0.91 0.99 0.99 1.00 
ClusterProminence GLCM 0.98 1.00 0.66 0.83 0.89 0.95 0.52 0.96 0.93 0.99 
ClusterShade GLCM 1.00 1.00 0.93 0.95 0.98 0.98 0.65 0.86 0.97 0.98 
ClusterTendendcy GLCM 0.99 1.00 0.68 0.88 0.91 0.97 0.41 0.90 0.93 0.99 
Contrast GLCM 0.97 1.00 0.89 0.90 0.89 0.98 0.84 0.88 0.97 0.99 
Correlation GLCM 1.00 1.00 0.82 0.82 0.92 0.92 0.79 0.79 0.94 0.94 
DifferenceEntropy GLCM 0.98 1.00 0.76 0.88 0.88 0.93 0.77 0.90 0.95 0.98 
Dissimilarity GLCM 0.98 1.00 0.86 0.95 0.91 0.97 0.86 0.94 0.96 0.99 
Energy GLCM 0.99 1.00 0.85 0.79 0.91 0.87 0.25 0.25 0.88 0.87 
Entropy GLCM 0.98 1.00 0.85 0.91 0.93 0.96 0.71 0.84 0.95 0.97 
Homogeneity GLCM 0.99 0.99 0.88 0.83 0.97 0.96 0.77 0.82 0.98 0.97 
Homogeneity2 GLCM 0.99 1.00 0.88 0.81 0.98 0.95 0.78 0.82 0.98 0.97 
InformationMeasureCorr1 GLCM 0.99 1.00 0.80 0.75 0.96 0.93 0.78 0.75 0.97 0.95 
InformationMeasureCorr2 GLCM 1.00 1.00 0.74 0.72 0.91 0.90 0.73 0.73 0.91 0.91 
InverseDiffMomentNorm GLCM 0.97 0.97 0.89 0.89 0.89 0.90 0.84 0.81 0.97 0.96 
InverseDiffNorm GLCM 0.99 0.98 0.85 0.84 0.92 0.91 0.86 0.84 0.96 0.96 
InverseVariance GLCM 0.99 0.98 0.68 0.77 0.89 0.78 0.62 0.00 0.91 0.87 
MaxProbability GLCM 0.99 1.00 0.84 0.88 0.88 0.88 0.54 0.62 0.92 0.94 
SumAverage GLCM 0.99 1.00 0.95 0.98 0.96 1.00 0.91 0.98 0.99 1.00 
SumEntropy GLCM 0.98 1.00 0.86 0.95 0.88 0.97 0.61 0.77 0.93 0.97 
SumVariance GLCM 0.99 1.00 0.90 0.98 0.91 0.99 0.90 0.99 0.98 1.00 
Variance GLCM 0.99 1.00 0.68 0.88 0.91 0.97 0.41 0.90 0.93 0.99 
GrayLevelNonuniformity GLRLM 0.99 1.00 0.96 0.76 0.97 0.98 0.85 0.69 0.99 0.98 
HighGrayLevelRunEmpha GLRLM 0.98 1.00 0.90 0.99 0.91 0.99 0.90 0.99 0.98 1.00 
LongRunEmphasis GLRLM 0.98 0.97 0.94 0.62 0.96 0.95 0.39 0.10 0.98 0.94 
LongRunHighGrayLevelEm
pha GLRLM 0.97 0.96 0.86 0.81 0.96 0.99 0.79 0.79 0.97 0.98 
LongRunLowGrayLevelEm
pha GLRLM 0.99 1.00 0.91 0.70 0.96 0.92 0.53 0.11 0.95 0.89 
LowGrayLevelRunEmpha GLRLM 1.00 1.00 0.96 0.95 0.98 1.00 0.96 0.94 0.99 0.99 
RunLengthNonuniformity GLRLM 0.98 0.99 0.91 0.82 0.97 0.92 0.77 0.85 0.97 0.96 
RunPercentage GLRLM 0.98 0.99 0.93 0.76 0.97 0.94 0.72 0.80 0.98 0.96 
ShortRunEmphasis GLRLM 0.98 0.99 0.90 0.61 0.97 0.87 0.63 0.68 0.96 0.94 
ShortRunHighGrayLevelEm
pha GLRLM 0.98 1.00 0.92 0.99 0.91 0.99 0.93 0.96 0.98 1.00 
ShortRunLowGrayLevelEm
pha GLRLM 0.99 0.99 0.93 0.80 0.94 0.96 0.94 0.70 0.98 0.96 
EnergyNorm IH 0.99 1.00 0.92 0.99 0.93 1.00 0.92 0.99 0.99 1.00 
GlobalEntropy IH 0.92 0.98 0.67 0.74 0.83 0.88 0.60 0.51 0.93 0.97 
GlobalStd IH 0.98 1.00 0.67 0.92 0.91 0.99 0.45 0.91 0.93 0.99 
GlobalUniformity IH 0.96 0.98 0.72 0.75 0.87 0.89 0.46 0.56 0.94 0.97 
Kurtosis IH 1.00 1.00 0.67 0.67 0.86 0.86 0.19 0.20 0.93 0.93 
Skewness IH 1.00 1.00 0.92 0.92 0.98 0.98 0.75 0.75 0.99 0.99 
Variance IH 0.98 1.00 0.66 0.89 0.90 0.98 0.42 0.92 0.93 0.99 
Busyness NGTDM 0.99 0.98 0.81 0.89 0.86 0.92 0.86 0.85 0.94 0.92 
Coarseness NGTDM 0.98 1.00 0.62 0.69 0.79 0.77 0.61 0.50 0.89 0.87 
Complexity NGTDM 0.92 0.93 0.77 0.72 0.82 0.84 0.80 0.70 0.97 0.87 
Contrast NGTDM 0.96 0.95 0.63 0.71 0.83 0.87 0.53 0.71 0.91 0.91 
TextureStrength NGTDM 1.00 1.00 0.98 0.90 0.99 0.98 0.98 0.86 0.99 0.98 
Feature Category 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
AutoCorrelation GLCM 0.99 1.00 0.91 0.99 0.92 1.00 0.91 0.99 0.99 1.00 
ClusterProminence GLCM 0.98 1.00 0.66 0.83 0.89 0.95 0.52 0.96 0.93 0.99 
ClusterShade GLCM 1.00 1.00 0.93 0.95 0.98 0.98 0.65 0.86 0.97 0.98 
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GLCM: gray level co-occurrence matrix; GLRLM: gray level run length matrix; IH: intensity histogram; NGTDM: neighborhood 
gray tone difference matrix 
Filter cutoff (subset): cutoff values < 6 mm 
Iterations and subsets (subset): 16 ≤ effective iterations ≤ 45 
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Table E-2. GE Scanner ICC Values for Protocol Parameters Changed 
  
Time per bed 
position Filter cutoff 
Filter cutoff 
(subset) Field of view 
Field of view 
resampled 
pixel 
Feature Category 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
AutoCorrelation GLCM 0.99 1.00 0.98 0.99 0.97 1.00 1.00 1.00 1.00 1.00 
ClusterProminence GLCM 0.96 1.00 0.90 0.97 0.91 0.99 0.99 0.99 0.99 0.99 
ClusterShade GLCM 1.00 1.00 0.96 0.99 0.98 1.00 0.99 1.00 1.00 1.00 
ClusterTendendcy GLCM 0.98 1.00 0.95 0.97 0.97 0.99 0.97 0.98 0.99 0.99 
Contrast GLCM 1.00 1.00 0.86 0.78 0.98 0.95 0.57 0.56 1.00 1.00 
Correlation GLCM 1.00 1.00 0.87 0.87 0.98 0.98 0.55 0.56 1.00 1.00 
DifferenceEntropy GLCM 1.00 1.00 0.98 0.98 0.99 1.00 0.99 0.98 1.00 1.00 
Dissimilarity GLCM 1.00 1.00 0.95 0.94 0.99 0.99 0.83 0.82 1.00 1.00 
Energy GLCM 1.00 1.00 0.99 0.98 0.99 0.99 0.92 0.97 1.00 1.00 
Entropy GLCM 1.00 1.00 0.99 0.99 0.99 1.00 1.00 1.00 1.00 1.00 
Homogeneity GLCM 1.00 1.00 0.99 0.99 0.99 1.00 1.00 0.99 1.00 1.00 
Homogeneity2 GLCM 1.00 1.00 0.99 0.99 0.99 1.00 1.00 0.98 1.00 1.00 
InformationMeasureCorr1 GLCM 1.00 1.00 0.99 0.98 1.00 0.99 1.00 0.99 1.00 1.00 
InformationMeasureCorr2 GLCM 1.00 1.00 0.86 0.83 0.97 0.97 0.42 0.35 0.99 0.99 
InverseDiffMomentNorm GLCM 1.00 0.99 0.87 0.87 0.98 0.98 0.60 0.59 1.00 0.99 
InverseDiffNorm GLCM 1.00 1.00 0.96 0.95 0.99 0.99 0.86 0.86 1.00 1.00 
InverseVariance GLCM 1.00 0.98 0.94 0.71 0.99 0.90 0.50 0.37 0.99 0.97 
MaxProbability GLCM 1.00 1.00 0.98 0.99 0.99 0.99 0.97 0.99 0.99 1.00 
SumAverage GLCM 1.00 1.00 0.99 1.00 0.99 1.00 1.00 1.00 1.00 1.00 
SumEntropy GLCM 1.00 1.00 0.99 1.00 0.99 1.00 0.99 0.99 1.00 1.00 
SumVariance GLCM 0.99 1.00 0.97 0.99 0.97 1.00 1.00 1.00 1.00 1.00 
Variance GLCM 0.98 1.00 0.95 0.97 0.97 0.99 0.97 0.98 0.99 0.99 
GrayLevelNonuniformity GLRLM 1.00 1.00 0.94 0.82 1.00 0.98 0.75 0.25 1.00 1.00 
HighGrayLevelRunEmpha GLRLM 0.99 1.00 0.97 0.99 0.97 1.00 1.00 1.00 1.00 1.00 
LongRunEmphasis GLRLM 1.00 1.00 0.99 0.97 1.00 0.99 0.56 0.44 1.00 1.00 
LongRunHighGrayLevelEm
pha GLRLM 0.99 0.99 0.95 0.86 0.98 0.97 0.77 0.51 0.99 0.99 
LongRunLowGrayLevelEm
pha GLRLM 1.00 1.00 0.99 0.98 0.99 0.99 0.60 0.45 1.00 1.00 
LowGrayLevelRunEmpha GLRLM 1.00 1.00 0.99 1.00 1.00 1.00 0.98 0.99 1.00 1.00 
RunLengthNonuniformity GLRLM 1.00 1.00 0.98 0.98 0.99 1.00 0.99 0.83 0.99 0.99 
RunPercentage GLRLM 1.00 1.00 0.99 0.99 0.99 1.00 0.96 0.98 1.00 1.00 
ShortRunEmphasis GLRLM 0.99 1.00 0.97 0.98 0.99 0.99 0.93 0.96 0.99 0.99 
ShortRunHighGrayLevelEm
pha GLRLM 0.99 1.00 0.97 0.98 0.97 1.00 0.99 0.97 1.00 1.00 
ShortRunLowGrayLevelEm
pha GLRLM 1.00 1.00 0.98 0.93 1.00 0.98 0.87 0.48 1.00 0.99 
EnergyNorm IH 1.00 1.00 0.98 0.99 0.98 1.00 1.00 1.00 1.00 1.00 
GlobalEntropy IH 1.00 0.99 0.96 0.98 0.98 0.99 1.00 1.00 1.00 0.99 
GlobalStd IH 0.98 1.00 0.88 0.96 0.96 0.99 1.00 1.00 0.99 1.00 
GlobalUniformity IH 1.00 0.99 0.97 0.98 1.00 0.99 1.00 1.00 1.00 0.99 
Kurtosis IH 1.00 1.00 0.94 0.94 0.99 0.99 1.00 1.00 1.00 1.00 
Skewness IH 1.00 1.00 0.99 0.99 1.00 1.00 1.00 1.00 1.00 1.00 
Variance IH 0.98 1.00 0.89 0.95 0.96 0.99 1.00 1.00 0.99 1.00 
Busyness NGTDM 0.98 0.90 0.89 0.57 0.94 0.65 0.86 0.60 0.99 0.98 
Coarseness NGTDM 1.00 1.00 0.97 0.91 0.98 0.96 0.90 0.95 1.00 1.00 
Complexity NGTDM 0.66 0.93 0.25 0.66 0.76 0.84 0.12 0.43 0.97 0.98 
Contrast NGTDM 0.98 0.97 0.78 0.79 0.94 0.95 0.69 0.59 0.99 0.99 
TextureStrength NGTDM 0.99 0.99 0.97 0.97 0.99 0.99 0.69 0.76 1.00 0.99 
Feature Category 0.99 1.00 0.98 0.99 0.97 1.00 1.00 1.00 1.00 1.00 
AutoCorrelation GLCM 0.96 1.00 0.90 0.97 0.91 0.99 0.99 0.99 0.99 0.99 
ClusterProminence GLCM 1.00 1.00 0.96 0.99 0.98 1.00 0.99 1.00 1.00 1.00 
ClusterShade GLCM 0.98 1.00 0.95 0.97 0.97 0.99 0.97 0.98 0.99 0.99 
Filter cutoff (subset): cutoff values < 6 mm 
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Table E-3. GE Scanner ICC Values for Protocol Parameters Changed Contd. 
  
Matrix size 
Matrix size 
resampled pixel Type of recon 
Type of recon 
w/o Q.Clear 
Feature Category 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
AutoCorrelation GLCM 0.95 1.00 0.99 1.00 0.96 0.98 0.99 1.00 
ClusterProminence GLCM 0.92 0.99 0.98 0.99 0.79 0.77 0.88 0.90 
ClusterShade GLCM 0.96 0.98 1.00 1.00 0.98 0.96 0.98 0.98 
ClusterTendendcy GLCM 0.94 0.95 0.98 0.99 0.76 0.75 0.90 0.91 
Contrast GLCM 0.68 0.61 0.99 1.00 0.92 0.91 0.99 0.99 
Correlation GLCM 0.64 0.64 1.00 1.00 0.94 0.94 0.98 0.98 
DifferenceEntropy GLCM 0.99 1.00 1.00 1.00 0.99 0.99 1.00 1.00 
Dissimilarity GLCM 0.90 0.88 1.00 1.00 0.98 0.98 0.99 1.00 
Energy GLCM 0.95 0.95 0.99 1.00 0.97 0.99 0.99 0.99 
Entropy GLCM 0.99 1.00 1.00 1.00 0.99 0.99 1.00 1.00 
Homogeneity GLCM 0.99 1.00 1.00 1.00 0.99 0.99 1.00 1.00 
Homogeneity2 GLCM 0.99 0.99 1.00 1.00 0.99 1.00 1.00 1.00 
InformationMeasureCorr1 GLCM 0.99 0.99 1.00 1.00 0.98 0.97 1.00 1.00 
InformationMeasureCorr2 GLCM 0.63 0.49 0.99 0.99 0.91 0.87 0.95 0.94 
InverseDiffMomentNorm GLCM 0.74 0.74 0.99 0.99 0.95 0.94 0.99 0.98 
InverseDiffNorm GLCM 0.94 0.94 1.00 1.00 0.99 0.98 1.00 0.99 
InverseVariance GLCM 0.96 0.49 0.99 0.96 0.98 0.88 0.99 0.91 
MaxProbability GLCM 0.97 0.97 0.99 1.00 0.99 0.99 0.99 1.00 
SumAverage GLCM 0.98 1.00 1.00 1.00 0.98 0.99 1.00 1.00 
SumEntropy GLCM 0.97 0.98 0.99 1.00 0.99 0.99 1.00 1.00 
SumVariance GLCM 0.95 1.00 0.99 1.00 0.95 0.98 0.99 1.00 
Variance GLCM 0.94 0.95 0.98 0.99 0.76 0.75 0.90 0.91 
GrayLevelNonuniformity GLRLM 0.94 0.47 0.99 1.00 0.99 0.91 1.00 0.99 
HighGrayLevelRunEmpha GLRLM 0.97 1.00 0.99 1.00 0.96 0.99 0.99 0.99 
LongRunEmphasis GLRLM 0.83 0.72 1.00 0.99 0.93 0.99 0.95 0.99 
LongRunHighGrayLevelEm
pha GLRLM 0.94 0.77 0.99 0.99 0.95 0.98 0.98 0.99 
LongRunLowGrayLevelEm
pha GLRLM 0.89 0.74 0.99 0.99 0.90 0.99 0.92 0.99 
LowGrayLevelRunEmpha GLRLM 1.00 0.99 1.00 1.00 0.99 0.99 1.00 1.00 
RunLengthNonuniformity GLRLM 0.98 0.98 0.99 1.00 0.98 0.99 0.99 0.99 
RunPercentage GLRLM 0.97 0.99 0.99 1.00 0.97 0.99 0.99 1.00 
ShortRunEmphasis GLRLM 0.95 0.95 0.98 1.00 0.98 0.99 0.99 1.00 
ShortRunHighGrayLevelEm
pha GLRLM 0.97 0.99 0.99 1.00 0.96 0.99 0.99 0.99 
ShortRunLowGrayLevelEm
pha GLRLM 0.99 0.63 1.00 1.00 0.99 0.90 0.99 0.95 
EnergyNorm IH 0.97 1.00 0.99 1.00 0.96 0.98 0.99 1.00 
GlobalEntropy IH 0.98 0.99 0.99 0.99 0.96 0.97 0.99 0.98 
GlobalStd IH 0.94 0.99 0.96 1.00 0.81 0.88 0.93 0.97 
GlobalUniformity IH 1.00 0.99 0.99 0.99 0.97 0.97 0.99 0.98 
Kurtosis IH 1.00 1.00 1.00 1.00 0.97 0.97 0.99 0.99 
Skewness IH 1.00 1.00 1.00 1.00 0.99 0.99 1.00 1.00 
Variance IH 0.94 0.99 0.97 1.00 0.77 0.83 0.92 0.96 
Busyness NGTDM 0.76 0.40 0.98 0.93 0.83 0.75 0.96 0.87 
Coarseness NGTDM 0.98 0.87 1.00 1.00 0.97 0.94 0.99 0.99 
Complexity NGTDM 0.00 0.33 0.92 0.94 0.51 0.72 0.84 0.90 
Contrast NGTDM 0.72 0.65 0.97 0.97 0.73 0.77 0.95 0.95 
TextureStrength NGTDM 0.85 0.92 1.00 0.98 0.99 0.96 0.99 0.95 
Feature Category 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
AutoCorrelation GLCM 0.95 1.00 0.99 1.00 0.96 0.98 0.99 1.00 
ClusterProminence GLCM 0.92 0.99 0.98 0.99 0.79 0.77 0.88 0.90 
ClusterShade GLCM 0.96 0.98 1.00 1.00 0.98 0.96 0.98 0.98 
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Table E-4. GE Scanner ICC Values for Protocol Parameters Changed Contd. 
  Iterations and 
subsets 
Iterations and 
subsets (subset) Z smoothing 
Feature Category 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
AutoCorrelation GLCM 0.94 0.98 0.98 1.00 0.99 1.00 
ClusterProminence GLCM 0.66 0.89 0.89 1.00 0.87 0.84 
ClusterShade GLCM 0.78 0.86 0.97 0.99 0.99 0.97 
ClusterTendendcy GLCM 0.40 0.76 0.90 0.99 0.89 0.88 
Contrast GLCM 0.79 0.72 0.96 0.93 0.99 1.00 
Correlation GLCM 0.76 0.76 0.95 0.95 1.00 1.00 
DifferenceEntropy GLCM 0.97 0.98 1.00 1.00 1.00 1.00 
Dissimilarity GLCM 0.89 0.86 0.98 0.97 1.00 1.00 
Energy GLCM 0.97 0.97 1.00 1.00 0.98 0.99 
Entropy GLCM 0.98 0.98 1.00 1.00 0.99 1.00 
Homogeneity GLCM 0.97 0.97 1.00 1.00 0.99 1.00 
Homogeneity2 GLCM 0.97 0.96 1.00 1.00 0.99 1.00 
InformationMeasureCorr1 GLCM 0.97 0.97 1.00 1.00 1.00 1.00 
InformationMeasureCorr2 GLCM 0.66 0.62 0.92 0.90 1.00 1.00 
InverseDiffMomentNorm GLCM 0.80 0.80 0.96 0.95 0.99 0.99 
InverseDiffNorm GLCM 0.91 0.91 0.98 0.98 1.00 1.00 
InverseVariance GLCM 0.85 0.35 0.98 0.85 0.99 0.96 
MaxProbability GLCM 0.97 0.97 1.00 1.00 1.00 1.00 
SumAverage GLCM 0.96 0.98 0.99 1.00 1.00 1.00 
SumEntropy GLCM 0.98 0.99 1.00 1.00 0.99 1.00 
SumVariance GLCM 0.93 0.97 0.98 1.00 0.98 0.99 
Variance GLCM 0.40 0.76 0.90 0.99 0.89 0.88 
GrayLevelNonuniformity GLRLM 0.78 0.38 0.96 0.88 0.99 1.00 
HighGrayLevelRunEmpha GLRLM 0.95 0.96 0.98 1.00 0.98 0.98 
LongRunEmphasis GLRLM 0.85 0.42 0.98 0.98 0.95 1.00 
LongRunHighGrayLevelEm
pha GLRLM 0.84 0.43 0.97 0.96 0.98 0.98 
LongRunLowGrayLevelEm
pha GLRLM 0.89 0.43 1.00 0.98 0.92 1.00 
LowGrayLevelRunEmpha GLRLM 0.89 0.97 0.99 1.00 0.99 1.00 
RunLengthNonuniformity GLRLM 0.95 0.85 0.99 0.97 0.99 1.00 
RunPercentage GLRLM 0.94 0.96 0.99 0.99 0.98 1.00 
ShortRunEmphasis GLRLM 0.91 0.98 0.99 0.99 0.98 1.00 
ShortRunHighGrayLevelEm
pha GLRLM 0.96 0.89 0.99 0.99 0.98 0.99 
ShortRunLowGrayLevelEm
pha GLRLM 0.80 0.44 0.98 0.95 1.00 0.99 
EnergyNorm IH 0.95 0.97 0.98 1.00 0.99 1.00 
GlobalEntropy IH 0.93 0.93 0.98 0.98 0.99 0.98 
GlobalStd IH 0.61 0.90 0.90 0.99 0.90 0.94 
GlobalUniformity IH 0.94 0.93 0.99 0.98 0.99 0.98 
Kurtosis IH 0.84 0.84 0.99 0.99 0.98 0.98 
Skewness IH 0.92 0.92 0.99 0.99 1.00 1.00 
Variance IH 0.58 0.91 0.89 0.99 0.89 0.91 
Busyness NGTDM 0.78 0.55 0.97 0.87 0.93 0.78 
Coarseness NGTDM 0.94 0.79 0.99 0.97 1.00 1.00 
Complexity NGTDM 0.30 0.62 0.50 0.88 0.85 0.90 
Contrast NGTDM 0.79 0.74 0.91 0.89 0.94 0.95 
TextureStrength NGTDM 0.96 0.79 0.99 0.92 1.00 0.95 
Feature Category 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
AutoCorrelation GLCM 0.94 0.98 0.98 1.00 0.99 1.00 
ClusterProminence GLCM 0.66 0.89 0.89 1.00 0.87 0.84 
ClusterShade GLCM 0.78 0.86 0.97 0.99 0.99 0.97 
Iterations and subsets (subset): 16 ≤ effective iterations ≤ 36  
  
 
264 
 
Table E-5. Siemens Continuous Bed Motion Scanner ICC Values for Protocol Parameters Changed 
  
Time per bed 
position Filter cutoff 
Filter cutoff 
(subset) Matrix size 
Matrix size 
resampled 
pixel 
Feature Category 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
AutoCorrelation GLCM 0.99 1.00 0.89 0.98 0.96 0.99 0.94 1.00 0.94 1.00 
ClusterProminence GLCM 0.98 1.00 0.76 0.73 0.91 0.91 0.94 0.95 0.92 0.99 
ClusterShade GLCM 1.00 1.00 0.88 0.93 0.95 0.98 0.95 0.96 1.00 1.00 
ClusterTendendcy GLCM 0.99 1.00 0.80 0.76 0.93 0.94 0.94 0.95 0.95 0.98 
Contrast GLCM 0.99 1.00 0.91 0.86 0.94 0.98 0.58 0.50 0.92 0.98 
Correlation GLCM 1.00 1.00 0.91 0.91 0.98 0.98 0.48 0.48 0.99 0.99 
DifferenceEntropy GLCM 0.99 1.00 0.87 0.95 0.91 0.98 0.98 0.99 0.96 1.00 
Dissimilarity GLCM 0.99 1.00 0.89 0.97 0.93 0.99 0.86 0.80 0.95 0.99 
Energy GLCM 1.00 1.00 0.77 0.98 0.91 0.99 0.72 0.74 0.98 0.99 
Entropy GLCM 0.99 1.00 0.86 0.97 0.94 0.99 0.98 1.00 0.98 0.99 
Homogeneity GLCM 1.00 1.00 0.83 0.92 0.96 0.98 0.95 0.98 0.98 0.99 
Homogeneity2 GLCM 1.00 1.00 0.83 0.90 0.96 0.98 0.93 0.96 0.98 0.99 
InformationMeasureCorr1 GLCM 1.00 1.00 0.93 0.88 0.99 0.98 0.91 0.99 0.99 0.99 
InformationMeasureCorr2 GLCM 1.00 1.00 0.86 0.84 0.97 0.96 0.43 0.39 0.99 0.98 
InverseDiffMomentNorm GLCM 0.99 0.98 0.91 0.90 0.93 0.93 0.65 0.65 0.93 0.92 
InverseDiffNorm GLCM 0.99 0.99 0.86 0.86 0.93 0.92 0.90 0.90 0.96 0.95 
InverseVariance GLCM 0.99 1.00 0.85 0.84 0.96 0.97 0.86 0.72 0.96 0.98 
MaxProbability GLCM 0.97 1.00 0.62 0.94 0.87 0.99 0.75 0.84 0.82 0.98 
SumAverage GLCM 0.99 1.00 0.94 0.99 0.98 1.00 0.98 1.00 0.97 1.00 
SumEntropy GLCM 0.98 1.00 0.77 0.98 0.88 0.99 0.77 0.96 0.89 1.00 
SumVariance GLCM 0.99 1.00 0.88 0.98 0.95 0.99 0.95 1.00 0.93 1.00 
Variance GLCM 0.99 1.00 0.80 0.76 0.93 0.94 0.94 0.95 0.95 0.98 
GrayLevelNonuniformity GLRLM 1.00 1.00 0.85 0.93 0.98 0.99 0.80 0.54 0.95 0.99 
HighGrayLevelRunEmpha GLRLM 0.99 1.00 0.88 0.98 0.96 0.99 0.96 1.00 0.94 1.00 
LongRunEmphasis GLRLM 0.96 0.99 0.82 0.88 0.95 0.98 0.58 0.57 0.93 0.97 
LongRunHighGrayLevelEm
pha GLRLM 0.99 0.99 0.87 0.87 0.96 0.98 0.71 0.66 0.91 0.97 
LongRunLowGrayLevelEm
pha GLRLM 0.98 1.00 0.77 0.95 0.91 0.98 0.70 0.62 0.91 0.99 
LowGrayLevelRunEmpha GLRLM 1.00 1.00 0.84 0.99 0.92 1.00 0.95 0.95 0.97 1.00 
RunLengthNonuniformity GLRLM 0.98 1.00 0.80 0.92 0.94 0.98 0.86 0.94 0.93 0.97 
RunPercentage GLRLM 0.98 1.00 0.83 0.91 0.95 0.98 0.80 0.95 0.95 0.98 
ShortRunEmphasis GLRLM 0.98 1.00 0.80 0.89 0.93 0.96 0.81 0.88 0.93 0.97 
ShortRunHighGrayLevelEm
pha GLRLM 0.99 1.00 0.88 0.99 0.95 0.99 0.96 0.99 0.95 0.99 
ShortRunLowGrayLevelEm
pha GLRLM 1.00 1.00 0.86 0.97 0.92 0.99 0.81 0.51 0.97 0.98 
EnergyNorm IH 0.99 1.00 0.90 0.99 0.96 1.00 0.96 1.00 0.94 1.00 
GlobalEntropy IH 0.96 0.97 0.61 0.74 0.72 0.98 0.87 0.95 0.83 0.91 
GlobalStd IH 0.98 1.00 0.72 0.87 0.90 0.97 0.94 0.99 0.90 0.98 
GlobalUniformity IH 0.98 0.97 0.60 0.76 0.77 0.98 0.92 0.96 0.90 0.92 
Kurtosis IH 1.00 1.00 0.78 0.78 0.89 0.89 0.98 0.98 0.96 0.96 
Skewness IH 1.00 1.00 0.93 0.93 0.99 0.99 1.00 1.00 0.99 0.99 
Variance IH 0.98 1.00 0.70 0.83 0.90 0.95 0.94 0.99 0.90 0.98 
Busyness NGTDM 0.99 0.97 0.89 0.84 0.93 0.86 0.73 0.59 0.97 0.93 
Coarseness NGTDM 1.00 1.00 0.77 0.61 0.93 0.88 0.96 0.84 0.98 0.97 
Complexity NGTDM 0.97 0.98 0.83 0.72 0.77 0.87 0.17 0.40 0.95 0.96 
Contrast NGTDM 0.95 0.97 0.64 0.81 0.87 0.94 0.67 0.53 0.74 0.88 
TextureStrength NGTDM 1.00 0.98 0.96 0.87 0.99 0.94 0.78 0.83 0.99 0.98 
Feature Category 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
AutoCorrelation GLCM 0.99 1.00 0.89 0.98 0.96 0.99 0.94 1.00 0.94 1.00 
ClusterProminence GLCM 0.98 1.00 0.76 0.73 0.91 0.91 0.94 0.95 0.92 0.99 
ClusterShade GLCM 1.00 1.00 0.88 0.93 0.95 0.98 0.95 0.96 1.00 1.00 
Filter cutoff (subset): cutoff values < 6 mm 
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Table E-6. Siemens Continuous Bed Motion Scanner ICC Values for Protocol Parameters Changed 
Contd. 
  
Type of recon Iterations 
Iterations and 
subsets non-
TOF 
Iterations and 
subsets non-
TOF (subset) 
Feature Category 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
AutoCorrelation GLCM 0.89 0.98 0.93 1.00 0.62 0.97 0.92 1.00 
ClusterProminence GLCM 0.91 0.94 0.86 0.99 0.60 0.86 0.83 0.98 
ClusterShade GLCM 0.97 0.97 0.92 0.95 0.50 0.68 0.90 0.95 
ClusterTendendcy GLCM 0.95 0.96 0.89 0.97 0.17 0.66 0.90 0.94 
Contrast GLCM 0.94 0.96 0.91 0.96 0.76 0.70 0.95 0.94 
Correlation GLCM 0.97 0.97 0.97 0.97 0.73 0.72 0.94 0.94 
DifferenceEntropy GLCM 0.94 0.99 0.95 0.99 0.82 0.96 0.95 1.00 
Dissimilarity GLCM 0.94 0.99 0.93 0.98 0.86 0.88 0.95 0.97 
Energy GLCM 0.44 0.56 0.96 0.90 0.31 0.23 0.84 0.82 
Entropy GLCM 0.84 0.96 0.96 0.99 0.80 0.92 0.96 0.99 
Homogeneity GLCM 0.90 0.95 0.96 0.98 0.65 0.84 0.96 0.98 
Homogeneity2 GLCM 0.90 0.95 0.97 0.97 0.60 0.83 0.95 0.98 
InformationMeasureCorr1 GLCM 0.97 0.96 0.99 0.98 0.86 0.85 0.99 0.99 
InformationMeasureCorr2 GLCM 0.98 0.97 0.91 0.90 0.59 0.56 0.90 0.90 
InverseDiffMomentNorm GLCM 0.95 0.94 0.92 0.92 0.79 0.80 0.95 0.95 
InverseDiffNorm GLCM 0.94 0.94 0.93 0.93 0.86 0.87 0.95 0.95 
InverseVariance GLCM 0.96 0.96 0.96 0.95 0.78 0.08 0.92 0.93 
MaxProbability GLCM 0.49 0.56 0.86 0.93 0.34 0.47 0.86 0.89 
SumAverage GLCM 0.93 0.98 0.97 1.00 0.71 0.96 0.96 1.00 
SumEntropy GLCM 0.64 0.94 0.92 0.98 0.56 0.79 0.90 0.99 
SumVariance GLCM 0.89 0.99 0.91 1.00 0.62 0.97 0.91 1.00 
Variance GLCM 0.95 0.96 0.89 0.97 0.17 0.66 0.90 0.94 
GrayLevelNonuniformity GLRLM 0.84 0.92 0.98 0.96 0.98 0.55 0.99 0.93 
HighGrayLevelRunEmpha GLRLM 0.91 0.99 0.94 1.00 0.70 0.97 0.92 1.00 
LongRunEmphasis GLRLM 0.63 0.86 0.89 0.93 0.18 0.10 0.85 0.91 
LongRunHighGrayLevelEm
pha GLRLM 0.89 0.98 0.92 0.96 0.50 0.51 0.88 0.96 
LongRunLowGrayLevelEm
pha GLRLM 0.52 0.81 0.92 0.92 0.36 0.12 0.94 0.91 
LowGrayLevelRunEmpha GLRLM 0.87 0.97 0.97 0.99 0.81 0.94 0.97 1.00 
RunLengthNonuniformity GLRLM 0.81 0.96 0.90 0.95 0.35 0.90 0.91 0.97 
RunPercentage GLRLM 0.75 0.94 0.92 0.96 0.36 0.83 0.93 0.98 
ShortRunEmphasis GLRLM 0.81 0.94 0.89 0.92 0.24 0.70 0.92 0.99 
ShortRunHighGrayLevelEm
pha GLRLM 0.91 0.99 0.94 1.00 0.71 0.90 0.92 0.99 
ShortRunLowGrayLevelEm
pha GLRLM 0.91 0.91 0.97 0.92 0.81 0.29 0.97 0.93 
EnergyNorm IH 0.89 0.98 0.93 1.00 0.66 0.97 0.92 1.00 
GlobalEntropy IH 0.67 0.86 0.73 0.98 0.47 0.30 0.90 0.92 
GlobalStd IH 0.86 0.96 0.82 0.98 0.10 0.74 0.86 0.96 
GlobalUniformity IH 0.73 0.86 0.81 0.98 0.51 0.38 0.93 0.92 
Kurtosis IH 0.93 0.93 0.90 0.90 0.00 0.00 0.81 0.81 
Skewness IH 0.96 0.96 0.97 0.97 0.65 0.65 0.95 0.95 
Variance IH 0.85 0.95 0.82 0.98 0.09 0.79 0.85 0.96 
Busyness NGTDM 0.95 0.92 0.92 0.90 0.74 0.79 0.98 0.93 
Coarseness NGTDM 0.95 0.97 0.91 0.85 0.81 0.70 0.96 0.94 
Complexity NGTDM 0.92 0.94 0.94 0.92 0.58 0.66 0.96 0.89 
Contrast NGTDM 0.69 0.86 0.67 0.87 0.10 0.66 0.56 0.82 
TextureStrength NGTDM 1.00 0.94 0.98 0.97 0.97 0.75 0.99 0.97 
Feature Category 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
AutoCorrelation GLCM 0.89 0.98 0.93 1.00 0.62 0.97 0.92 1.00 
ClusterProminence GLCM 0.91 0.94 0.86 0.99 0.60 0.86 0.83 0.98 
ClusterShade GLCM 1.00 1.00 0.88 0.93 0.95 0.98 0.95 0.96 
Iterations and subsets (subset): 16 ≤ effective iterations ≤ 24 
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Table E-7. Siemens Scanner ICC Values for Protocol Parameters Changed 
  
Time per bed 
position Filter cutoff 
Filter cutoff 
(subset) Matrix size 
Matrix size 
resampled 
pixel 
Feature Category 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
AutoCorrelation GLCM 0.99 1.00 0.92 0.99 0.97 0.99 0.97 1.00 0.98 1.00 
ClusterProminence GLCM 0.99 1.00 0.70 0.51 0.97 0.78 0.90 0.94 0.92 0.98 
ClusterShade GLCM 1.00 1.00 0.95 0.88 0.98 0.95 0.97 0.97 1.00 1.00 
ClusterTendendcy GLCM 0.99 1.00 0.71 0.60 0.98 0.87 0.87 0.93 0.94 0.98 
Contrast GLCM 1.00 1.00 0.92 0.87 0.97 0.98 0.60 0.51 0.95 0.98 
Correlation GLCM 1.00 1.00 0.90 0.90 0.98 0.98 0.48 0.48 0.99 0.99 
DifferenceEntropy GLCM 1.00 1.00 0.93 0.94 0.96 0.98 0.98 0.99 0.99 0.99 
Dissimilarity GLCM 1.00 1.00 0.93 0.96 0.97 0.99 0.86 0.81 0.98 0.99 
Energy GLCM 1.00 1.00 0.77 0.93 0.87 0.96 0.74 0.74 0.99 0.99 
Entropy GLCM 1.00 1.00 0.90 0.96 0.96 0.99 0.99 1.00 0.99 0.99 
Homogeneity GLCM 1.00 1.00 0.92 0.94 0.98 0.99 0.97 0.99 0.99 0.99 
Homogeneity2 GLCM 1.00 1.00 0.92 0.93 0.98 0.99 0.95 0.97 0.99 0.99 
InformationMeasureCorr1 GLCM 1.00 1.00 0.93 0.91 0.99 0.98 0.96 0.99 0.99 0.99 
InformationMeasureCorr2 GLCM 1.00 1.00 0.86 0.85 0.97 0.97 0.46 0.40 0.99 0.98 
InverseDiffMomentNorm GLCM 1.00 0.99 0.93 0.92 0.97 0.96 0.66 0.65 0.96 0.95 
InverseDiffNorm GLCM 1.00 1.00 0.92 0.92 0.97 0.97 0.90 0.91 0.98 0.98 
InverseVariance GLCM 1.00 1.00 0.90 0.87 0.98 0.98 0.85 0.63 0.99 0.97 
MaxProbability GLCM 0.97 0.99 0.75 0.93 0.82 0.90 0.76 0.78 0.87 0.97 
SumAverage GLCM 1.00 1.00 0.97 0.99 0.99 1.00 0.98 1.00 0.99 1.00 
SumEntropy GLCM 0.99 1.00 0.82 0.96 0.93 0.99 0.76 0.93 0.94 0.99 
SumVariance GLCM 0.99 1.00 0.92 0.98 0.97 0.99 0.97 1.00 0.98 1.00 
Variance GLCM 0.99 1.00 0.71 0.60 0.98 0.87 0.87 0.93 0.94 0.98 
GrayLevelNonuniformity GLRLM 1.00 1.00 0.87 0.92 0.97 0.99 0.80 0.53 0.97 0.97 
HighGrayLevelRunEmpha GLRLM 0.99 1.00 0.92 0.97 0.97 0.98 0.98 0.99 0.98 1.00 
LongRunEmphasis GLRLM 0.99 1.00 0.93 0.94 0.96 0.99 0.62 0.59 0.97 0.99 
LongRunHighGrayLevelEm
pha GLRLM 0.99 0.99 0.88 0.82 0.98 0.99 0.80 0.62 0.95 0.96 
LongRunLowGrayLevelEm
pha GLRLM 1.00 1.00 0.80 0.95 0.85 0.97 0.73 0.62 0.96 0.99 
LowGrayLevelRunEmpha GLRLM 1.00 1.00 0.85 0.99 0.93 1.00 0.98 0.96 0.98 1.00 
RunLengthNonuniformity GLRLM 0.99 1.00 0.90 0.92 0.98 0.99 0.92 0.94 0.97 0.98 
RunPercentage GLRLM 0.99 1.00 0.93 0.93 0.98 0.99 0.87 0.96 0.98 0.99 
ShortRunEmphasis GLRLM 0.99 1.00 0.91 0.90 0.98 0.98 0.88 0.90 0.97 0.97 
ShortRunHighGrayLevelEm
pha GLRLM 0.99 1.00 0.92 0.98 0.97 0.99 0.98 0.99 0.98 1.00 
ShortRunLowGrayLevelEm
pha GLRLM 0.99 1.00 0.85 0.97 0.93 1.00 0.93 0.56 0.98 0.99 
EnergyNorm IH 0.99 1.00 0.94 0.99 0.98 1.00 0.98 1.00 0.98 1.00 
GlobalEntropy IH 0.97 1.00 0.65 0.68 0.83 0.86 0.87 0.92 0.85 0.96 
GlobalStd IH 0.99 1.00 0.63 0.72 0.96 0.91 0.89 0.99 0.88 0.98 
GlobalUniformity IH 0.99 1.00 0.59 0.70 0.79 0.86 0.90 0.93 0.90 0.96 
Kurtosis IH 1.00 1.00 0.74 0.74 0.85 0.85 0.98 0.98 0.96 0.96 
Skewness IH 1.00 1.00 0.95 0.95 0.99 0.99 1.00 1.00 1.00 1.00 
Variance IH 0.99 1.00 0.61 0.68 0.96 0.88 0.89 0.99 0.89 0.98 
Busyness NGTDM 0.99 0.99 0.90 0.73 0.93 0.71 0.71 0.50 0.97 0.92 
Coarseness NGTDM 1.00 1.00 0.84 0.60 0.95 0.87 0.94 0.81 0.99 0.97 
Complexity NGTDM 0.97 0.97 0.80 0.78 0.76 0.89 0.19 0.35 0.93 0.95 
Contrast NGTDM 0.98 0.98 0.76 0.85 0.92 0.96 0.69 0.56 0.91 0.94 
TextureStrength NGTDM 1.00 1.00 0.97 0.85 0.99 0.94 0.75 0.91 0.99 0.97 
Feature Category 0.99 1.00 0.92 0.99 0.97 0.99 0.97 1.00 0.98 1.00 
AutoCorrelation GLCM 0.99 1.00 0.70 0.51 0.97 0.78 0.90 0.94 0.92 0.98 
ClusterProminence GLCM 1.00 1.00 0.95 0.88 0.98 0.95 0.97 0.97 1.00 1.00 
ClusterShade GLCM 0.99 1.00 0.71 0.60 0.98 0.87 0.87 0.93 0.94 0.98 
Filter cutoff (subset): cutoff values < 6 mm 
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Table E-8. Siemens Scanner ICC Values for Protocol Parameters Changed Contd. 
  
Type of recon Iterations 
Iterations and 
subsets non-
TOF 
Iterations and 
subsets non-
TOF (subset) 
Feature Category 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
64 
levels 
fixed 
bin 
AutoCorrelation GLCM 0.96 0.99 0.95 1.00 0.80 0.97 0.95 1.00 
ClusterProminence GLCM 0.88 0.83 0.87 0.98 0.34 0.77 0.65 0.97 
ClusterShade GLCM 0.99 0.96 0.96 0.97 0.52 0.74 0.93 0.96 
ClusterTendendcy GLCM 0.91 0.88 0.82 0.96 0.09 0.48 0.69 0.86 
Contrast GLCM 0.97 0.97 0.93 0.96 0.77 0.69 0.94 0.95 
Correlation GLCM 0.97 0.97 0.97 0.97 0.72 0.71 0.93 0.93 
DifferenceEntropy GLCM 0.99 0.99 0.98 0.99 0.96 0.97 0.98 1.00 
Dissimilarity GLCM 0.99 0.99 0.96 0.98 0.90 0.87 0.97 0.98 
Energy GLCM 0.86 0.84 0.91 0.86 0.36 0.20 0.83 0.76 
Entropy GLCM 0.98 0.99 0.97 0.98 0.91 0.92 0.98 0.99 
Homogeneity GLCM 0.99 0.99 0.99 0.99 0.89 0.89 0.99 0.98 
Homogeneity2 GLCM 0.99 0.99 0.99 0.98 0.87 0.89 0.99 0.98 
InformationMeasureCorr1 GLCM 0.99 0.99 0.99 0.99 0.90 0.88 0.99 0.99 
InformationMeasureCorr2 GLCM 0.98 0.98 0.91 0.91 0.58 0.56 0.88 0.88 
InverseDiffMomentNorm GLCM 0.98 0.97 0.94 0.94 0.80 0.78 0.95 0.94 
InverseDiffNorm GLCM 0.99 0.99 0.97 0.97 0.92 0.92 0.97 0.97 
InverseVariance GLCM 0.99 0.98 0.98 0.94 0.90 0.10 0.97 0.91 
MaxProbability GLCM 0.71 0.77 0.78 0.83 0.40 0.40 0.82 0.81 
SumAverage GLCM 0.98 0.99 0.98 1.00 0.83 0.97 0.98 1.00 
SumEntropy GLCM 0.94 0.98 0.91 0.98 0.75 0.76 0.93 0.98 
SumVariance GLCM 0.96 0.99 0.94 1.00 0.80 0.97 0.94 1.00 
Variance GLCM 0.91 0.88 0.82 0.96 0.09 0.48 0.69 0.86 
GrayLevelNonuniformity GLRLM 0.93 0.91 0.98 0.94 0.97 0.49 0.99 0.92 
HighGrayLevelRunEmpha GLRLM 0.96 0.99 0.95 1.00 0.83 0.96 0.94 1.00 
LongRunEmphasis GLRLM 0.97 0.98 0.95 0.97 0.62 0.19 0.97 0.96 
LongRunHighGrayLevelEm
pha GLRLM 0.95 0.96 0.94 0.96 0.59 0.41 0.90 0.97 
LongRunLowGrayLevelEm
pha GLRLM 0.92 0.98 0.95 0.95 0.67 0.15 0.96 0.92 
LowGrayLevelRunEmpha GLRLM 0.95 0.98 0.98 0.99 0.88 0.96 0.96 1.00 
RunLengthNonuniformity GLRLM 0.97 0.99 0.98 0.97 0.74 0.88 0.96 0.98 
RunPercentage GLRLM 0.98 0.99 0.98 0.98 0.76 0.88 0.97 0.98 
ShortRunEmphasis GLRLM 0.96 0.98 0.98 0.95 0.63 0.78 0.95 0.98 
ShortRunHighGrayLevelEm
pha GLRLM 0.96 0.99 0.95 0.99 0.84 0.89 0.94 0.99 
ShortRunLowGrayLevelEm
pha GLRLM 0.94 0.95 0.97 0.93 0.79 0.38 0.92 0.93 
EnergyNorm IH 0.97 0.99 0.95 1.00 0.81 0.97 0.95 1.00 
GlobalEntropy IH 0.87 0.83 0.70 0.95 0.55 0.19 0.80 0.84 
GlobalStd IH 0.81 0.90 0.71 0.97 0.11 0.58 0.62 0.91 
GlobalUniformity IH 0.90 0.84 0.73 0.95 0.54 0.23 0.88 0.85 
Kurtosis IH 0.95 0.95 0.86 0.86 0.18 0.18 0.86 0.86 
Skewness IH 0.99 0.99 0.98 0.98 0.71 0.71 0.97 0.97 
Variance IH 0.82 0.90 0.71 0.97 0.11 0.66 0.61 0.90 
Busyness NGTDM 0.97 0.89 0.94 0.91 0.81 0.74 0.97 0.93 
Coarseness NGTDM 0.99 0.97 0.95 0.86 0.89 0.72 0.97 0.95 
Complexity NGTDM 0.91 0.88 0.91 0.91 0.51 0.64 0.92 0.90 
Contrast NGTDM 0.88 0.93 0.80 0.89 0.54 0.68 0.70 0.87 
TextureStrength NGTDM 0.99 0.92 0.97 0.98 0.97 0.79 0.99 0.98 
Feature Category 0.96 0.99 0.95 1.00 0.80 0.97 0.95 1.00 
AutoCorrelation GLCM 0.88 0.83 0.87 0.98 0.34 0.77 0.65 0.97 
ClusterProminence GLCM 0.99 0.96 0.96 0.97 0.52 0.74 0.93 0.96 
ClusterShade GLCM 0.91 0.88 0.82 0.96 0.09 0.48 0.69 0.86 
Iterations and subsets (subset): 16 ≤ effective iterations ≤ 24 
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Table E-9. Interscanner Standard Deviation Compared to NSCLC Interpatient Standard Deviation 
Feature Category 64 levels fixed bin 
AutoCorrelation GLCM 0.835 0.418 
ClusterProminence GLCM 1.856 0.099 
ClusterShade GLCM 2.987 0.576 
ClusterTendendcy GLCM 1.160 0.296 
Contrast GLCM 0.383 0.188 
Correlation GLCM 0.479 0.478 
DifferenceEntropy GLCM 0.776 0.602 
Dissimilarity GLCM 0.482 0.389 
Energy GLCM 3.697 3.117 
Entropy GLCM 0.702 0.708 
Homogeneity GLCM 1.107 0.890 
Homogeneity2 GLCM 1.301 0.949 
InformationMeasureCorr1 GLCM 0.421 0.732 
InformationMeasureCorr2 GLCM 0.422 0.364 
InverseDiffMomentNorm GLCM 0.363 0.379 
InverseDiffNorm GLCM 0.510 0.533 
InverseVariance GLCM 0.884 0.474 
MaxProbability GLCM 2.584 3.498 
SumAverage GLCM 0.912 0.569 
SumEntropy GLCM 0.843 0.529 
SumVariance GLCM 0.805 0.377 
Variance GLCM 1.160 0.296 
GrayLevelNonuniformity GLRLM 1.354 0.266 
HighGrayLevelRunEmpha GLRLM 0.813 0.404 
LongRunEmphasis GLRLM 3.035 2.419 
LongRunHighGrayLevelEmpha GLRLM 0.738 0.508 
LongRunLowGrayLevelEmpha GLRLM 1.991 3.633 
LowGrayLevelRunEmpha GLRLM 1.447 1.023 
RunLengthNonuniformity GLRLM 1.257 0.759 
RunPercentage GLRLM 1.628 1.001 
ShortRunEmphasis GLRLM 1.347 0.888 
ShortRunHighGrayLevelEmpha GLRLM 0.826 0.395 
ShortRunLowGrayLevelEmpha GLRLM 1.400 0.625 
EnergyNorm IH 0.841 0.391 
GlobalEntropy IH 0.554 0.265 
GlobalMax IH 0.000 0.327 
GlobalMean IH 0.928 0.600 
GlobalMedian IH 1.264 0.785 
GlobalMin IH 0.127 0.002 
GlobalStd IH 0.518 0.342 
GlobalUniformity IH 0.591 0.334 
Kurtosis IH 0.378 0.382 
Skewness IH 1.014 1.019 
Variance IH 0.708 0.279 
Busyness NGTDM 0.290 0.121 
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Coarseness NGTDM 0.983 1.739 
Complexity NGTDM 0.832 0.120 
Contrast NGTDM 0.182 0.432 
TextureStrength NGTDM 0.534 0.219 
 
Each value is: standard deviation from standard-protocol scans of phantom/standard deviation from NSCLC patients 
Highlighted values are those features with the phantom-scan mean more than 2 standard deviations away from patient-scan 
mean  
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Appendix F: Supplemental Material for Chapter 9 
 
 
Table F-1. Radiomics Features used in CT Analysis 
 Gray Level Co-occurrence Matrix Gray Level Run Length Matrix Intensity Histogram Neighborhood Gray Tone Difference Matrix 
 Auto Correlation Gray Level Nonuniformity Energy Busyness 
 Cluster Prominence High Gray Level Run Emphasis Entropy Coarseness 
 Cluster Shade Long Run Emphasis Kurtosis Complexity 
 Cluster Tendency Long Run High Gray Level Emphasis Mean Contrast 
 Contrast Long Run Low Gray Level Emphasis Median Texture Strength 
 Correlation Low Gray Level Run Emphasis Minimum  
 Difference Entropy Run Length Nonuniformity Skewness  
 Dissimilarity Run Percentage Standard Deviation  
 Energy Short Run Emphasis Uniformity  
 Entropy Short Run High Gray Level Emphasis Variance  
 Homogeneity Short Run Low Gray Level Emphasis   
 Homogeneity 2    
 Information Measure Correlation 1    
 Information Measure Correlation 2    
 Inverse Difference Moment Norm    
 Inverse Difference Norm    
 Inverse Variance    
 Max Probability    
 Sum Average    
 Sum Entropy    
 Sum Variance    
 Variance    
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Table F-2. Radiomics Features used in PET Analysis 
 Gray Level Co-occurrence Matrix Gray Level Run Length Matrix Intensity Histogram Neighborhood Gray Tone Difference Matrix 
 Auto Correlation Gray Level Nonuniformity Energy Busyness 
 Cluster Prominence High Gray Level Run Emphasis Entropy Coarseness 
 Cluster Shade Long Run Emphasis Kurtosis Complexity 
 Cluster Tendency Long Run High Gray Level Emphasis Maximum Contrast 
 Contrast Long Run Low Gray Level Emphasis Mean Texture Strength 
 Correlation Low Gray Level Run Emphasis Median  
 Difference Entropy Run Length Nonuniformity Minimum  
 Dissimilarity Run Percentage Skewness  
 Energy Short Run Emphasis Standard Deviation  
 Entropy Short Run High Gray Level Emphasis Uniformity  
 Homogeneity Short Run Low Gray Level Emphasis Variance  
 Homogeneity 2    
 Information Measure Correlation 1    
 Information Measure Correlation 2    
 Inverse Difference Moment Norm    
 Inverse Difference Norm    
 Inverse Variance    
 Max Probability    
 Sum Average    
 Sum Entropy    
 Sum Variance    
 Variance    
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Table F-3. Results of CT Patient Models 
Subset of 
Patients 
Patients in 
training 
Patients in 
testing 
Covariates in 
final model 
p-value of 
covariates 
when fit on 
testing data 
AUC 
Same imaging 
protocol 
260 251 HPV status 
 
Cluster tendency 
(GLCM) 
calculated using 
thresholding,  
smoothing, and 
bit depth 
resampling 
p = 0.79 
 
p = 0.90 
0.55 
Same imaging 
protocol HPV 
positive 
168 152 Complexity 
(NGTDM) 
calculated using 
thresholding and 
smoothing 
p = 0.16 
 
0.65 
Same imaging 
protocol HPV 
negative 
92 99 Volume p = 0.001 
 
 
 
 
0.62 
HPV positive 224 189 Volume 
 
Complexity 
(NGTDM) 
calculated using 
thresholding 
p = 2.1 x 10-4 
 
p = 0.26 
0.75 
(volume 
alone 0.76) 
HPV negative 153 160 Volume 
 
Sum entropy 
(GLCM) 
calculated using 
thresholding  
p = 3.6 x 10-4 
 
p = 0.021 
0.65 
(volume 
alone 0.72) 
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Oropharynx 362 324 Volume 
 
HPV status 
 
Contrast (GLCM) 
calculated using 
thresholding 
 
Information 
measure 
correlation 2 
(GLCM) 
calculated using 
thresholding, 
smoothing, and 
bit depth 
resampling 
p = 0.013 
 
p = 0.19 
 
p = 0.94 
 
 
 
 
p = 0.060 
0.69 
(volume 
alone 0.71) 
Oropharynx HPV 
positive 
224 189 Volume 
 
Complexity 
(NGTDM) 
calculated using 
thresholding 
p = 2.1 x 10-4 
 
p = 0.26 
0.75 
(volume 
alone 0.76) 
Oropharynx HPV 
negative 
138 135 Volume 
 
Sum entropy 
(GLCM) 
calculated using 
thresholding 
p = 0.012 
 
p = 0.13 
 
0.64 
(volume 
alone 0.68) 
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Table F-4. Results of PET Patient Models 
Subset of Patients Patients in 
training 
Patients in 
testing 
Covariates in 
final model 
p-value of 
covariates 
when fit on 
testing data 
AUC 
Same imaging 
protocol 
144 167  None  
 
 
Same imaging 
protocol HPV 
positive 
117 137 None   
Same imaging 
protocol HPV 
negative 
27 30 None   
HPV positive 207 206 Coarseness 
(NGTDM) 
calculated using 
64 gray levels 
 
Sum average 
(GLCM) 
calculated using 
64 gray levels 
p = 0.28 
 
 
 
p = 0.85 
0.55 
HPV negative 138 135 None   
Oropharynx 318 310 HPV status 
 
Coarseness 
(NGTDM) 
calculated using 
fixed bin width 
p = 0.61 
 
p = 0.20 
 
0.58 
Oropharynx HPV 
positive 
206 206 Coarseness 
(NGTDM) 
calculated using 
64 gray levels 
p = 0.28 
 
0.59 
Oropharynx HPV 
negative 
112 104 None   
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